Search Results

Cancer LncRNAID LncRNAName SubpathwayID PathwayName GeneNumber t Pvalue pAdj Cytoscape
OV ENSG00000248015 AC005329.7 path:00564_69 Glycerophospholipid metabolism 13 4.51457269871885 1.88571648769571e-05 0.00358286132662184
OV ENSG00000248015 AC005329.7 path:04012_51 ErbB signaling pathway 37 3.6928489076753 0.000466805495665125 0.0253408697646782
OV ENSG00000248015 AC005329.7 path:04066_123 HIF-1 signaling pathway 6 -6.05789117389942 3.77265266868722e-07 0.000143360801410114
OV ENSG00000248015 AC005329.7 path:04510_223 Focal adhesion 15 3.66387953312694 0.000442389273098165 0.0253408697646782
OV ENSG00000248015 AC005329.7 path:04910_133 Insulin signaling pathway 9 -4.55038533428259 3.64275836224858e-05 0.00461416059218153
OV ENSG00000248015 AC005329.7 path:04916_110 Melanogenesis 11 -3.75623877038534 0.000434097682773682 0.0253408697646782
OV ENSG00000248015 AC005329.7 path:05032_55 Morphine addiction 30 4.32084071166962 5.40324419943096e-05 0.00513308198945941
OV ENSG00000269688 AC008982.2 path:00250_24 Alanine, aspartate and glutamate metabolism 14 3.23798086474749 0.00135018104872506 0.031292431364569
OV ENSG00000269688 AC008982.2 path:00260_1 Glycine, serine and threonine metabolism 29 3.03261363503718 0.00266044500637803 0.0476461514778612
OV ENSG00000269688 AC008982.2 path:00500_1 Starch and sucrose metabolism 32 3.55510376853031 0.000444362149863924 0.0145898905871988
OV ENSG00000269688 AC008982.2 path:00520_3 Amino sugar and nucleotide sugar metabolism 29 4.02531976991084 7.53507346718925e-05 0.0042411699229608
OV ENSG00000269688 AC008982.2 path:00564_46 Glycerophospholipid metabolism 26 4.28188635362308 2.59146126814265e-05 0.00204207147929641
OV ENSG00000269688 AC008982.2 path:00565_8 Ether lipid metabolism 23 3.94176523942678 0.00010559102059269 0.00520035776418996
OV ENSG00000269688 AC008982.2 path:03015_27 mRNA surveillance pathway 5 3.3785356299539 0.000829156068670909 0.0217791660704225
OV ENSG00000269688 AC008982.2 path:04014_180 Ras signaling pathway 7 3.74281687145899 0.000220633845717546 0.00963442182487266
OV ENSG00000269688 AC008982.2 path:04020_172 Calcium signaling pathway 19 3.09460155654882 0.0021700779742067 0.0427185653609692
OV ENSG00000269688 AC008982.2 path:04022_118 cGMP-PKG signaling pathway 8 3.34739671457872 0.000929862323714552 0.0228978597214709
OV ENSG00000269688 AC008982.2 path:04115_18 p53 signaling pathway 8 3.39294894700735 0.000798708528619853 0.0217791660704225
OV ENSG00000269688 AC008982.2 path:04728_237 Dopaminergic synapse 4 6.95136655329171 3.24022077968637e-11 6.38323493598214e-09
OV ENSG00000269688 AC008982.2 path:04744_5 Phototransduction 5 3.50159009513366 0.000535984246369104 0.0162444456207251
OV ENSG00000269688 AC008982.2 path:04810_222 Regulation of actin cytoskeleton 7 6.07144615347655 4.62508756380099e-09 6.0742816671253e-07
OV ENSG00000269688 AC008982.2 path:04921_202 Oxytocin signaling pathway 5 3.17595840812236 0.00166649491756045 0.0345578419746747
OV ENSG00000269688 AC008982.2 path:04922_4 Glucagon signaling pathway 76 3.72311842466283 0.000244528472712504 0.00963442182487266
OV ENSG00000269688 AC008982.2 path:04930_3 Type II diabetes mellitus 38 -3.08426068747438 0.00227687784918872 0.0427185653609692
OV ENSG00000269688 AC008982.2 path:04971_45 Gastric acid secretion 7 3.56091041538407 0.000432650288711969 0.0145898905871988
OV ENSG00000269688 AC008982.2 path:05161_36 Hepatitis B 49 3.1989995584333 0.00155966327393143 0.0341392961071658
OV ENSG00000269688 AC008982.2 path:05206_134 MicroRNAs in cancer 3 8.08445645150367 2.82070832522952e-14 1.11135908014043e-11
OV ENSG00000269688 AC008982.2 path:05212_36 Pancreatic cancer 8 4.32592385203328 2.1173206285541e-05 0.00204207147929641
OV ENSG00000269688 AC008982.2 path:05221_48 Acute myeloid leukemia 10 4.01905220957872 7.48023288073058e-05 0.0042411699229608
OV ENSG00000223884 AC019048.1 path:00410_21 beta-Alanine metabolism 5 -3.69158749213393 0.00036979250997791 0.0477032337871503
OV ENSG00000223884 AC019048.1 path:00740_1 Riboflavin metabolism 8 -5.20430951479565 1.07651299466018e-06 0.000416610528933491
OV ENSG00000223884 AC019048.1 path:04115_5 p53 signaling pathway 64 -4.4413410290748 2.38422868626104e-05 0.00461348250791512
OV ENSG00000260279 AC137932.5 path:00360_9 Phenylalanine metabolism 8 -3.82309377003417 0.00024841972236511 0.0212647282344534
OV ENSG00000260279 AC137932.5 path:04151_204 PI3K-Akt signaling pathway 38 4.22755389932184 4.05057658384008e-05 0.00577882259294519
OV ENSG00000260279 AC137932.5 path:04510_112 Focal adhesion 44 4.07963859642916 7.59020643159256e-05 0.00812152088180403
OV ENSG00000260279 AC137932.5 path:04510_250 Focal adhesion 13 3.62601307314756 0.000392182022308337 0.0279756509246614
OV ENSG00000260279 AC137932.5 path:04512_32 ECM-receptor interaction 49 4.23377784206805 3.95335021584829e-05 0.00577882259294519
OV ENSG00000260279 AC137932.5 path:04611_46 Platelet activation 56 4.27477782678233 3.4139493896568e-05 0.00577882259294519
OV ENSG00000260279 AC137932.5 path:05215_109 Prostate cancer 5 3.52539210324215 0.000496758070748045 0.030373207754309
OV ENSG00000229047 AF127577.10 path:00260_35 Glycine, serine and threonine metabolism 13 -3.51000010712623 0.000542112243896796 0.0336109591216014
OV ENSG00000229047 AF127577.10 path:00600_74 Sphingolipid metabolism 2 3.7254943094246 0.000266569668905985 0.0198327833666053
OV ENSG00000229047 AF127577.10 path:04062_310 Chemokine signaling pathway 4 -4.65671777973551 5.45291604725896e-06 0.00202848476958033
OV ENSG00000229047 AF127577.10 path:04611_235 Platelet activation 7 -3.81852461676631 0.000179471303141547 0.0166908311921638
OV ENSG00000229047 AF127577.10 path:04670_125 Leukocyte transendothelial migration 11 -4.13582586075778 5.06325642619672e-05 0.00627843796848394
OV ENSG00000229047 AF127577.10 path:04670_72 Leukocyte transendothelial migration 30 -3.46499648541352 0.000661010071956497 0.0351279638239738
OV ENSG00000229047 AF127577.10 path:05210_31 Colorectal cancer 8 -4.14724608397788 4.7856793004485e-05 0.00627843796848394
OV ENSG00000231201 AF127577.11 path:00260_35 Glycine, serine and threonine metabolism 13 -3.51000010712623 0.000542112243896796 0.0336109591216014
OV ENSG00000231201 AF127577.11 path:00600_74 Sphingolipid metabolism 2 3.7254943094246 0.000266569668905985 0.0198327833666053
OV ENSG00000231201 AF127577.11 path:04062_310 Chemokine signaling pathway 4 -4.65671777973551 5.45291604725896e-06 0.00202848476958033
OV ENSG00000231201 AF127577.11 path:04611_235 Platelet activation 7 -3.81852461676631 0.000179471303141547 0.0166908311921638
OV ENSG00000231201 AF127577.11 path:04670_125 Leukocyte transendothelial migration 11 -4.13582586075778 5.06325642619672e-05 0.00627843796848394
OV ENSG00000231201 AF127577.11 path:04670_72 Leukocyte transendothelial migration 30 -3.46499648541352 0.000661010071956497 0.0351279638239738
OV ENSG00000231201 AF127577.11 path:05210_31 Colorectal cancer 8 -4.14724608397788 4.7856793004485e-05 0.00627843796848394
OV ENSG00000236471 AF127577.12 path:00260_35 Glycine, serine and threonine metabolism 13 -3.41318857241423 0.000765037415897805 0.0406562741019976
OV ENSG00000236471 AF127577.12 path:00600_74 Sphingolipid metabolism 2 3.64181220030239 0.000363413733390173 0.0270379817642289
OV ENSG00000236471 AF127577.12 path:04062_310 Chemokine signaling pathway 4 -4.64475740887941 5.81192530509515e-06 0.00216203621349539
OV ENSG00000236471 AF127577.12 path:04611_235 Platelet activation 7 -3.71540300582328 0.000265211147485972 0.0246646367161954
OV ENSG00000236471 AF127577.12 path:04670_125 Leukocyte transendothelial migration 11 -4.05243100803797 7.11882935803558e-05 0.00882734840396412
OV ENSG00000236471 AF127577.12 path:04670_72 Leukocyte transendothelial migration 30 -3.47094528685008 0.000650861017560797 0.0403533830887694
OV ENSG00000236471 AF127577.12 path:05210_31 Colorectal cancer 8 -4.11263998430382 5.5443698361365e-05 0.00882734840396412
OV ENSG00000235277 AF127577.8 path:00260_35 Glycine, serine and threonine metabolism 13 -3.50879856736519 0.000542304405111483 0.033622873116912
OV ENSG00000235277 AF127577.8 path:00600_74 Sphingolipid metabolism 2 3.53933487207693 0.000518778217361573 0.033622873116912
OV ENSG00000235277 AF127577.8 path:04062_310 Chemokine signaling pathway 4 -4.63376260080064 5.97771405150438e-06 0.00222370962715963
OV ENSG00000235277 AF127577.8 path:04611_235 Platelet activation 7 -3.82018216723213 0.000177195217148101 0.0164791551947734
OV ENSG00000235277 AF127577.8 path:04670_125 Leukocyte transendothelial migration 11 -4.11603370885284 5.44407675966019e-05 0.00675065518197864
OV ENSG00000235277 AF127577.8 path:05210_31 Colorectal cancer 8 -4.16640389210088 4.39531172359593e-05 0.00675065518197864
OV ENSG00000232884 AF127936.3 path:00260_35 Glycine, serine and threonine metabolism 13 -3.41318857241423 0.000765037415897805 0.0406562741019976
OV ENSG00000232884 AF127936.3 path:00600_74 Sphingolipid metabolism 2 3.64181220030239 0.000363413733390173 0.0270379817642289
OV ENSG00000232884 AF127936.3 path:04062_310 Chemokine signaling pathway 4 -4.64475740887941 5.81192530509515e-06 0.00216203621349539
OV ENSG00000232884 AF127936.3 path:04611_235 Platelet activation 7 -3.71540300582328 0.000265211147485972 0.0246646367161954
OV ENSG00000232884 AF127936.3 path:04670_125 Leukocyte transendothelial migration 11 -4.05243100803797 7.11882935803558e-05 0.00882734840396412
OV ENSG00000232884 AF127936.3 path:04670_72 Leukocyte transendothelial migration 30 -3.47094528685008 0.000650861017560797 0.0403533830887694
OV ENSG00000232884 AF127936.3 path:05210_31 Colorectal cancer 8 -4.11263998430382 5.5443698361365e-05 0.00882734840396412
OV ENSG00000226751 AF127936.5 path:00260_35 Glycine, serine and threonine metabolism 13 -3.41318857241423 0.000765037415897805 0.0406562741019976
OV ENSG00000226751 AF127936.5 path:00600_74 Sphingolipid metabolism 2 3.64181220030239 0.000363413733390173 0.0270379817642289
OV ENSG00000226751 AF127936.5 path:04062_310 Chemokine signaling pathway 4 -4.64475740887941 5.81192530509515e-06 0.00216203621349539
OV ENSG00000226751 AF127936.5 path:04611_235 Platelet activation 7 -3.71540300582328 0.000265211147485972 0.0246646367161954
OV ENSG00000226751 AF127936.5 path:04670_125 Leukocyte transendothelial migration 11 -4.05243100803797 7.11882935803558e-05 0.00882734840396412
OV ENSG00000226751 AF127936.5 path:04670_72 Leukocyte transendothelial migration 30 -3.47094528685008 0.000650861017560797 0.0403533830887694
OV ENSG00000226751 AF127936.5 path:05210_31 Colorectal cancer 8 -4.11263998430382 5.5443698361365e-05 0.00882734840396412
OV ENSG00000235609 AF127936.9 path:00260_35 Glycine, serine and threonine metabolism 13 -3.41318857241423 0.000765037415897805 0.0406562741019976
OV ENSG00000235609 AF127936.9 path:00600_74 Sphingolipid metabolism 2 3.64181220030239 0.000363413733390173 0.0270379817642289
OV ENSG00000235609 AF127936.9 path:04062_310 Chemokine signaling pathway 4 -4.64475740887941 5.81192530509515e-06 0.00216203621349539
OV ENSG00000235609 AF127936.9 path:04611_235 Platelet activation 7 -3.71540300582328 0.000265211147485972 0.0246646367161954
OV ENSG00000235609 AF127936.9 path:04670_125 Leukocyte transendothelial migration 11 -4.05243100803797 7.11882935803558e-05 0.00882734840396412
OV ENSG00000235609 AF127936.9 path:04670_72 Leukocyte transendothelial migration 30 -3.47094528685008 0.000650861017560797 0.0403533830887694
OV ENSG00000235609 AF127936.9 path:05210_31 Colorectal cancer 8 -4.11263998430382 5.5443698361365e-05 0.00882734840396412
OV ENSG00000258604 AL161668.5 path:03460_61 Fanconi anemia pathway 2 -4.28780200535 2.49714012617544e-05 0.0107377025425544
OV ENSG00000259430 CERS3-AS1 path:00230_7 Purine metabolism 131 3.66788400119959 0.000316284666357069 0.0331308188009029
OV ENSG00000259430 CERS3-AS1 path:00620_13 Pyruvate metabolism 25 3.38241818844834 0.000848129798293117 0.0394851539427573
OV ENSG00000259430 CERS3-AS1 path:04015_113 Rap1 signaling pathway 31 -3.54341985167259 0.000461383557118581 0.0386639420865371
OV ENSG00000259430 CERS3-AS1 path:04015_165 Rap1 signaling pathway 11 4.23678670103596 3.80528870849527e-05 0.0159441596885952
OV ENSG00000259430 CERS3-AS1 path:04210_51 Apoptosis 27 -3.47357166895856 0.00061733593691024 0.0394359645578652
OV ENSG00000259430 CERS3-AS1 path:04360_145 Axon guidance 8 -3.46177950672123 0.000658910191411421 0.0394359645578652
OV ENSG00000259430 CERS3-AS1 path:05120_21 Epithelial cell signaling in Helicobacter pylori infection 3 3.91674291382661 0.000128479965837864 0.0269165528430326
OV ENSG00000259430 CERS3-AS1 path:05162_31 Measles 9 -3.7336434617593 0.000231215128259826 0.0322930462469558
OV ENSG00000259430 CERS3-AS1 path:05206_26 MicroRNAs in cancer 97 -3.4080242258611 0.000752953977238477 0.0394359645578652
OV ENSG00000267317 CTB-25B13.12 path:00280_35 Valine, leucine and isoleucine degradation 22 3.39228393669082 0.000997850992501503 0.0344712161045974
OV ENSG00000267317 CTB-25B13.12 path:00564_69 Glycerophospholipid metabolism 13 4.52175616471624 1.80797537133342e-05 0.00229010213702233
OV ENSG00000267317 CTB-25B13.12 path:04012_51 ErbB signaling pathway 37 3.57678281661143 0.000725550688638382 0.0306343624091761
OV ENSG00000267317 CTB-25B13.12 path:04066_123 HIF-1 signaling pathway 6 -5.94271653147828 7.08712709730901e-07 0.000269310829697742
OV ENSG00000267317 CTB-25B13.12 path:04370_82 VEGF signaling pathway 10 3.40582862552646 0.000823776828679565 0.0313035194898235
OV ENSG00000267317 CTB-25B13.12 path:04510_223 Focal adhesion 15 3.89956863302923 0.000203639541822442 0.012897170982088
OV ENSG00000267317 CTB-25B13.12 path:04725_135 Cholinergic synapse 6 4.97687197142129 1.83966467294001e-06 0.000349536287858603
OV ENSG00000267317 CTB-25B13.12 path:04910_133 Insulin signaling pathway 9 -4.40784257494742 6.65409473027924e-05 0.00625195412576587
OV ENSG00000267317 CTB-25B13.12 path:04916_110 Melanogenesis 11 -3.73491810833325 0.000502632969345889 0.0238750660439297
OV ENSG00000267317 CTB-25B13.12 path:05032_55 Morphine addiction 30 4.2330081568506 8.2262554286393e-05 0.00625195412576587
OV ENSG00000267317 CTB-25B13.12 path:05215_106 Prostate cancer 5 3.60294604249466 0.00044204289578129 0.0238750660439297
OV ENSG00000267317 CTB-25B13.12 path:05221_56 Acute myeloid leukemia 5 -3.38698169266325 0.00146891795309623 0.0465157351813806
OV ENSG00000267092 CTB-25B13.9 path:00280_35 Valine, leucine and isoleucine degradation 22 3.39228393669082 0.000997850992501503 0.0344712161045974
OV ENSG00000267092 CTB-25B13.9 path:00564_69 Glycerophospholipid metabolism 13 4.52175616471624 1.80797537133342e-05 0.00229010213702233
OV ENSG00000267092 CTB-25B13.9 path:04012_51 ErbB signaling pathway 37 3.57678281661143 0.000725550688638382 0.0306343624091761
OV ENSG00000267092 CTB-25B13.9 path:04066_123 HIF-1 signaling pathway 6 -5.94271653147828 7.08712709730901e-07 0.000269310829697742
OV ENSG00000267092 CTB-25B13.9 path:04370_82 VEGF signaling pathway 10 3.40582862552646 0.000823776828679565 0.0313035194898235
OV ENSG00000267092 CTB-25B13.9 path:04510_223 Focal adhesion 15 3.89956863302923 0.000203639541822442 0.012897170982088
OV ENSG00000267092 CTB-25B13.9 path:04725_135 Cholinergic synapse 6 4.97687197142129 1.83966467294001e-06 0.000349536287858603
OV ENSG00000267092 CTB-25B13.9 path:04910_133 Insulin signaling pathway 9 -4.40784257494742 6.65409473027924e-05 0.00625195412576587
OV ENSG00000267092 CTB-25B13.9 path:04916_110 Melanogenesis 11 -3.73491810833325 0.000502632969345889 0.0238750660439297
OV ENSG00000267092 CTB-25B13.9 path:05032_55 Morphine addiction 30 4.2330081568506 8.2262554286393e-05 0.00625195412576587
OV ENSG00000267092 CTB-25B13.9 path:05215_106 Prostate cancer 5 3.60294604249466 0.00044204289578129 0.0238750660439297
OV ENSG00000267092 CTB-25B13.9 path:05221_56 Acute myeloid leukemia 5 -3.38698169266325 0.00146891795309623 0.0465157351813806
OV ENSG00000269050 CTC-360G5.6 path:00250_24 Alanine, aspartate and glutamate metabolism 14 3.23798086474749 0.00135018104872506 0.031292431364569
OV ENSG00000269050 CTC-360G5.6 path:00260_1 Glycine, serine and threonine metabolism 29 3.03261363503718 0.00266044500637803 0.0476461514778612
OV ENSG00000269050 CTC-360G5.6 path:00500_1 Starch and sucrose metabolism 32 3.55510376853031 0.000444362149863924 0.0145898905871988
OV ENSG00000269050 CTC-360G5.6 path:00520_3 Amino sugar and nucleotide sugar metabolism 29 4.02531976991084 7.53507346718925e-05 0.0042411699229608
OV ENSG00000269050 CTC-360G5.6 path:00564_46 Glycerophospholipid metabolism 26 4.28188635362308 2.59146126814265e-05 0.00204207147929641
OV ENSG00000269050 CTC-360G5.6 path:00565_8 Ether lipid metabolism 23 3.94176523942678 0.00010559102059269 0.00520035776418996
OV ENSG00000269050 CTC-360G5.6 path:03015_27 mRNA surveillance pathway 5 3.3785356299539 0.000829156068670909 0.0217791660704225
OV ENSG00000269050 CTC-360G5.6 path:04014_180 Ras signaling pathway 7 3.74281687145899 0.000220633845717546 0.00963442182487266
OV ENSG00000269050 CTC-360G5.6 path:04020_172 Calcium signaling pathway 19 3.09460155654882 0.0021700779742067 0.0427185653609692
OV ENSG00000269050 CTC-360G5.6 path:04022_118 cGMP-PKG signaling pathway 8 3.34739671457872 0.000929862323714552 0.0228978597214709
OV ENSG00000269050 CTC-360G5.6 path:04115_18 p53 signaling pathway 8 3.39294894700735 0.000798708528619853 0.0217791660704225
OV ENSG00000269050 CTC-360G5.6 path:04728_237 Dopaminergic synapse 4 6.95136655329171 3.24022077968637e-11 6.38323493598214e-09
OV ENSG00000269050 CTC-360G5.6 path:04744_5 Phototransduction 5 3.50159009513366 0.000535984246369104 0.0162444456207251
OV ENSG00000269050 CTC-360G5.6 path:04810_222 Regulation of actin cytoskeleton 7 6.07144615347655 4.62508756380099e-09 6.0742816671253e-07
OV ENSG00000269050 CTC-360G5.6 path:04921_202 Oxytocin signaling pathway 5 3.17595840812236 0.00166649491756045 0.0345578419746747
OV ENSG00000269050 CTC-360G5.6 path:04922_4 Glucagon signaling pathway 76 3.72311842466283 0.000244528472712504 0.00963442182487266
OV ENSG00000269050 CTC-360G5.6 path:04930_3 Type II diabetes mellitus 38 -3.08426068747438 0.00227687784918872 0.0427185653609692
OV ENSG00000269050 CTC-360G5.6 path:04971_45 Gastric acid secretion 7 3.56091041538407 0.000432650288711969 0.0145898905871988
OV ENSG00000269050 CTC-360G5.6 path:05161_36 Hepatitis B 49 3.1989995584333 0.00155966327393143 0.0341392961071658
OV ENSG00000269050 CTC-360G5.6 path:05206_134 MicroRNAs in cancer 3 8.08445645150367 2.82070832522952e-14 1.11135908014043e-11
OV ENSG00000269050 CTC-360G5.6 path:05212_36 Pancreatic cancer 8 4.32592385203328 2.1173206285541e-05 0.00204207147929641
OV ENSG00000269050 CTC-360G5.6 path:05221_48 Acute myeloid leukemia 10 4.01905220957872 7.48023288073058e-05 0.0042411699229608
OV ENSG00000269486 CTC-360G5.9 path:00010_30 Glycolysis / Gluconeogenesis 27 3.22459606929424 0.00142004062304465 0.0294471581831364
OV ENSG00000269486 CTC-360G5.9 path:00250_24 Alanine, aspartate and glutamate metabolism 14 3.34758712905166 0.000927312616765419 0.0260972265003982
OV ENSG00000269486 CTC-360G5.9 path:00260_1 Glycine, serine and threonine metabolism 29 3.31582733088405 0.00103949022935419 0.0273039433577034
OV ENSG00000269486 CTC-360G5.9 path:00500_1 Starch and sucrose metabolism 32 3.54338877448074 0.000464227723834399 0.0182905723190753
OV ENSG00000269486 CTC-360G5.9 path:00520_3 Amino sugar and nucleotide sugar metabolism 29 4.01417817690459 7.85226899286482e-05 0.00386724247898592
OV ENSG00000269486 CTC-360G5.9 path:00564_46 Glycerophospholipid metabolism 26 4.27076472757119 2.7228931199185e-05 0.00268204972311972
OV ENSG00000269486 CTC-360G5.9 path:00565_8 Ether lipid metabolism 23 4.0617929397201 6.57328275962518e-05 0.00369981915327474
OV ENSG00000269486 CTC-360G5.9 path:00620_11 Pyruvate metabolism 26 3.18803729174657 0.00159777913323047 0.0314762489246402
OV ENSG00000269486 CTC-360G5.9 path:04014_180 Ras signaling pathway 7 3.71450291805353 0.000245327639942528 0.0107398989041506
OV ENSG00000269486 CTC-360G5.9 path:04020_172 Calcium signaling pathway 19 3.23305317174767 0.00137051656208181 0.0294471581831364
OV ENSG00000269486 CTC-360G5.9 path:04115_18 p53 signaling pathway 8 3.49030565485916 0.000565010513092283 0.020115854315116
OV ENSG00000269486 CTC-360G5.9 path:04728_237 Dopaminergic synapse 4 6.84010956433919 6.36091679671172e-11 1.25310060895221e-08
OV ENSG00000269486 CTC-360G5.9 path:04744_5 Phototransduction 5 3.23100016354518 0.00137694794789744 0.0294471581831364
OV ENSG00000269486 CTC-360G5.9 path:04810_222 Regulation of actin cytoskeleton 7 5.65146382826863 4.2882612473054e-08 5.63191643812776e-06
OV ENSG00000269486 CTC-360G5.9 path:04921_202 Oxytocin signaling pathway 5 3.36572722333577 0.000873473509572081 0.0260972265003982
OV ENSG00000269486 CTC-360G5.9 path:04922_4 Glucagon signaling pathway 76 3.47093753809287 0.000612665613658357 0.020115854315116
OV ENSG00000269486 CTC-360G5.9 path:04930_3 Type II diabetes mellitus 38 -3.09005452504496 0.00223238143432465 0.0418837278630434
OV ENSG00000269486 CTC-360G5.9 path:04971_45 Gastric acid secretion 7 3.23202268154106 0.00137282118630337 0.0294471581831364
OV ENSG00000269486 CTC-360G5.9 path:05206_134 MicroRNAs in cancer 3 8.17349468728991 1.62937883801212e-14 6.41975262176776e-12
OV ENSG00000269486 CTC-360G5.9 path:05212_36 Pancreatic cancer 8 4.14126537892709 4.56742749581509e-05 0.00299927738891857
OV ENSG00000269486 CTC-360G5.9 path:05221_48 Acute myeloid leukemia 10 4.19370641592321 3.66123148503253e-05 0.00288505041020564
OV ENSG00000258714 ENSG00000258714 path:03460_61 Fanconi anemia pathway 2 -4.60119415723038 6.42586644633312e-06 0.00276312257192324
OV ENSG00000258714 ENSG00000258714 path:04530_221 Tight junction 2 3.75039737925368 0.00021589088269476 0.0464165397793734
OV ENSG00000260637 ENSG00000260637 path:00360_9 Phenylalanine metabolism 8 -3.7269893497186 0.000350320256762902 0.0276107344596041
OV ENSG00000260637 ENSG00000260637 path:04151_204 PI3K-Akt signaling pathway 38 4.1748246059085 5.07939190923719e-05 0.00724659912384505
OV ENSG00000260637 ENSG00000260637 path:04510_112 Focal adhesion 44 4.02699812613518 9.43639112312957e-05 0.0100969385017486
OV ENSG00000260637 ENSG00000260637 path:04510_250 Focal adhesion 13 3.63266287356303 0.000387066370929029 0.0276107344596041
OV ENSG00000260637 ENSG00000260637 path:04512_32 ECM-receptor interaction 49 4.17854234772487 5.00795779595536e-05 0.00724659912384505
OV ENSG00000260637 ENSG00000260637 path:04611_46 Platelet activation 56 4.22594834957973 4.22454094829659e-05 0.00724659912384505
OV ENSG00000260637 ENSG00000260637 path:05215_109 Prostate cancer 5 3.46870718919722 0.000610113925052499 0.0373041085603528
OV ENSG00000266926 ENSG00000266926 path:00280_35 Valine, leucine and isoleucine degradation 22 3.39228393669082 0.000997850992501503 0.0344712161045974
OV ENSG00000266926 ENSG00000266926 path:00564_69 Glycerophospholipid metabolism 13 4.52175616471624 1.80797537133342e-05 0.00229010213702233
OV ENSG00000266926 ENSG00000266926 path:04012_51 ErbB signaling pathway 37 3.57678281661143 0.000725550688638382 0.0306343624091761
OV ENSG00000266926 ENSG00000266926 path:04066_123 HIF-1 signaling pathway 6 -5.94271653147828 7.08712709730901e-07 0.000269310829697742
OV ENSG00000266926 ENSG00000266926 path:04370_82 VEGF signaling pathway 10 3.40582862552646 0.000823776828679565 0.0313035194898235
OV ENSG00000266926 ENSG00000266926 path:04510_223 Focal adhesion 15 3.89956863302923 0.000203639541822442 0.012897170982088
OV ENSG00000266926 ENSG00000266926 path:04725_135 Cholinergic synapse 6 4.97687197142129 1.83966467294001e-06 0.000349536287858603
OV ENSG00000266926 ENSG00000266926 path:04910_133 Insulin signaling pathway 9 -4.40784257494742 6.65409473027924e-05 0.00625195412576587
OV ENSG00000266926 ENSG00000266926 path:04916_110 Melanogenesis 11 -3.73491810833325 0.000502632969345889 0.0238750660439297
OV ENSG00000266926 ENSG00000266926 path:05032_55 Morphine addiction 30 4.2330081568506 8.2262554286393e-05 0.00625195412576587
OV ENSG00000266926 ENSG00000266926 path:05215_106 Prostate cancer 5 3.60294604249466 0.00044204289578129 0.0238750660439297
OV ENSG00000266926 ENSG00000266926 path:05221_56 Acute myeloid leukemia 5 -3.38698169266325 0.00146891795309623 0.0465157351813806
OV ENSG00000267161 ENSG00000267161 path:00280_35 Valine, leucine and isoleucine degradation 22 3.39228393669082 0.000997850992501503 0.0344712161045974
OV ENSG00000267161 ENSG00000267161 path:00564_69 Glycerophospholipid metabolism 13 4.52175616471624 1.80797537133342e-05 0.00229010213702233
OV ENSG00000267161 ENSG00000267161 path:04012_51 ErbB signaling pathway 37 3.57678281661143 0.000725550688638382 0.0306343624091761
OV ENSG00000267161 ENSG00000267161 path:04066_123 HIF-1 signaling pathway 6 -5.94271653147828 7.08712709730901e-07 0.000269310829697742
OV ENSG00000267161 ENSG00000267161 path:04370_82 VEGF signaling pathway 10 3.40582862552646 0.000823776828679565 0.0313035194898235
OV ENSG00000267161 ENSG00000267161 path:04510_223 Focal adhesion 15 3.89956863302923 0.000203639541822442 0.012897170982088
OV ENSG00000267161 ENSG00000267161 path:04725_135 Cholinergic synapse 6 4.97687197142129 1.83966467294001e-06 0.000349536287858603
OV ENSG00000267161 ENSG00000267161 path:04910_133 Insulin signaling pathway 9 -4.40784257494742 6.65409473027924e-05 0.00625195412576587
OV ENSG00000267161 ENSG00000267161 path:04916_110 Melanogenesis 11 -3.73491810833325 0.000502632969345889 0.0238750660439297
OV ENSG00000267161 ENSG00000267161 path:05032_55 Morphine addiction 30 4.2330081568506 8.2262554286393e-05 0.00625195412576587
OV ENSG00000267161 ENSG00000267161 path:05215_106 Prostate cancer 5 3.60294604249466 0.00044204289578129 0.0238750660439297
OV ENSG00000267161 ENSG00000267161 path:05221_56 Acute myeloid leukemia 5 -3.38698169266325 0.00146891795309623 0.0465157351813806
OV ENSG00000267715 ENSG00000267715 path:00280_35 Valine, leucine and isoleucine degradation 22 3.39228393669082 0.000997850992501503 0.0344712161045974
OV ENSG00000267715 ENSG00000267715 path:00564_69 Glycerophospholipid metabolism 13 4.52175616471624 1.80797537133342e-05 0.00229010213702233
OV ENSG00000267715 ENSG00000267715 path:04012_51 ErbB signaling pathway 37 3.57678281661143 0.000725550688638382 0.0306343624091761
OV ENSG00000267715 ENSG00000267715 path:04066_123 HIF-1 signaling pathway 6 -5.94271653147828 7.08712709730901e-07 0.000269310829697742
OV ENSG00000267715 ENSG00000267715 path:04370_82 VEGF signaling pathway 10 3.40582862552646 0.000823776828679565 0.0313035194898235
OV ENSG00000267715 ENSG00000267715 path:04510_223 Focal adhesion 15 3.89956863302923 0.000203639541822442 0.012897170982088
OV ENSG00000267715 ENSG00000267715 path:04725_135 Cholinergic synapse 6 4.97687197142129 1.83966467294001e-06 0.000349536287858603
OV ENSG00000267715 ENSG00000267715 path:04910_133 Insulin signaling pathway 9 -4.40784257494742 6.65409473027924e-05 0.00625195412576587
OV ENSG00000267715 ENSG00000267715 path:04916_110 Melanogenesis 11 -3.73491810833325 0.000502632969345889 0.0238750660439297
OV ENSG00000267715 ENSG00000267715 path:05032_55 Morphine addiction 30 4.2330081568506 8.2262554286393e-05 0.00625195412576587
OV ENSG00000267715 ENSG00000267715 path:05215_106 Prostate cancer 5 3.60294604249466 0.00044204289578129 0.0238750660439297
OV ENSG00000267715 ENSG00000267715 path:05221_56 Acute myeloid leukemia 5 -3.38698169266325 0.00146891795309623 0.0465157351813806
OV ENSG00000267759 ENSG00000267759 path:00564_69 Glycerophospholipid metabolism 13 4.7469647513925 7.81699867620756e-06 0.00148522974847944
OV ENSG00000267759 ENSG00000267759 path:04012_51 ErbB signaling pathway 37 3.55838692472091 0.000742174950488608 0.0304220111643078
OV ENSG00000267759 ENSG00000267759 path:04066_123 HIF-1 signaling pathway 6 -5.90312943817948 7.08890146140921e-07 0.00026937825553355
OV ENSG00000267759 ENSG00000267759 path:04370_82 VEGF signaling pathway 10 3.4715300131157 0.000646994067327825 0.0304220111643078
OV ENSG00000267759 ENSG00000267759 path:04510_223 Focal adhesion 15 3.49192144410072 0.000800579241165996 0.0304220111643078
OV ENSG00000267759 ENSG00000267759 path:04725_135 Cholinergic synapse 6 3.58958256672685 0.000540566215460009 0.0304220111643078
OV ENSG00000267759 ENSG00000267759 path:04910_133 Insulin signaling pathway 9 -4.46598678133262 5.15334669272523e-05 0.00489567935808897
OV ENSG00000267759 ENSG00000267759 path:04916_110 Melanogenesis 11 -3.76093181867514 0.000444899372493109 0.0304220111643078
OV ENSG00000267759 ENSG00000267759 path:04921_47 Oxytocin signaling pathway 76 -3.41813700736757 0.00143112903431579 0.0494390030036364
OV ENSG00000267759 ENSG00000267759 path:05032_55 Morphine addiction 30 4.39388849678004 4.41845530328613e-05 0.00489567935808897
OV ENSG00000267759 ENSG00000267759 path:05215_106 Prostate cancer 5 3.4319031677669 0.000790317413903402 0.0304220111643078
OV ENSG00000270143 ENSG00000270143 path:00260_1 Glycine, serine and threonine metabolism 29 2.83658785522619 0.00492454400480772 0.0495268425626376
OV ENSG00000270143 ENSG00000270143 path:00270_17 Cysteine and methionine metabolism 19 5.83744444873909 1.57694910079313e-08 5.55086083479183e-06
OV ENSG00000270143 ENSG00000270143 path:00512_22 Mucin type O-Glycan biosynthesis 6 -3.40730882874856 0.000809935035138053 0.0178185707730372
OV ENSG00000270143 ENSG00000270143 path:00564_109 Glycerophospholipid metabolism 2 -3.16444936761939 0.00179418756291699 0.0251433787693708
OV ENSG00000270143 ENSG00000270143 path:03015_30 mRNA surveillance pathway 3 3.27506872344998 0.0012017921027915 0.0235017122323671
OV ENSG00000270143 ENSG00000270143 path:04014_62 Ras signaling pathway 66 -3.3818664491919 0.000895261298268118 0.018537175117081
OV ENSG00000270143 ENSG00000270143 path:04015_114 Rap1 signaling pathway 29 -3.47538514269811 0.000656701820278707 0.0175096817254965
OV ENSG00000270143 ENSG00000270143 path:04022_96 cGMP-PKG signaling pathway 13 3.69885578970396 0.000270565405421929 0.0118986447520177
OV ENSG00000270143 ENSG00000270143 path:04060_19 Cytokine-cytokine receptor interaction 5 -3.03169158903822 0.00276047040002704 0.0347030564574828
OV ENSG00000270143 ENSG00000270143 path:04062_239 Chemokine signaling pathway 12 -3.44647236101583 0.000736529064399132 0.0175096817254965
OV ENSG00000270143 ENSG00000270143 path:04151_138 PI3K-Akt signaling pathway 60 -3.69003270691812 0.000304226712409543 0.0118986447520177
OV ENSG00000270143 ENSG00000270143 path:04151_213 PI3K-Akt signaling pathway 34 -3.23847672836577 0.00147961214754935 0.0236737943607896
OV ENSG00000270143 ENSG00000270143 path:04151_225 PI3K-Akt signaling pathway 28 -2.87335232811178 0.00452886054005854 0.0483078457606244
OV ENSG00000270143 ENSG00000270143 path:04151_84 PI3K-Akt signaling pathway 137 3.01640489395245 0.002887516868301 0.0350484806083432
OV ENSG00000270143 ENSG00000270143 path:04261_4 Adrenergic signaling in cardiomyocytes 126 3.15651887639012 0.00185718138637398 0.0251433787693708
OV ENSG00000270143 ENSG00000270143 path:04310_189 Wnt signaling pathway 4 -3.66430521650483 0.000349081151649336 0.0122876565380566
OV ENSG00000270143 ENSG00000270143 path:04360_110 Axon guidance 18 -3.53693452399389 0.000511611931299578 0.0150072833181209
OV ENSG00000270143 ENSG00000270143 path:04390_145 Hippo signaling pathway 5 -3.03169158903822 0.00276047040002704 0.0347030564574828
OV ENSG00000270143 ENSG00000270143 path:04510_108 Focal adhesion 47 -3.18431652550632 0.00176449493805796 0.0251433787693708
OV ENSG00000270143 ENSG00000270143 path:04512_17 ECM-receptor interaction 62 -3.22393225797389 0.00155109865412415 0.0237385533152913
OV ENSG00000270143 ENSG00000270143 path:04540_97 Gap junction 10 -4.3087161836983 2.91707538874705e-05 0.0025670263420974
OV ENSG00000270143 ENSG00000270143 path:04611_181 Platelet activation 13 -3.27734112861321 0.00130911880974765 0.023638558294648
OV ENSG00000270143 ENSG00000270143 path:04611_182 Platelet activation 13 -2.94609987345278 0.00359654022621465 0.0421994053209186
OV ENSG00000270143 ENSG00000270143 path:04621_44 NOD-like receptor signaling pathway 11 -4.12308903150751 5.43937840301118e-05 0.00382932239571987
OV ENSG00000270143 ENSG00000270143 path:04666_84 Fc gamma R-mediated phagocytosis 40 4.67837759298732 4.83172061855556e-06 0.000566921885910519
OV ENSG00000270143 ENSG00000270143 path:04725_130 Cholinergic synapse 7 5.53192439463579 8.28543332390827e-08 1.45823626500786e-05
OV ENSG00000270143 ENSG00000270143 path:04726_28 Serotonergic synapse 12 2.91406429756586 0.00389739702706628 0.0442543146299139
OV ENSG00000270143 ENSG00000270143 path:04727_38 GABAergic synapse 24 -3.91930387904652 0.000133942584392966 0.00785796495105401
OV ENSG00000270143 ENSG00000270143 path:04919_46 Thyroid hormone signaling pathway 34 2.90284623752767 0.00410866485778858 0.0451953134356744
OV ENSG00000270143 ENSG00000270143 path:05032_63 Morphine addiction 24 -2.86655250792727 0.00475026188684843 0.049179181887372
OV ENSG00000270143 ENSG00000270143 path:05100_68 Bacterial invasion of epithelial cells 17 3.73312890102689 0.000236781538249515 0.0118986447520177
OV ENSG00000270143 ENSG00000270143 path:05100_80 Bacterial invasion of epithelial cells 6 3.53871684643657 0.000475124589999444 0.0150072833181209
OV ENSG00000270143 ENSG00000270143 path:05220_3 Chronic myeloid leukemia 56 3.41969810304134 0.000746151209893316 0.0175096817254965
OV ENSG00000270143 ENSG00000270143 path:05330_2 Allograft rejection 2 -3.23897417607757 0.00141025489826025 0.023638558294648
OV ENSG00000270143 ENSG00000270143 path:05332_5 Graft-versus-host disease 2 -3.23897417607757 0.00141025489826025 0.023638558294648
OV ENSG00000229921 KIF25-AS1 path:00120_6 Primary bile acid biosynthesis 3 3.18535658928001 0.00165788465840394 0.0309543292303518
OV ENSG00000229921 KIF25-AS1 path:00330_90 Arginine and proline metabolism 6 3.96375495313566 9.42295561785887e-05 0.00694680101925293
OV ENSG00000229921 KIF25-AS1 path:00561_55 Glycerolipid metabolism 7 3.42911855411097 0.000710060255826291 0.0176031602709445
OV ENSG00000229921 KIF25-AS1 path:00565_8 Ether lipid metabolism 23 -3.13878614893191 0.00206304046816838 0.0348997679198484
OV ENSG00000229921 KIF25-AS1 path:00760_14 Nicotinate and nicotinamide metabolism 15 3.04874989841356 0.00256092170374297 0.0399897773738325
OV ENSG00000229921 KIF25-AS1 path:00983_2 Drug metabolism - other enzymes 16 3.00219547419417 0.00294155179202089 0.0442322232429807
OV ENSG00000229921 KIF25-AS1 path:04068_37 FoxO signaling pathway 42 -4.80612289700125 3.2769338922829e-06 0.000665217580133429
OV ENSG00000229921 KIF25-AS1 path:04140_1 Regulation of autophagy 10 -3.5047474955029 0.000562082204905186 0.0166030394707407
OV ENSG00000229921 KIF25-AS1 path:04330_24 Notch signaling pathway 16 -3.5219030469935 0.000534233572296435 0.0166030394707407
OV ENSG00000229921 KIF25-AS1 path:04360_145 Axon guidance 8 -3.18109905200329 0.00168047022364146 0.0309543292303518
OV ENSG00000229921 KIF25-AS1 path:04510_310 Focal adhesion 7 -4.04510021824649 7.2690942738889e-05 0.00694680101925293
OV ENSG00000229921 KIF25-AS1 path:04510_63 Focal adhesion 76 -3.18550052112093 0.00175357037511845 0.0309543292303518
OV ENSG00000229921 KIF25-AS1 path:04550_2 Signaling pathways regulating pluripotency of stem cells 91 -3.41493390716594 0.00078043567703695 0.0176031602709445
OV ENSG00000229921 KIF25-AS1 path:04621_50 NOD-like receptor signaling pathway 7 -6.92752096188275 5.40021786737194e-11 2.19248845415301e-08
OV ENSG00000229921 KIF25-AS1 path:04623_19 Cytosolic DNA-sensing pathway 3 3.10218079489719 0.00216248720607672 0.035118792226686
OV ENSG00000229921 KIF25-AS1 path:04666_159 Fc gamma R-mediated phagocytosis 19 -3.52129249322459 0.000550530934565086 0.0166030394707407
OV ENSG00000229921 KIF25-AS1 path:04670_105 Leukocyte transendothelial migration 16 3.23861546253146 0.00135832133437783 0.02757392308787
OV ENSG00000229921 KIF25-AS1 path:04670_163 Leukocyte transendothelial migration 4 -3.7922983342269 0.000198174702130028 0.0112077821550028
OV ENSG00000229921 KIF25-AS1 path:04720_55 Long-term potentiation 18 4.19011622680633 3.72788790685877e-05 0.0050450749672822
OV ENSG00000229921 KIF25-AS1 path:04723_39 Retrograde endocannabinoid signaling 14 3.65238104851373 0.000318443128835207 0.0143653233674549
OV ENSG00000229921 KIF25-AS1 path:04932_84 Non-alcoholic fatty liver disease (NAFLD) 11 -3.47733475662725 0.000613412788327859 0.0166030394707407
OV ENSG00000229921 KIF25-AS1 path:05033_8 Nicotine addiction 9 3.29797181356696 0.00111366369926839 0.0237972348369983
OV ENSG00000229921 KIF25-AS1 path:05131_27 Shigellosis 2 -3.49264909618988 0.000574812339876785 0.0166030394707407
OV ENSG00000229921 KIF25-AS1 path:05143_1 African trypanosomiasis 9 3.95180282508953 0.000102662084028368 0.00694680101925293
OV ENSG00000229921 KIF25-AS1 path:05206_22 MicroRNAs in cancer 98 -3.78291492791227 0.000220842998128135 0.0112077821550028
OV ENSG00000229921 KIF25-AS1 path:05211_17 Renal cell carcinoma 6 -3.59136233410258 0.00040762955968946 0.0165497601233921
OV ENSG00000229921 KIF25-AS1 path:05212_5 Pancreatic cancer 46 -3.43821231229403 0.000772283036547218 0.0176031602709445
OV ENSG00000198221 MLLT4-AS1 path:00100_10 Steroid biosynthesis 10 2.87093377530285 0.00443378392554821 0.0493797044840981
OV ENSG00000198221 MLLT4-AS1 path:00120_6 Primary bile acid biosynthesis 3 3.37791928562181 0.000859237595362444 0.0193805813176196
OV ENSG00000198221 MLLT4-AS1 path:00330_90 Arginine and proline metabolism 6 3.88897008617019 0.000126318115246594 0.00732645068430247
OV ENSG00000198221 MLLT4-AS1 path:00524_1 Butirosin and neomycin biosynthesis 4 -3.01399467102562 0.00293993647339391 0.0438824722970206
OV ENSG00000198221 MLLT4-AS1 path:00561_55 Glycerolipid metabolism 7 3.22113303481992 0.00145062586365298 0.0268320792106822
OV ENSG00000198221 MLLT4-AS1 path:00565_8 Ether lipid metabolism 23 -3.15851475914324 0.00193161154985689 0.031369371569676
OV ENSG00000198221 MLLT4-AS1 path:00983_2 Drug metabolism - other enzymes 16 3.1600516243159 0.00175918638689991 0.0297595697117236
OV ENSG00000198221 MLLT4-AS1 path:04014_21 Ras signaling pathway 155 -2.96629604298501 0.00334171874807055 0.0441790540033559
OV ENSG00000198221 MLLT4-AS1 path:04068_37 FoxO signaling pathway 42 -4.72348422240979 4.66625725851313e-06 0.000947250223478165
OV ENSG00000198221 MLLT4-AS1 path:04140_1 Regulation of autophagy 10 -3.26934537046421 0.00126344187383331 0.0256478700388162
OV ENSG00000198221 MLLT4-AS1 path:04330_24 Notch signaling pathway 16 -3.59852024270707 0.000404105287323363 0.0145227295077435
OV ENSG00000198221 MLLT4-AS1 path:04360_143 Axon guidance 9 -2.89065044091061 0.00421838613673413 0.0493797044840981
OV ENSG00000198221 MLLT4-AS1 path:04360_145 Axon guidance 8 -3.4445832856097 0.000683915278849054 0.0163335060713362
OV ENSG00000198221 MLLT4-AS1 path:04390_125 Hippo signaling pathway 10 -2.95399813803269 0.00348209292637288 0.0441790540033559
OV ENSG00000198221 MLLT4-AS1 path:04510_310 Focal adhesion 7 -4.09316761353922 5.95817311350318e-05 0.00498560980608799
OV ENSG00000198221 MLLT4-AS1 path:04510_63 Focal adhesion 76 -3.35206044427342 0.00100770664867631 0.0215330999664517
OV ENSG00000198221 MLLT4-AS1 path:04550_2 Signaling pathways regulating pluripotency of stem cells 91 -3.64923005659467 0.000337794308078854 0.0144491932827961
OV ENSG00000198221 MLLT4-AS1 path:04621_50 NOD-like receptor signaling pathway 7 -7.51700111475503 1.65061591341748e-12 6.70150060847497e-10
OV ENSG00000198221 MLLT4-AS1 path:04623_19 Cytosolic DNA-sensing pathway 3 3.2216086658782 0.00145395503112071 0.0268320792106822
OV ENSG00000198221 MLLT4-AS1 path:04666_159 Fc gamma R-mediated phagocytosis 19 -3.55208299860538 0.000491411977129663 0.0153471740549725
OV ENSG00000198221 MLLT4-AS1 path:04670_105 Leukocyte transendothelial migration 16 3.18555722231736 0.0016201776836279 0.0285996582414317
OV ENSG00000198221 MLLT4-AS1 path:04670_163 Leukocyte transendothelial migration 4 -3.82119532026206 0.000177156063901317 0.00899067024299186
OV ENSG00000198221 MLLT4-AS1 path:04720_55 Long-term potentiation 18 4.06825075287858 6.13991355429556e-05 0.00498560980608799
OV ENSG00000198221 MLLT4-AS1 path:04720_60 Long-term potentiation 16 -2.96360519332466 0.00345761918879733 0.0441790540033559
OV ENSG00000198221 MLLT4-AS1 path:04723_39 Retrograde endocannabinoid signaling 14 3.62173583001926 0.000355891460167391 0.0144491932827961
OV ENSG00000198221 MLLT4-AS1 path:04932_84 Non-alcoholic fatty liver disease (NAFLD) 11 -3.47837649319126 0.000609687967999611 0.0163335060713362
OV ENSG00000198221 MLLT4-AS1 path:05033_8 Nicotine addiction 9 3.07144934384726 0.00236221222400283 0.0368868524209673
OV ENSG00000198221 MLLT4-AS1 path:05131_27 Shigellosis 2 -3.47229754069797 0.00061634900633344 0.0163335060713362
OV ENSG00000198221 MLLT4-AS1 path:05134_11 Legionellosis 7 2.91032414211015 0.00395062380125599 0.0486046443427252
OV ENSG00000198221 MLLT4-AS1 path:05143_1 African trypanosomiasis 9 4.0852600418552 6.02306071056266e-05 0.00498560980608799
OV ENSG00000198221 MLLT4-AS1 path:05164_41 Influenza A 6 2.87422410800824 0.00442435120464645 0.0493797044840981
OV ENSG00000198221 MLLT4-AS1 path:05206_22 MicroRNAs in cancer 98 -4.02626993689228 8.77461921120874e-05 0.00593749233291792
OV ENSG00000198221 MLLT4-AS1 path:05211_17 Renal cell carcinoma 6 -3.575982431959 0.000429243236682073 0.0145227295077435
OV ENSG00000198221 MLLT4-AS1 path:05212_5 Pancreatic cancer 46 -3.48476678161276 0.00065559834240241 0.0163335060713362
OV ENSG00000198221 MLLT4-AS1 path:05214_7 Glioma 50 -2.98977152878203 0.00313446230693004 0.0438824722970206
OV ENSG00000198221 MLLT4-AS1 path:05215_53 Prostate cancer 30 -3.0164845840865 0.00309640582064933 0.0438824722970206
OV ENSG00000198221 MLLT4-AS1 path:05221_34 Acute myeloid leukemia 23 -2.88107945441955 0.00450012085199909 0.0493797044840981
OV ENSG00000226194 RP1-137D17.1 path:00120_6 Primary bile acid biosynthesis 3 3.27982287872725 0.00121219229158587 0.0212518364073704
OV ENSG00000226194 RP1-137D17.1 path:00232_1 Caffeine metabolism 3 3.09590435658879 0.00218922682311687 0.028671809360821
OV ENSG00000226194 RP1-137D17.1 path:00270_54 Cysteine and methionine metabolism 8 -3.04094208170284 0.00269807657925275 0.0322182085640182
OV ENSG00000226194 RP1-137D17.1 path:00310_9 Lysine degradation 23 -2.9094302455081 0.00407956957274702 0.0430342028574483
OV ENSG00000226194 RP1-137D17.1 path:00330_90 Arginine and proline metabolism 6 3.95758327858767 9.68034955837723e-05 0.00696809969951166
OV ENSG00000226194 RP1-137D17.1 path:00561_55 Glycerolipid metabolism 7 3.47215115338152 0.000608921929461986 0.0145424884330333
OV ENSG00000226194 RP1-137D17.1 path:00565_8 Ether lipid metabolism 23 -3.03338321731197 0.00288329025677681 0.033446166978611
OV ENSG00000226194 RP1-137D17.1 path:00760_14 Nicotinate and nicotinamide metabolism 15 3.62382428828218 0.000355595459978415 0.0142692887664769
OV ENSG00000226194 RP1-137D17.1 path:00983_2 Drug metabolism - other enzymes 16 3.35768689674812 0.000905105760253571 0.0183736469331475
OV ENSG00000226194 RP1-137D17.1 path:04014_21 Ras signaling pathway 155 -2.90202121373419 0.00409453745575513 0.0430342028574483
OV ENSG00000226194 RP1-137D17.1 path:04068_37 FoxO signaling pathway 42 -4.71465999932722 4.92929216468777e-06 0.00100064630943162
OV ENSG00000226194 RP1-137D17.1 path:04140_1 Regulation of autophagy 10 -3.19912265120832 0.00159109059949078 0.024369537863355
OV ENSG00000226194 RP1-137D17.1 path:04330_24 Notch signaling pathway 16 -3.80668344071695 0.000188855386856904 0.00851947634043367
OV ENSG00000226194 RP1-137D17.1 path:04350_19 TGF-beta signaling pathway 35 -3.08228920893903 0.00233016556825505 0.0295639756472359
OV ENSG00000226194 RP1-137D17.1 path:04360_145 Axon guidance 8 -3.14566583671036 0.00189103848751532 0.0264745388252145
OV ENSG00000226194 RP1-137D17.1 path:04370_87 VEGF signaling pathway 8 2.85199897440019 0.00467325128203264 0.0474335005126313
OV ENSG00000226194 RP1-137D17.1 path:04390_125 Hippo signaling pathway 10 -3.19334532601235 0.00162063429140538 0.024369537863355
OV ENSG00000226194 RP1-137D17.1 path:04510_310 Focal adhesion 7 -3.861677288122 0.00014923520035667 0.0077026702272142
OV ENSG00000226194 RP1-137D17.1 path:04510_63 Focal adhesion 76 -3.31274162727229 0.00115736151452945 0.0212518364073704
OV ENSG00000226194 RP1-137D17.1 path:04550_2 Signaling pathways regulating pluripotency of stem cells 91 -3.55065941934199 0.000486081990338362 0.0142692887664769
OV ENSG00000226194 RP1-137D17.1 path:04621_50 NOD-like receptor signaling pathway 7 -6.94791073317465 4.99636261155829e-11 2.02852322029267e-08
OV ENSG00000226194 RP1-137D17.1 path:04623_19 Cytosolic DNA-sensing pathway 3 3.41298198744888 0.000760095887074655 0.0162420489553847
OV ENSG00000226194 RP1-137D17.1 path:04666_159 Fc gamma R-mediated phagocytosis 19 -3.36179007918222 0.00095622989921806 0.0184871113848825
OV ENSG00000226194 RP1-137D17.1 path:04670_105 Leukocyte transendothelial migration 16 3.10253037562148 0.00213396849736702 0.028671809360821
OV ENSG00000226194 RP1-137D17.1 path:04670_163 Leukocyte transendothelial migration 4 -3.57105649362106 0.000441239014139581 0.0142692887664769
OV ENSG00000226194 RP1-137D17.1 path:04720_55 Long-term potentiation 18 4.48181181105412 1.07792252824031e-05 0.00145878848821855
OV ENSG00000226194 RP1-137D17.1 path:04723_39 Retrograde endocannabinoid signaling 14 3.95022705122676 0.000102976842849926 0.00696809969951166
OV ENSG00000226194 RP1-137D17.1 path:04919_54 Thyroid hormone signaling pathway 25 -2.90418803871038 0.00413382736808001 0.0430342028574483
OV ENSG00000226194 RP1-137D17.1 path:04932_84 Non-alcoholic fatty liver disease (NAFLD) 11 -3.43942723458786 0.000702520901005899 0.0158457492115775
OV ENSG00000226194 RP1-137D17.1 path:05033_8 Nicotine addiction 9 3.51218324000185 0.000527190471667866 0.0142692887664769
OV ENSG00000226194 RP1-137D17.1 path:05100_92 Bacterial invasion of epithelial cells 3 -3.0347310877741 0.00268627906501031 0.0322182085640182
OV ENSG00000226194 RP1-137D17.1 path:05131_27 Shigellosis 2 -3.53470375613801 0.000496432434399115 0.0142692887664769
OV ENSG00000226194 RP1-137D17.1 path:05133_14 Pertussis 7 3.21331430504994 0.0014962896152301 0.0242997433513368
OV ENSG00000226194 RP1-137D17.1 path:05134_11 Legionellosis 7 3.26538384860128 0.00125626619156869 0.0212518364073704
OV ENSG00000226194 RP1-137D17.1 path:05143_1 African trypanosomiasis 9 4.15385057426483 4.60993866836999e-05 0.00467908774839554
OV ENSG00000226194 RP1-137D17.1 path:05164_41 Influenza A 6 3.17774294613345 0.00168970102017936 0.0245006647926007
OV ENSG00000226194 RP1-137D17.1 path:05206_22 MicroRNAs in cancer 98 -3.88501162002109 0.0001517767532456 0.0077026702272142
OV ENSG00000226194 RP1-137D17.1 path:05211_17 Renal cell carcinoma 6 -3.59793551442739 0.000399612394902221 0.0142692887664769
OV ENSG00000226194 RP1-137D17.1 path:05212_5 Pancreatic cancer 46 -3.52253852550851 0.000580306719284574 0.0145424884330333
OV ENSG00000226194 RP1-137D17.1 path:05215_53 Prostate cancer 30 -2.96696324014519 0.00361654174728939 0.0407865541499859
OV ENSG00000272848 RP1-137D17.2 path:00120_6 Primary bile acid biosynthesis 3 3.38884158655323 0.000837188299465955 0.0141624353992991
OV ENSG00000272848 RP1-137D17.2 path:00140_44 Steroid hormone biosynthesis 3 2.87683756986704 0.00436138223103422 0.0410634926172592
OV ENSG00000272848 RP1-137D17.2 path:00232_1 Caffeine metabolism 3 3.17511920070391 0.00169140712471673 0.0231240669718614
OV ENSG00000272848 RP1-137D17.2 path:00270_54 Cysteine and methionine metabolism 8 -3.02223661479392 0.00286908435605543 0.0324441108824388
OV ENSG00000272848 RP1-137D17.2 path:00310_9 Lysine degradation 23 -2.94089801683832 0.00371263743812725 0.0386495076892221
OV ENSG00000272848 RP1-137D17.2 path:00330_90 Arginine and proline metabolism 6 3.95786848242361 9.69538964775886e-05 0.00514035536748906
OV ENSG00000272848 RP1-137D17.2 path:00561_55 Glycerolipid metabolism 7 3.4530420749726 0.000650511000555761 0.013205373311282
OV ENSG00000272848 RP1-137D17.2 path:00565_8 Ether lipid metabolism 23 -3.03128440575094 0.00290957061460978 0.0324441108824388
OV ENSG00000272848 RP1-137D17.2 path:00760_14 Nicotinate and nicotinamide metabolism 15 3.58074008802633 0.000417410298058374 0.0109006570530322
OV ENSG00000272848 RP1-137D17.2 path:00983_2 Drug metabolism - other enzymes 16 3.59682534092725 0.000386127831721043 0.0109006570530322
OV ENSG00000272848 RP1-137D17.2 path:04014_21 Ras signaling pathway 155 -3.06210571275096 0.00248157410669591 0.0305308814338951
OV ENSG00000272848 RP1-137D17.2 path:04068_37 FoxO signaling pathway 42 -4.76730662556041 3.96150404063651e-06 0.000804185320249211
OV ENSG00000272848 RP1-137D17.2 path:04140_1 Regulation of autophagy 10 -3.24576103356596 0.00136611095874687 0.0198086089018296
OV ENSG00000272848 RP1-137D17.2 path:04330_22 Notch signaling pathway 24 -2.89930882120382 0.0042271314360157 0.0410634926172592
OV ENSG00000272848 RP1-137D17.2 path:04330_24 Notch signaling pathway 16 -3.94034606699777 0.000113948764303945 0.00514035536748906
OV ENSG00000272848 RP1-137D17.2 path:04350_19 TGF-beta signaling pathway 35 -3.16592226731329 0.0017800451500416 0.0233128493844158
OV ENSG00000272848 RP1-137D17.2 path:04360_145 Axon guidance 8 -3.17732585703725 0.00170867489939863 0.0231240669718614
OV ENSG00000272848 RP1-137D17.2 path:04370_87 VEGF signaling pathway 8 2.88248899220463 0.00425905236793765 0.0410634926172592
OV ENSG00000272848 RP1-137D17.2 path:04390_125 Hippo signaling pathway 10 -3.29537458373214 0.00115482684295468 0.0173651740088741
OV ENSG00000272848 RP1-137D17.2 path:04510_310 Focal adhesion 7 -3.98861101302226 9.1613402545256e-05 0.00514035536748906
OV ENSG00000272848 RP1-137D17.2 path:04510_63 Focal adhesion 76 -3.41859171334773 0.000812680969667235 0.0141624353992991
OV ENSG00000272848 RP1-137D17.2 path:04520_57 Adherens junction 18 -2.88951539962003 0.00427657342390834 0.0410634926172592
OV ENSG00000272848 RP1-137D17.2 path:04550_2 Signaling pathways regulating pluripotency of stem cells 91 -3.71899513900063 0.000264824175025844 0.0107518615060493
OV ENSG00000272848 RP1-137D17.2 path:04621_50 NOD-like receptor signaling pathway 7 -7.1655668837164 1.44119797557122e-11 5.85126378081915e-09
OV ENSG00000272848 RP1-137D17.2 path:04623_19 Cytosolic DNA-sensing pathway 3 3.62144613202814 0.000361146761209101 0.0109006570530322
OV ENSG00000272848 RP1-137D17.2 path:04666_159 Fc gamma R-mediated phagocytosis 19 -3.45560531301564 0.00069546024248193 0.013445564687984
OV ENSG00000272848 RP1-137D17.2 path:04670_105 Leukocyte transendothelial migration 16 3.09962737822953 0.00215750712881221 0.0273733716968049
OV ENSG00000272848 RP1-137D17.2 path:04670_163 Leukocyte transendothelial migration 4 -3.56273190968785 0.000456431452959477 0.0109006570530322
OV ENSG00000272848 RP1-137D17.2 path:04720_55 Long-term potentiation 18 4.38496579700125 1.64383216354341e-05 0.00222465286132874
OV ENSG00000272848 RP1-137D17.2 path:04720_60 Long-term potentiation 16 -2.87041958027391 0.00462037130914022 0.0416860167002429
OV ENSG00000272848 RP1-137D17.2 path:04723_39 Retrograde endocannabinoid signaling 14 3.95562195874869 0.000101281700280803 0.00514035536748906
OV ENSG00000272848 RP1-137D17.2 path:04919_54 Thyroid hormone signaling pathway 25 -2.94541087991296 0.00365051161836521 0.0386495076892221
OV ENSG00000272848 RP1-137D17.2 path:04932_84 Non-alcoholic fatty liver disease (NAFLD) 11 -3.56714385955486 0.000447772415625607 0.0109006570530322
OV ENSG00000272848 RP1-137D17.2 path:05033_8 Nicotine addiction 9 3.56211335233421 0.000441460489653485 0.0109006570530322
OV ENSG00000272848 RP1-137D17.2 path:05100_92 Bacterial invasion of epithelial cells 3 -3.00508662175664 0.0029567293168725 0.0324441108824388
OV ENSG00000272848 RP1-137D17.2 path:05131_27 Shigellosis 2 -3.51367843362155 0.000536994706667724 0.0114747289951103
OV ENSG00000272848 RP1-137D17.2 path:05133_14 Pertussis 7 3.35002755404032 0.000942908712305621 0.0153128374878433
OV ENSG00000272848 RP1-137D17.2 path:05134_11 Legionellosis 7 3.39830458789143 0.000797684872496265 0.0141624353992991
OV ENSG00000272848 RP1-137D17.2 path:05143_1 African trypanosomiasis 9 4.12959224239255 5.11587852959769e-05 0.00514035536748906
OV ENSG00000272848 RP1-137D17.2 path:05164_41 Influenza A 6 3.31483841310998 0.00106822989652627 0.0166808206919102
OV ENSG00000272848 RP1-137D17.2 path:05206_22 MicroRNAs in cancer 98 -3.97054505579205 0.000110513685118534 0.00514035536748906
OV ENSG00000272848 RP1-137D17.2 path:05211_17 Renal cell carcinoma 6 -3.58622178259928 0.000418561662254356 0.0109006570530322
OV ENSG00000272848 RP1-137D17.2 path:05212_5 Pancreatic cancer 46 -3.56591894929295 0.000501251634687144 0.0113060090934989
OV ENSG00000272848 RP1-137D17.2 path:05214_7 Glioma 50 -2.87791626531538 0.0044502307269936 0.0410634926172592
OV ENSG00000272848 RP1-137D17.2 path:05215_53 Prostate cancer 30 -3.04078938359577 0.002891391980288 0.0324441108824388
OV ENSG00000260771 RP1-39J2.1 path:00120_6 Primary bile acid biosynthesis 3 3.18535658928001 0.00165788465840394 0.0309543292303518
OV ENSG00000260771 RP1-39J2.1 path:00330_90 Arginine and proline metabolism 6 3.96375495313566 9.42295561785887e-05 0.00694680101925293
OV ENSG00000260771 RP1-39J2.1 path:00561_55 Glycerolipid metabolism 7 3.42911855411097 0.000710060255826291 0.0176031602709445
OV ENSG00000260771 RP1-39J2.1 path:00565_8 Ether lipid metabolism 23 -3.13878614893191 0.00206304046816838 0.0348997679198484
OV ENSG00000260771 RP1-39J2.1 path:00760_14 Nicotinate and nicotinamide metabolism 15 3.04874989841356 0.00256092170374297 0.0399897773738325
OV ENSG00000260771 RP1-39J2.1 path:00983_2 Drug metabolism - other enzymes 16 3.00219547419417 0.00294155179202089 0.0442322232429807
OV ENSG00000260771 RP1-39J2.1 path:04068_37 FoxO signaling pathway 42 -4.80612289700125 3.2769338922829e-06 0.000665217580133429
OV ENSG00000260771 RP1-39J2.1 path:04140_1 Regulation of autophagy 10 -3.5047474955029 0.000562082204905186 0.0166030394707407
OV ENSG00000260771 RP1-39J2.1 path:04330_24 Notch signaling pathway 16 -3.5219030469935 0.000534233572296435 0.0166030394707407
OV ENSG00000260771 RP1-39J2.1 path:04360_145 Axon guidance 8 -3.18109905200329 0.00168047022364146 0.0309543292303518
OV ENSG00000260771 RP1-39J2.1 path:04510_310 Focal adhesion 7 -4.04510021824649 7.2690942738889e-05 0.00694680101925293
OV ENSG00000260771 RP1-39J2.1 path:04510_63 Focal adhesion 76 -3.18550052112093 0.00175357037511845 0.0309543292303518
OV ENSG00000260771 RP1-39J2.1 path:04550_2 Signaling pathways regulating pluripotency of stem cells 91 -3.41493390716594 0.00078043567703695 0.0176031602709445
OV ENSG00000260771 RP1-39J2.1 path:04621_50 NOD-like receptor signaling pathway 7 -6.92752096188275 5.40021786737194e-11 2.19248845415301e-08
OV ENSG00000260771 RP1-39J2.1 path:04623_19 Cytosolic DNA-sensing pathway 3 3.10218079489719 0.00216248720607672 0.035118792226686
OV ENSG00000260771 RP1-39J2.1 path:04666_159 Fc gamma R-mediated phagocytosis 19 -3.52129249322459 0.000550530934565086 0.0166030394707407
OV ENSG00000260771 RP1-39J2.1 path:04670_105 Leukocyte transendothelial migration 16 3.23861546253146 0.00135832133437783 0.02757392308787
OV ENSG00000260771 RP1-39J2.1 path:04670_163 Leukocyte transendothelial migration 4 -3.7922983342269 0.000198174702130028 0.0112077821550028
OV ENSG00000260771 RP1-39J2.1 path:04720_55 Long-term potentiation 18 4.19011622680633 3.72788790685877e-05 0.0050450749672822
OV ENSG00000260771 RP1-39J2.1 path:04723_39 Retrograde endocannabinoid signaling 14 3.65238104851373 0.000318443128835207 0.0143653233674549
OV ENSG00000260771 RP1-39J2.1 path:04932_84 Non-alcoholic fatty liver disease (NAFLD) 11 -3.47733475662725 0.000613412788327859 0.0166030394707407
OV ENSG00000260771 RP1-39J2.1 path:05033_8 Nicotine addiction 9 3.29797181356696 0.00111366369926839 0.0237972348369983
OV ENSG00000260771 RP1-39J2.1 path:05131_27 Shigellosis 2 -3.49264909618988 0.000574812339876785 0.0166030394707407
OV ENSG00000260771 RP1-39J2.1 path:05143_1 African trypanosomiasis 9 3.95180282508953 0.000102662084028368 0.00694680101925293
OV ENSG00000260771 RP1-39J2.1 path:05206_22 MicroRNAs in cancer 98 -3.78291492791227 0.000220842998128135 0.0112077821550028
OV ENSG00000260771 RP1-39J2.1 path:05211_17 Renal cell carcinoma 6 -3.59136233410258 0.00040762955968946 0.0165497601233921
OV ENSG00000260771 RP1-39J2.1 path:05212_5 Pancreatic cancer 46 -3.43821231229403 0.000772283036547218 0.0176031602709445
OV ENSG00000261837 RP11-264L1.3 path:00400_1 Phenylalanine, tyrosine and tryptophan biosynthesis 4 -3.60499766561857 0.000509896190271264 0.0407771488268489
OV ENSG00000261837 RP11-264L1.3 path:00564_95 Glycerophospholipid metabolism 5 3.51649114405958 0.000607103952757056 0.0407771488268489
OV ENSG00000261837 RP11-264L1.3 path:00670_1 One carbon pool by folate 10 3.42394929765647 0.000779954792821142 0.0449031116438457
OV ENSG00000261837 RP11-264L1.3 path:04110_116 Cell cycle 31 3.68559997250085 0.000339847662093693 0.0369310181413433
OV ENSG00000261837 RP11-264L1.3 path:04390_83 Hippo signaling pathway 32 4.02167237362301 0.000101824796335445 0.0293957871050197
OV ENSG00000261837 RP11-264L1.3 path:04725_152 Cholinergic synapse 4 3.63356018386926 0.000366560974107626 0.0369310181413433
OV ENSG00000261837 RP11-264L1.3 path:05215_109 Prostate cancer 5 3.85519869568223 0.000145884799528634 0.0293957871050197
OV ENSG00000260733 RP11-264L1.4 path:04110_116 Cell cycle 31 3.74558164224349 0.000270660556801761 0.0371707164674419
OV ENSG00000260733 RP11-264L1.4 path:04390_83 Hippo signaling pathway 32 4.11434380334637 7.04372337429851e-05 0.0271085674008939
OV ENSG00000260733 RP11-264L1.4 path:05215_109 Prostate cancer 5 3.88066905840834 0.00013159498738298 0.0271085674008939
OV ENSG00000203688 RP11-351J23.1 path:00100_10 Steroid biosynthesis 10 2.87093377530285 0.00443378392554821 0.0493797044840981
OV ENSG00000203688 RP11-351J23.1 path:00120_6 Primary bile acid biosynthesis 3 3.37791928562181 0.000859237595362444 0.0193805813176196
OV ENSG00000203688 RP11-351J23.1 path:00330_90 Arginine and proline metabolism 6 3.88897008617019 0.000126318115246594 0.00732645068430247
OV ENSG00000203688 RP11-351J23.1 path:00524_1 Butirosin and neomycin biosynthesis 4 -3.01399467102562 0.00293993647339391 0.0438824722970206
OV ENSG00000203688 RP11-351J23.1 path:00561_55 Glycerolipid metabolism 7 3.22113303481992 0.00145062586365298 0.0268320792106822
OV ENSG00000203688 RP11-351J23.1 path:00565_8 Ether lipid metabolism 23 -3.15851475914324 0.00193161154985689 0.031369371569676
OV ENSG00000203688 RP11-351J23.1 path:00983_2 Drug metabolism - other enzymes 16 3.1600516243159 0.00175918638689991 0.0297595697117236
OV ENSG00000203688 RP11-351J23.1 path:04014_21 Ras signaling pathway 155 -2.96629604298501 0.00334171874807055 0.0441790540033559
OV ENSG00000203688 RP11-351J23.1 path:04068_37 FoxO signaling pathway 42 -4.72348422240979 4.66625725851313e-06 0.000947250223478165
OV ENSG00000203688 RP11-351J23.1 path:04140_1 Regulation of autophagy 10 -3.26934537046421 0.00126344187383331 0.0256478700388162
OV ENSG00000203688 RP11-351J23.1 path:04330_24 Notch signaling pathway 16 -3.59852024270707 0.000404105287323363 0.0145227295077435
OV ENSG00000203688 RP11-351J23.1 path:04360_143 Axon guidance 9 -2.89065044091061 0.00421838613673413 0.0493797044840981
OV ENSG00000203688 RP11-351J23.1 path:04360_145 Axon guidance 8 -3.4445832856097 0.000683915278849054 0.0163335060713362
OV ENSG00000203688 RP11-351J23.1 path:04390_125 Hippo signaling pathway 10 -2.95399813803269 0.00348209292637288 0.0441790540033559
OV ENSG00000203688 RP11-351J23.1 path:04510_310 Focal adhesion 7 -4.09316761353922 5.95817311350318e-05 0.00498560980608799
OV ENSG00000203688 RP11-351J23.1 path:04510_63 Focal adhesion 76 -3.35206044427342 0.00100770664867631 0.0215330999664517
OV ENSG00000203688 RP11-351J23.1 path:04550_2 Signaling pathways regulating pluripotency of stem cells 91 -3.64923005659467 0.000337794308078854 0.0144491932827961
OV ENSG00000203688 RP11-351J23.1 path:04621_50 NOD-like receptor signaling pathway 7 -7.51700111475503 1.65061591341748e-12 6.70150060847497e-10
OV ENSG00000203688 RP11-351J23.1 path:04623_19 Cytosolic DNA-sensing pathway 3 3.2216086658782 0.00145395503112071 0.0268320792106822
OV ENSG00000203688 RP11-351J23.1 path:04666_159 Fc gamma R-mediated phagocytosis 19 -3.55208299860538 0.000491411977129663 0.0153471740549725
OV ENSG00000203688 RP11-351J23.1 path:04670_105 Leukocyte transendothelial migration 16 3.18555722231736 0.0016201776836279 0.0285996582414317
OV ENSG00000203688 RP11-351J23.1 path:04670_163 Leukocyte transendothelial migration 4 -3.82119532026206 0.000177156063901317 0.00899067024299186
OV ENSG00000203688 RP11-351J23.1 path:04720_55 Long-term potentiation 18 4.06825075287858 6.13991355429556e-05 0.00498560980608799
OV ENSG00000203688 RP11-351J23.1 path:04720_60 Long-term potentiation 16 -2.96360519332466 0.00345761918879733 0.0441790540033559
OV ENSG00000203688 RP11-351J23.1 path:04723_39 Retrograde endocannabinoid signaling 14 3.62173583001926 0.000355891460167391 0.0144491932827961
OV ENSG00000203688 RP11-351J23.1 path:04932_84 Non-alcoholic fatty liver disease (NAFLD) 11 -3.47837649319126 0.000609687967999611 0.0163335060713362
OV ENSG00000203688 RP11-351J23.1 path:05033_8 Nicotine addiction 9 3.07144934384726 0.00236221222400283 0.0368868524209673
OV ENSG00000203688 RP11-351J23.1 path:05131_27 Shigellosis 2 -3.47229754069797 0.00061634900633344 0.0163335060713362
OV ENSG00000203688 RP11-351J23.1 path:05134_11 Legionellosis 7 2.91032414211015 0.00395062380125599 0.0486046443427252
OV ENSG00000203688 RP11-351J23.1 path:05143_1 African trypanosomiasis 9 4.0852600418552 6.02306071056266e-05 0.00498560980608799
OV ENSG00000203688 RP11-351J23.1 path:05164_41 Influenza A 6 2.87422410800824 0.00442435120464645 0.0493797044840981
OV ENSG00000203688 RP11-351J23.1 path:05206_22 MicroRNAs in cancer 98 -4.02626993689228 8.77461921120874e-05 0.00593749233291792
OV ENSG00000203688 RP11-351J23.1 path:05211_17 Renal cell carcinoma 6 -3.575982431959 0.000429243236682073 0.0145227295077435
OV ENSG00000203688 RP11-351J23.1 path:05212_5 Pancreatic cancer 46 -3.48476678161276 0.00065559834240241 0.0163335060713362
OV ENSG00000203688 RP11-351J23.1 path:05214_7 Glioma 50 -2.98977152878203 0.00313446230693004 0.0438824722970206
OV ENSG00000203688 RP11-351J23.1 path:05215_53 Prostate cancer 30 -3.0164845840865 0.00309640582064933 0.0438824722970206
OV ENSG00000203688 RP11-351J23.1 path:05221_34 Acute myeloid leukemia 23 -2.88107945441955 0.00450012085199909 0.0493797044840981
OV ENSG00000272549 RP11-351J23.2 path:00100_10 Steroid biosynthesis 10 2.87093377530285 0.00443378392554821 0.0493797044840981
OV ENSG00000272549 RP11-351J23.2 path:00120_6 Primary bile acid biosynthesis 3 3.37791928562181 0.000859237595362444 0.0193805813176196
OV ENSG00000272549 RP11-351J23.2 path:00330_90 Arginine and proline metabolism 6 3.88897008617019 0.000126318115246594 0.00732645068430247
OV ENSG00000272549 RP11-351J23.2 path:00524_1 Butirosin and neomycin biosynthesis 4 -3.01399467102562 0.00293993647339391 0.0438824722970206
OV ENSG00000272549 RP11-351J23.2 path:00561_55 Glycerolipid metabolism 7 3.22113303481992 0.00145062586365298 0.0268320792106822
OV ENSG00000272549 RP11-351J23.2 path:00565_8 Ether lipid metabolism 23 -3.15851475914324 0.00193161154985689 0.031369371569676
OV ENSG00000272549 RP11-351J23.2 path:00983_2 Drug metabolism - other enzymes 16 3.1600516243159 0.00175918638689991 0.0297595697117236
OV ENSG00000272549 RP11-351J23.2 path:04014_21 Ras signaling pathway 155 -2.96629604298501 0.00334171874807055 0.0441790540033559
OV ENSG00000272549 RP11-351J23.2 path:04068_37 FoxO signaling pathway 42 -4.72348422240979 4.66625725851313e-06 0.000947250223478165
OV ENSG00000272549 RP11-351J23.2 path:04140_1 Regulation of autophagy 10 -3.26934537046421 0.00126344187383331 0.0256478700388162
OV ENSG00000272549 RP11-351J23.2 path:04330_24 Notch signaling pathway 16 -3.59852024270707 0.000404105287323363 0.0145227295077435
OV ENSG00000272549 RP11-351J23.2 path:04360_143 Axon guidance 9 -2.89065044091061 0.00421838613673413 0.0493797044840981
OV ENSG00000272549 RP11-351J23.2 path:04360_145 Axon guidance 8 -3.4445832856097 0.000683915278849054 0.0163335060713362
OV ENSG00000272549 RP11-351J23.2 path:04390_125 Hippo signaling pathway 10 -2.95399813803269 0.00348209292637288 0.0441790540033559
OV ENSG00000272549 RP11-351J23.2 path:04510_310 Focal adhesion 7 -4.09316761353922 5.95817311350318e-05 0.00498560980608799
OV ENSG00000272549 RP11-351J23.2 path:04510_63 Focal adhesion 76 -3.35206044427342 0.00100770664867631 0.0215330999664517
OV ENSG00000272549 RP11-351J23.2 path:04550_2 Signaling pathways regulating pluripotency of stem cells 91 -3.64923005659467 0.000337794308078854 0.0144491932827961
OV ENSG00000272549 RP11-351J23.2 path:04621_50 NOD-like receptor signaling pathway 7 -7.51700111475503 1.65061591341748e-12 6.70150060847497e-10
OV ENSG00000272549 RP11-351J23.2 path:04623_19 Cytosolic DNA-sensing pathway 3 3.2216086658782 0.00145395503112071 0.0268320792106822
OV ENSG00000272549 RP11-351J23.2 path:04666_159 Fc gamma R-mediated phagocytosis 19 -3.55208299860538 0.000491411977129663 0.0153471740549725
OV ENSG00000272549 RP11-351J23.2 path:04670_105 Leukocyte transendothelial migration 16 3.18555722231736 0.0016201776836279 0.0285996582414317
OV ENSG00000272549 RP11-351J23.2 path:04670_163 Leukocyte transendothelial migration 4 -3.82119532026206 0.000177156063901317 0.00899067024299186
OV ENSG00000272549 RP11-351J23.2 path:04720_55 Long-term potentiation 18 4.06825075287858 6.13991355429556e-05 0.00498560980608799
OV ENSG00000272549 RP11-351J23.2 path:04720_60 Long-term potentiation 16 -2.96360519332466 0.00345761918879733 0.0441790540033559
OV ENSG00000272549 RP11-351J23.2 path:04723_39 Retrograde endocannabinoid signaling 14 3.62173583001926 0.000355891460167391 0.0144491932827961
OV ENSG00000272549 RP11-351J23.2 path:04932_84 Non-alcoholic fatty liver disease (NAFLD) 11 -3.47837649319126 0.000609687967999611 0.0163335060713362
OV ENSG00000272549 RP11-351J23.2 path:05033_8 Nicotine addiction 9 3.07144934384726 0.00236221222400283 0.0368868524209673
OV ENSG00000272549 RP11-351J23.2 path:05131_27 Shigellosis 2 -3.47229754069797 0.00061634900633344 0.0163335060713362
OV ENSG00000272549 RP11-351J23.2 path:05134_11 Legionellosis 7 2.91032414211015 0.00395062380125599 0.0486046443427252
OV ENSG00000272549 RP11-351J23.2 path:05143_1 African trypanosomiasis 9 4.0852600418552 6.02306071056266e-05 0.00498560980608799
OV ENSG00000272549 RP11-351J23.2 path:05164_41 Influenza A 6 2.87422410800824 0.00442435120464645 0.0493797044840981
OV ENSG00000272549 RP11-351J23.2 path:05206_22 MicroRNAs in cancer 98 -4.02626993689228 8.77461921120874e-05 0.00593749233291792
OV ENSG00000272549 RP11-351J23.2 path:05211_17 Renal cell carcinoma 6 -3.575982431959 0.000429243236682073 0.0145227295077435
OV ENSG00000272549 RP11-351J23.2 path:05212_5 Pancreatic cancer 46 -3.48476678161276 0.00065559834240241 0.0163335060713362
OV ENSG00000272549 RP11-351J23.2 path:05214_7 Glioma 50 -2.98977152878203 0.00313446230693004 0.0438824722970206
OV ENSG00000272549 RP11-351J23.2 path:05215_53 Prostate cancer 30 -3.0164845840865 0.00309640582064933 0.0438824722970206
OV ENSG00000272549 RP11-351J23.2 path:05221_34 Acute myeloid leukemia 23 -2.88107945441955 0.00450012085199909 0.0493797044840981
OV ENSG00000256955 RP11-417L19.2 path:00120_5 Primary bile acid biosynthesis 4 4.34195377550443 2.24692188447678e-05 0.000956710118782273
OV ENSG00000256955 RP11-417L19.2 path:00140_7 Steroid hormone biosynthesis 23 2.71756167579368 0.00724880506373806 0.0399737701779041
OV ENSG00000256955 RP11-417L19.2 path:00232_1 Caffeine metabolism 3 2.99291126009978 0.00316683811912061 0.0216706131152794
OV ENSG00000256955 RP11-417L19.2 path:00270_17 Cysteine and methionine metabolism 19 -3.31891766346046 0.00103562787826463 0.0108740927217787
OV ENSG00000256955 RP11-417L19.2 path:00270_51 Cysteine and methionine metabolism 8 -2.68604352386049 0.00764873507990748 0.0402551056806751
OV ENSG00000256955 RP11-417L19.2 path:00310_9 Lysine degradation 23 -4.58167639833063 7.35244594320513e-06 0.000419089418762692
OV ENSG00000256955 RP11-417L19.2 path:00450_8 Selenocompound metabolism 3 -5.9146809411007 1.07060841612419e-08 1.42390919344518e-06
OV ENSG00000256955 RP11-417L19.2 path:00562_2 Inositol phosphate metabolism 44 -2.89904466608991 0.0040807199076784 0.0262614071478013
OV ENSG00000256955 RP11-417L19.2 path:00562_70 Inositol phosphate metabolism 7 -3.84316635366397 0.000150424289233826 0.00300641527210726
OV ENSG00000256955 RP11-417L19.2 path:00565_22 Ether lipid metabolism 13 2.90954336503297 0.00415318485572434 0.0263035040862542
OV ENSG00000256955 RP11-417L19.2 path:00591_12 Linoleic acid metabolism 16 3.19250660972243 0.00170840475512197 0.0151478554954148
OV ENSG00000256955 RP11-417L19.2 path:00601_16 Glycosphingolipid biosynthesis - lacto and neolacto series 12 3.50223893044274 0.000577082215921537 0.00677222953390274
OV ENSG00000256955 RP11-417L19.2 path:00603_1 Glycosphingolipid biosynthesis - globo series 9 3.66676896681137 0.000300918779853197 0.00431749364504043
OV ENSG00000256955 RP11-417L19.2 path:00604_1 Glycosphingolipid biosynthesis - ganglio series 9 3.88994809282333 0.000136907749391259 0.00300641527210726
OV ENSG00000256955 RP11-417L19.2 path:00760_1 Nicotinate and nicotinamide metabolism 20 4.11803493070203 5.53161180458461e-05 0.00169777931540712
OV ENSG00000256955 RP11-417L19.2 path:00983_2 Drug metabolism - other enzymes 16 3.82633637079882 0.000180837008848557 0.00300641527210726
OV ENSG00000256955 RP11-417L19.2 path:03320_1 PPAR signaling pathway 48 -3.2104428658955 0.00154599336298451 0.0140522278796805
OV ENSG00000256955 RP11-417L19.2 path:04012_22 ErbB signaling pathway 65 -3.05797073101882 0.00244193126821179 0.0194866115203301
OV ENSG00000256955 RP11-417L19.2 path:04014_12 Ras signaling pathway 180 -3.39431969226969 0.00079506667106656 0.00906376005015879
OV ENSG00000256955 RP11-417L19.2 path:04024_125 cAMP signaling pathway 23 -4.13648344206064 4.64130116750283e-05 0.00154323263819469
OV ENSG00000256955 RP11-417L19.2 path:04062_228 Chemokine signaling pathway 13 2.85683063390582 0.00479057643323499 0.0289612120736479
OV ENSG00000256955 RP11-417L19.2 path:04062_26 Chemokine signaling pathway 106 -3.21092767809999 0.00151293974060751 0.0140522278796805
OV ENSG00000256955 RP11-417L19.2 path:04064_1 NF-kappa B signaling pathway 69 3.04585452090235 0.00263038076896721 0.0201831139772677
OV ENSG00000256955 RP11-417L19.2 path:04070_22 Phosphatidylinositol signaling system 29 -3.51295089580531 0.000522678414439849 0.00631965719277272
OV ENSG00000256955 RP11-417L19.2 path:04122_1 Sulfur relay system 5 2.64693683957269 0.00871840324241918 0.0440334543509526
OV ENSG00000256955 RP11-417L19.2 path:04140_2 Regulation of autophagy 4 -7.18583149713795 5.71384299224867e-12 2.27982335390722e-09
OV ENSG00000256955 RP11-417L19.2 path:04145_13 Phagosome 10 -3.21241210542898 0.00152329978669899 0.0140522278796805
OV ENSG00000256955 RP11-417L19.2 path:04151_233 PI3K-Akt signaling pathway 26 2.71042738747593 0.00731487011124955 0.0399737701779041
OV ENSG00000256955 RP11-417L19.2 path:04151_67 PI3K-Akt signaling pathway 164 -3.56563987250422 0.000463401704139851 0.00577803999849376
OV ENSG00000256955 RP11-417L19.2 path:04152_50 AMPK signaling pathway 21 -5.22498039643753 3.95885513904348e-07 3.94895800119587e-05
OV ENSG00000256955 RP11-417L19.2 path:04210_36 Apoptosis 36 -2.86701093661245 0.0044633532771611 0.0273981224244197
OV ENSG00000256955 RP11-417L19.2 path:04261_51 Adrenergic signaling in cardiomyocytes 66 -3.88941153161631 0.000132069225672664 0.00300641527210726
OV ENSG00000256955 RP11-417L19.2 path:04330_22 Notch signaling pathway 24 -4.30333237977485 2.39776972125883e-05 0.000956710118782273
OV ENSG00000256955 RP11-417L19.2 path:04330_24 Notch signaling pathway 16 -6.05801749429401 4.8276791595908e-09 9.63121992338366e-07
OV ENSG00000256955 RP11-417L19.2 path:04360_145 Axon guidance 8 -2.80436649576071 0.00544385361571119 0.0324193670547577
OV ENSG00000256955 RP11-417L19.2 path:04370_42 VEGF signaling pathway 22 -3.29429900760846 0.00113874131092459 0.0116501995656132
OV ENSG00000256955 RP11-417L19.2 path:04370_66 VEGF signaling pathway 14 -3.13324587637491 0.00191189649607257 0.0162307808921905
OV ENSG00000256955 RP11-417L19.2 path:04510_126 Focal adhesion 38 -3.09974293968889 0.00213686744421092 0.0174237381395233
OV ENSG00000256955 RP11-417L19.2 path:04510_137 Focal adhesion 32 -3.01611294564293 0.00285982808854827 0.0211309519876067
OV ENSG00000256955 RP11-417L19.2 path:04510_283 Focal adhesion 10 -3.04388261578839 0.00259063371524695 0.0201831139772677
OV ENSG00000256955 RP11-417L19.2 path:04611_279 Platelet activation 2 3.00704159998309 0.00303746554120097 0.0216419419810569
OV ENSG00000256955 RP11-417L19.2 path:04620_60 Toll-like receptor signaling pathway 22 4.93633660779526 1.73779632766323e-06 0.000115563455789605
OV ENSG00000256955 RP11-417L19.2 path:04620_92 Toll-like receptor signaling pathway 11 -3.65390007639631 0.000309334889436814 0.00431749364504043
OV ENSG00000256955 RP11-417L19.2 path:04621_22 NOD-like receptor signaling pathway 28 -3.631717877703 0.000356149164438062 0.00473678388702622
OV ENSG00000256955 RP11-417L19.2 path:04650_115 Natural killer cell mediated cytotoxicity 5 3.35696234360302 0.000969995048539834 0.0104602168747944
OV ENSG00000256955 RP11-417L19.2 path:04650_139 Natural killer cell mediated cytotoxicity 2 2.89792855491181 0.00426111133244916 0.0265653659632378
OV ENSG00000256955 RP11-417L19.2 path:04664_71 Fc epsilon RI signaling pathway 10 -2.90576225364913 0.00395191909440296 0.0258494380109309
OV ENSG00000256955 RP11-417L19.2 path:04664_75 Fc epsilon RI signaling pathway 9 -3.09890749262546 0.00213975731538006 0.0174237381395233
OV ENSG00000256955 RP11-417L19.2 path:04720_79 Long-term potentiation 3 -2.69941117471501 0.00741368168713008 0.0399737701779041
OV ENSG00000256955 RP11-417L19.2 path:04725_86 Cholinergic synapse 18 -3.65052643682297 0.000313802796256071 0.00431749364504043
OV ENSG00000256955 RP11-417L19.2 path:04742_1 Taste transduction 14 -3.57253669789689 0.000430801495481054 0.00554483215151421
OV ENSG00000256955 RP11-417L19.2 path:04810_241 Regulation of actin cytoskeleton 4 -4.40249896092598 1.56177639100603e-05 0.000778935975014256
OV ENSG00000256955 RP11-417L19.2 path:04810_68 Regulation of actin cytoskeleton 69 -3.86495257424228 0.000142704515453312 0.00300641527210726
OV ENSG00000256955 RP11-417L19.2 path:04916_128 Melanogenesis 6 -3.20123283579129 0.00154961911455123 0.0140522278796805
OV ENSG00000256955 RP11-417L19.2 path:04916_139 Melanogenesis 2 -3.68997918016985 0.000269384365644165 0.00413401391892392
OV ENSG00000256955 RP11-417L19.2 path:04916_75 Melanogenesis 23 -2.98549644547524 0.00315526451006006 0.0216706131152794
OV ENSG00000256955 RP11-417L19.2 path:04917_119 Prolactin signaling pathway 10 -3.13851815858974 0.00188371333840654 0.0162307808921905
OV ENSG00000256955 RP11-417L19.2 path:04919_50 Thyroid hormone signaling pathway 33 -2.64852768017977 0.00864353415722225 0.0440334543509526
OV ENSG00000256955 RP11-417L19.2 path:04919_84 Thyroid hormone signaling pathway 5 -3.00453798657641 0.00292713411214106 0.0212350274680779
OV ENSG00000256955 RP11-417L19.2 path:04940_2 Type I diabetes mellitus 2 3.82985124115553 0.000179541911893609 0.00300641527210726
OV ENSG00000256955 RP11-417L19.2 path:04960_8 Aldosterone-regulated sodium reabsorption 14 -4.20684209158807 3.45929632977722e-05 0.00125478112325555
OV ENSG00000256955 RP11-417L19.2 path:04961_12 Endocrine and other factor-regulated calcium reabsorption 11 2.73148685206949 0.00691599377293584 0.0388659368366395
OV ENSG00000256955 RP11-417L19.2 path:04973_1 Carbohydrate digestion and absorption 12 -3.01506650065409 0.00280457143784636 0.021113660447183
OV ENSG00000256955 RP11-417L19.2 path:04976_8 Bile secretion 8 2.67935241341786 0.00809326064487638 0.041937805159814
OV ENSG00000256955 RP11-417L19.2 path:05132_39 Salmonella infection 8 -2.77088542880957 0.00615364240598926 0.0361074017645546
OV ENSG00000256955 RP11-417L19.2 path:05140_54 Leishmaniasis 15 3.25116027133203 0.00136347217526574 0.0136006349482758
OV ENSG00000256955 RP11-417L19.2 path:05140_84 Leishmaniasis 3 2.98817746745875 0.0032044265007556 0.0216706131152794
OV ENSG00000256955 RP11-417L19.2 path:05206_109 MicroRNAs in cancer 14 -5.00464007024165 9.77630018465642e-07 7.80148754735582e-05
OV ENSG00000256955 RP11-417L19.2 path:05206_112 MicroRNAs in cancer 11 -2.94470712378743 0.00353064299206078 0.0234787758972042
OV ENSG00000256955 RP11-417L19.2 path:05211_9 Renal cell carcinoma 14 -2.68779325039084 0.00766763917727145 0.0402551056806751
OV ENSG00000256955 RP11-417L19.2 path:05212_61 Pancreatic cancer 2 -2.72636656538376 0.00690620060306928 0.0388659368366395
OV ENSG00000256955 RP11-417L19.2 path:05215_50 Prostate cancer 35 -3.93668847076429 0.000103860644977709 0.0029600283818647
OV ENSG00000256955 RP11-417L19.2 path:05215_83 Prostate cancer 9 -3.9141070531498 0.000124447931276524 0.00300641527210726
OV ENSG00000256955 RP11-417L19.2 path:05218_1 Melanoma 63 -2.61499925508358 0.00951655832233571 0.0474638346326494
OV ENSG00000256955 RP11-417L19.2 path:05221_7 Acute myeloid leukemia 49 -3.72298220959101 0.000248729764025945 0.00396972703385408
OV ENSG00000256955 RP11-417L19.2 path:05231_31 Choline metabolism in cancer 35 -3.34963183039395 0.000933585509813083 0.0103472394004283
OV ENSG00000256955 RP11-417L19.2 path:05231_42 Choline metabolism in cancer 26 -2.74461863558082 0.00660695743407369 0.0382054495100783
OV ENSG00000256955 RP11-417L19.2 path:05320_2 Autoimmune thyroid disease 2 3.82985124115553 0.000179541911893609 0.00300641527210726
OV ENSG00000256955 RP11-417L19.2 path:05330_2 Allograft rejection 2 3.82985124115553 0.000179541911893609 0.00300641527210726
OV ENSG00000256955 RP11-417L19.2 path:05332_5 Graft-versus-host disease 2 3.82985124115553 0.000179541911893609 0.00300641527210726
OV ENSG00000255992 RP11-417L19.4 path:00120_5 Primary bile acid biosynthesis 4 4.34195377550443 2.24692188447678e-05 0.000956710118782273
OV ENSG00000255992 RP11-417L19.4 path:00140_7 Steroid hormone biosynthesis 23 2.71756167579368 0.00724880506373806 0.0399737701779041
OV ENSG00000255992 RP11-417L19.4 path:00232_1 Caffeine metabolism 3 2.99291126009978 0.00316683811912061 0.0216706131152794
OV ENSG00000255992 RP11-417L19.4 path:00270_17 Cysteine and methionine metabolism 19 -3.31891766346046 0.00103562787826463 0.0108740927217787
OV ENSG00000255992 RP11-417L19.4 path:00270_51 Cysteine and methionine metabolism 8 -2.68604352386049 0.00764873507990748 0.0402551056806751
OV ENSG00000255992 RP11-417L19.4 path:00310_9 Lysine degradation 23 -4.58167639833063 7.35244594320513e-06 0.000419089418762692
OV ENSG00000255992 RP11-417L19.4 path:00450_8 Selenocompound metabolism 3 -5.9146809411007 1.07060841612419e-08 1.42390919344518e-06
OV ENSG00000255992 RP11-417L19.4 path:00562_2 Inositol phosphate metabolism 44 -2.89904466608991 0.0040807199076784 0.0262614071478013
OV ENSG00000255992 RP11-417L19.4 path:00562_70 Inositol phosphate metabolism 7 -3.84316635366397 0.000150424289233826 0.00300641527210726
OV ENSG00000255992 RP11-417L19.4 path:00565_22 Ether lipid metabolism 13 2.90954336503297 0.00415318485572434 0.0263035040862542
OV ENSG00000255992 RP11-417L19.4 path:00591_12 Linoleic acid metabolism 16 3.19250660972243 0.00170840475512197 0.0151478554954148
OV ENSG00000255992 RP11-417L19.4 path:00601_16 Glycosphingolipid biosynthesis - lacto and neolacto series 12 3.50223893044274 0.000577082215921537 0.00677222953390274
OV ENSG00000255992 RP11-417L19.4 path:00603_1 Glycosphingolipid biosynthesis - globo series 9 3.66676896681137 0.000300918779853197 0.00431749364504043
OV ENSG00000255992 RP11-417L19.4 path:00604_1 Glycosphingolipid biosynthesis - ganglio series 9 3.88994809282333 0.000136907749391259 0.00300641527210726
OV ENSG00000255992 RP11-417L19.4 path:00760_1 Nicotinate and nicotinamide metabolism 20 4.11803493070203 5.53161180458461e-05 0.00169777931540712
OV ENSG00000255992 RP11-417L19.4 path:00983_2 Drug metabolism - other enzymes 16 3.82633637079882 0.000180837008848557 0.00300641527210726
OV ENSG00000255992 RP11-417L19.4 path:03320_1 PPAR signaling pathway 48 -3.2104428658955 0.00154599336298451 0.0140522278796805
OV ENSG00000255992 RP11-417L19.4 path:04012_22 ErbB signaling pathway 65 -3.05797073101882 0.00244193126821179 0.0194866115203301
OV ENSG00000255992 RP11-417L19.4 path:04014_12 Ras signaling pathway 180 -3.39431969226969 0.00079506667106656 0.00906376005015879
OV ENSG00000255992 RP11-417L19.4 path:04024_125 cAMP signaling pathway 23 -4.13648344206064 4.64130116750283e-05 0.00154323263819469
OV ENSG00000255992 RP11-417L19.4 path:04062_228 Chemokine signaling pathway 13 2.85683063390582 0.00479057643323499 0.0289612120736479
OV ENSG00000255992 RP11-417L19.4 path:04062_26 Chemokine signaling pathway 106 -3.21092767809999 0.00151293974060751 0.0140522278796805
OV ENSG00000255992 RP11-417L19.4 path:04064_1 NF-kappa B signaling pathway 69 3.04585452090235 0.00263038076896721 0.0201831139772677
OV ENSG00000255992 RP11-417L19.4 path:04070_22 Phosphatidylinositol signaling system 29 -3.51295089580531 0.000522678414439849 0.00631965719277272
OV ENSG00000255992 RP11-417L19.4 path:04122_1 Sulfur relay system 5 2.64693683957269 0.00871840324241918 0.0440334543509526
OV ENSG00000255992 RP11-417L19.4 path:04140_2 Regulation of autophagy 4 -7.18583149713795 5.71384299224867e-12 2.27982335390722e-09
OV ENSG00000255992 RP11-417L19.4 path:04145_13 Phagosome 10 -3.21241210542898 0.00152329978669899 0.0140522278796805
OV ENSG00000255992 RP11-417L19.4 path:04151_233 PI3K-Akt signaling pathway 26 2.71042738747593 0.00731487011124955 0.0399737701779041
OV ENSG00000255992 RP11-417L19.4 path:04151_67 PI3K-Akt signaling pathway 164 -3.56563987250422 0.000463401704139851 0.00577803999849376
OV ENSG00000255992 RP11-417L19.4 path:04152_50 AMPK signaling pathway 21 -5.22498039643753 3.95885513904348e-07 3.94895800119587e-05
OV ENSG00000255992 RP11-417L19.4 path:04210_36 Apoptosis 36 -2.86701093661245 0.0044633532771611 0.0273981224244197
OV ENSG00000255992 RP11-417L19.4 path:04261_51 Adrenergic signaling in cardiomyocytes 66 -3.88941153161631 0.000132069225672664 0.00300641527210726
OV ENSG00000255992 RP11-417L19.4 path:04330_22 Notch signaling pathway 24 -4.30333237977485 2.39776972125883e-05 0.000956710118782273
OV ENSG00000255992 RP11-417L19.4 path:04330_24 Notch signaling pathway 16 -6.05801749429401 4.8276791595908e-09 9.63121992338366e-07
OV ENSG00000255992 RP11-417L19.4 path:04360_145 Axon guidance 8 -2.80436649576071 0.00544385361571119 0.0324193670547577
OV ENSG00000255992 RP11-417L19.4 path:04370_42 VEGF signaling pathway 22 -3.29429900760846 0.00113874131092459 0.0116501995656132
OV ENSG00000255992 RP11-417L19.4 path:04370_66 VEGF signaling pathway 14 -3.13324587637491 0.00191189649607257 0.0162307808921905
OV ENSG00000255992 RP11-417L19.4 path:04510_126 Focal adhesion 38 -3.09974293968889 0.00213686744421092 0.0174237381395233
OV ENSG00000255992 RP11-417L19.4 path:04510_137 Focal adhesion 32 -3.01611294564293 0.00285982808854827 0.0211309519876067
OV ENSG00000255992 RP11-417L19.4 path:04510_283 Focal adhesion 10 -3.04388261578839 0.00259063371524695 0.0201831139772677
OV ENSG00000255992 RP11-417L19.4 path:04611_279 Platelet activation 2 3.00704159998309 0.00303746554120097 0.0216419419810569
OV ENSG00000255992 RP11-417L19.4 path:04620_60 Toll-like receptor signaling pathway 22 4.93633660779526 1.73779632766323e-06 0.000115563455789605
OV ENSG00000255992 RP11-417L19.4 path:04620_92 Toll-like receptor signaling pathway 11 -3.65390007639631 0.000309334889436814 0.00431749364504043
OV ENSG00000255992 RP11-417L19.4 path:04621_22 NOD-like receptor signaling pathway 28 -3.631717877703 0.000356149164438062 0.00473678388702622
OV ENSG00000255992 RP11-417L19.4 path:04650_115 Natural killer cell mediated cytotoxicity 5 3.35696234360302 0.000969995048539834 0.0104602168747944
OV ENSG00000255992 RP11-417L19.4 path:04650_139 Natural killer cell mediated cytotoxicity 2 2.89792855491181 0.00426111133244916 0.0265653659632378
OV ENSG00000255992 RP11-417L19.4 path:04664_71 Fc epsilon RI signaling pathway 10 -2.90576225364913 0.00395191909440296 0.0258494380109309
OV ENSG00000255992 RP11-417L19.4 path:04664_75 Fc epsilon RI signaling pathway 9 -3.09890749262546 0.00213975731538006 0.0174237381395233
OV ENSG00000255992 RP11-417L19.4 path:04720_79 Long-term potentiation 3 -2.69941117471501 0.00741368168713008 0.0399737701779041
OV ENSG00000255992 RP11-417L19.4 path:04725_86 Cholinergic synapse 18 -3.65052643682297 0.000313802796256071 0.00431749364504043
OV ENSG00000255992 RP11-417L19.4 path:04742_1 Taste transduction 14 -3.57253669789689 0.000430801495481054 0.00554483215151421
OV ENSG00000255992 RP11-417L19.4 path:04810_241 Regulation of actin cytoskeleton 4 -4.40249896092598 1.56177639100603e-05 0.000778935975014256
OV ENSG00000255992 RP11-417L19.4 path:04810_68 Regulation of actin cytoskeleton 69 -3.86495257424228 0.000142704515453312 0.00300641527210726
OV ENSG00000255992 RP11-417L19.4 path:04916_128 Melanogenesis 6 -3.20123283579129 0.00154961911455123 0.0140522278796805
OV ENSG00000255992 RP11-417L19.4 path:04916_139 Melanogenesis 2 -3.68997918016985 0.000269384365644165 0.00413401391892392
OV ENSG00000255992 RP11-417L19.4 path:04916_75 Melanogenesis 23 -2.98549644547524 0.00315526451006006 0.0216706131152794
OV ENSG00000255992 RP11-417L19.4 path:04917_119 Prolactin signaling pathway 10 -3.13851815858974 0.00188371333840654 0.0162307808921905
OV ENSG00000255992 RP11-417L19.4 path:04919_50 Thyroid hormone signaling pathway 33 -2.64852768017977 0.00864353415722225 0.0440334543509526
OV ENSG00000255992 RP11-417L19.4 path:04919_84 Thyroid hormone signaling pathway 5 -3.00453798657641 0.00292713411214106 0.0212350274680779
OV ENSG00000255992 RP11-417L19.4 path:04940_2 Type I diabetes mellitus 2 3.82985124115553 0.000179541911893609 0.00300641527210726
OV ENSG00000255992 RP11-417L19.4 path:04960_8 Aldosterone-regulated sodium reabsorption 14 -4.20684209158807 3.45929632977722e-05 0.00125478112325555
OV ENSG00000255992 RP11-417L19.4 path:04961_12 Endocrine and other factor-regulated calcium reabsorption 11 2.73148685206949 0.00691599377293584 0.0388659368366395
OV ENSG00000255992 RP11-417L19.4 path:04973_1 Carbohydrate digestion and absorption 12 -3.01506650065409 0.00280457143784636 0.021113660447183
OV ENSG00000255992 RP11-417L19.4 path:04976_8 Bile secretion 8 2.67935241341786 0.00809326064487638 0.041937805159814
OV ENSG00000255992 RP11-417L19.4 path:05132_39 Salmonella infection 8 -2.77088542880957 0.00615364240598926 0.0361074017645546
OV ENSG00000255992 RP11-417L19.4 path:05140_54 Leishmaniasis 15 3.25116027133203 0.00136347217526574 0.0136006349482758
OV ENSG00000255992 RP11-417L19.4 path:05140_84 Leishmaniasis 3 2.98817746745875 0.0032044265007556 0.0216706131152794
OV ENSG00000255992 RP11-417L19.4 path:05206_109 MicroRNAs in cancer 14 -5.00464007024165 9.77630018465642e-07 7.80148754735582e-05
OV ENSG00000255992 RP11-417L19.4 path:05206_112 MicroRNAs in cancer 11 -2.94470712378743 0.00353064299206078 0.0234787758972042
OV ENSG00000255992 RP11-417L19.4 path:05211_9 Renal cell carcinoma 14 -2.68779325039084 0.00766763917727145 0.0402551056806751
OV ENSG00000255992 RP11-417L19.4 path:05212_61 Pancreatic cancer 2 -2.72636656538376 0.00690620060306928 0.0388659368366395
OV ENSG00000255992 RP11-417L19.4 path:05215_50 Prostate cancer 35 -3.93668847076429 0.000103860644977709 0.0029600283818647
OV ENSG00000255992 RP11-417L19.4 path:05215_83 Prostate cancer 9 -3.9141070531498 0.000124447931276524 0.00300641527210726
OV ENSG00000255992 RP11-417L19.4 path:05218_1 Melanoma 63 -2.61499925508358 0.00951655832233571 0.0474638346326494
OV ENSG00000255992 RP11-417L19.4 path:05221_7 Acute myeloid leukemia 49 -3.72298220959101 0.000248729764025945 0.00396972703385408
OV ENSG00000255992 RP11-417L19.4 path:05231_31 Choline metabolism in cancer 35 -3.34963183039395 0.000933585509813083 0.0103472394004283
OV ENSG00000255992 RP11-417L19.4 path:05231_42 Choline metabolism in cancer 26 -2.74461863558082 0.00660695743407369 0.0382054495100783
OV ENSG00000255992 RP11-417L19.4 path:05320_2 Autoimmune thyroid disease 2 3.82985124115553 0.000179541911893609 0.00300641527210726
OV ENSG00000255992 RP11-417L19.4 path:05330_2 Allograft rejection 2 3.82985124115553 0.000179541911893609 0.00300641527210726
OV ENSG00000255992 RP11-417L19.4 path:05332_5 Graft-versus-host disease 2 3.82985124115553 0.000179541911893609 0.00300641527210726
OV ENSG00000248703 RP11-495K9.3 path:00120_5 Primary bile acid biosynthesis 4 4.38877074501238 1.83646678006328e-05 0.000666136586586588
OV ENSG00000248703 RP11-495K9.3 path:00270_17 Cysteine and methionine metabolism 19 -3.25574832940647 0.00128393503301192 0.0111367408298208
OV ENSG00000248703 RP11-495K9.3 path:00310_9 Lysine degradation 23 -5.02931465432279 9.60297332587184e-07 6.38597726170478e-05
OV ENSG00000248703 RP11-495K9.3 path:00450_8 Selenocompound metabolism 3 -5.9206616008005 1.0536338924127e-08 1.40133307690889e-06
OV ENSG00000248703 RP11-495K9.3 path:00562_2 Inositol phosphate metabolism 44 -2.92857068164102 0.0037272370724713 0.0236058347923183
OV ENSG00000248703 RP11-495K9.3 path:00562_70 Inositol phosphate metabolism 7 -4.32127679721445 2.14981768121379e-05 0.000714814379003584
OV ENSG00000248703 RP11-495K9.3 path:00564_106 Glycerophospholipid metabolism 3 2.78295783462893 0.00592254710649351 0.0319337337228501
OV ENSG00000248703 RP11-495K9.3 path:00565_22 Ether lipid metabolism 13 2.72035619027343 0.00723523479711315 0.0356402306672611
OV ENSG00000248703 RP11-495K9.3 path:00591_12 Linoleic acid metabolism 16 2.92817730194694 0.00390659985799374 0.0243552084896798
OV ENSG00000248703 RP11-495K9.3 path:00600_45 Sphingolipid metabolism 6 2.74128970570189 0.00677122494686619 0.0346374199205078
OV ENSG00000248703 RP11-495K9.3 path:00601_16 Glycosphingolipid biosynthesis - lacto and neolacto series 12 3.43845479204251 0.000721448125076083 0.00799605005292659
OV ENSG00000248703 RP11-495K9.3 path:00603_1 Glycosphingolipid biosynthesis - globo series 9 3.47068162691206 0.000614927292383562 0.00743502998972853
OV ENSG00000248703 RP11-495K9.3 path:00604_1 Glycosphingolipid biosynthesis - ganglio series 9 3.71770788899947 0.000263582033100958 0.00403159960468996
OV ENSG00000248703 RP11-495K9.3 path:00760_1 Nicotinate and nicotinamide metabolism 20 3.94279412396165 0.000110695205776767 0.00245374372805168
OV ENSG00000248703 RP11-495K9.3 path:00770_1 Pantothenate and CoA biosynthesis 6 2.72450081893177 0.00701067392504536 0.0349657362011637
OV ENSG00000248703 RP11-495K9.3 path:00860_2 Porphyrin and chlorophyll metabolism 10 2.78593985519487 0.0058712081454304 0.0319337337228501
OV ENSG00000248703 RP11-495K9.3 path:00983_2 Drug metabolism - other enzymes 16 4.18456536428136 4.59837483655255e-05 0.00122316770652298
OV ENSG00000248703 RP11-495K9.3 path:03320_1 PPAR signaling pathway 48 -3.09776354692265 0.00223745467076595 0.0156621826953617
OV ENSG00000248703 RP11-495K9.3 path:04012_22 ErbB signaling pathway 65 -3.18989455073017 0.00158313030639077 0.0133648763747039
OV ENSG00000248703 RP11-495K9.3 path:04014_12 Ras signaling pathway 180 -3.7044256670576 0.000259179909262384 0.00403159960468996
OV ENSG00000248703 RP11-495K9.3 path:04014_139 Ras signaling pathway 15 -2.78311760409252 0.00584387638819669 0.0319337337228501
OV ENSG00000248703 RP11-495K9.3 path:04024_110 cAMP signaling pathway 29 -2.82743792325403 0.00511961278038954 0.028770781681344
OV ENSG00000248703 RP11-495K9.3 path:04024_125 cAMP signaling pathway 23 -4.27486108156866 2.60987755060623e-05 0.000801031648224527
OV ENSG00000248703 RP11-495K9.3 path:04062_26 Chemokine signaling pathway 106 -3.45287276253949 0.000661410199738429 0.00754007627701809
OV ENSG00000248703 RP11-495K9.3 path:04064_1 NF-kappa B signaling pathway 69 2.90197848070236 0.00412479293049036 0.0249362481706917
OV ENSG00000248703 RP11-495K9.3 path:04066_94 HIF-1 signaling pathway 15 -2.63326592595006 0.00898560345475359 0.0437226314444717
OV ENSG00000248703 RP11-495K9.3 path:04070_22 Phosphatidylinositol signaling system 29 -3.82469893338433 0.000163420322170316 0.00283498732808505
OV ENSG00000248703 RP11-495K9.3 path:04122_1 Sulfur relay system 5 3.11902843394646 0.00206519027975331 0.0150957351107514
OV ENSG00000248703 RP11-495K9.3 path:04140_2 Regulation of autophagy 4 -7.05067015864455 1.31564783651466e-11 5.24943486769351e-09
OV ENSG00000248703 RP11-495K9.3 path:04145_13 Phagosome 10 -2.84084916243482 0.00494154753659456 0.028166820958589
OV ENSG00000248703 RP11-495K9.3 path:04151_67 PI3K-Akt signaling pathway 164 -3.60257490956741 0.000405808889997928 0.00558337058997149
OV ENSG00000248703 RP11-495K9.3 path:04152_50 AMPK signaling pathway 21 -5.50049844207082 1.02559454621525e-07 1.02303055984971e-05
OV ENSG00000248703 RP11-495K9.3 path:04210_36 Apoptosis 36 -3.130386434893 0.00193482526768292 0.0148460631116439
OV ENSG00000248703 RP11-495K9.3 path:04261_51 Adrenergic signaling in cardiomyocytes 66 -4.23826534085201 3.28543066263916e-05 0.000936347738852161
OV ENSG00000248703 RP11-495K9.3 path:04310_144 Wnt signaling pathway 11 -2.95442389015462 0.00345999979250882 0.0226778955624639
OV ENSG00000248703 RP11-495K9.3 path:04330_22 Notch signaling pathway 24 -4.44014057016702 1.34084587699425e-05 0.000534997504920705
OV ENSG00000248703 RP11-495K9.3 path:04330_24 Notch signaling pathway 16 -6.33308135787459 1.05543798044907e-09 2.1055987709959e-07
OV ENSG00000248703 RP11-495K9.3 path:04360_145 Axon guidance 8 -3.14521765335435 0.00186660666856028 0.0148460631116439
OV ENSG00000248703 RP11-495K9.3 path:04370_42 VEGF signaling pathway 22 -3.86324686553049 0.000145128178293592 0.00263209741541561
OV ENSG00000248703 RP11-495K9.3 path:04370_66 VEGF signaling pathway 14 -3.13395378151433 0.00190865257770143 0.0148460631116439
OV ENSG00000248703 RP11-495K9.3 path:04510_126 Focal adhesion 38 -3.2588085977412 0.0012583938246382 0.0111367408298208
OV ENSG00000248703 RP11-495K9.3 path:04510_137 Focal adhesion 32 -3.45430067177936 0.000660657812124062 0.00754007627701809
OV ENSG00000248703 RP11-495K9.3 path:04510_283 Focal adhesion 10 -3.40176683165439 0.000783262477345242 0.00822425601212504
OV ENSG00000248703 RP11-495K9.3 path:04512_79 ECM-receptor interaction 8 -2.77740802012505 0.00600747748755447 0.0319597802337898
OV ENSG00000248703 RP11-495K9.3 path:04611_164 Platelet activation 15 -2.91256093290087 0.00398013088700973 0.024431880367952
OV ENSG00000248703 RP11-495K9.3 path:04611_279 Platelet activation 2 2.72816407098852 0.00700529035226658 0.0349657362011637
OV ENSG00000248703 RP11-495K9.3 path:04620_60 Toll-like receptor signaling pathway 22 4.78001219215098 3.54502149580349e-06 0.000202066225260799
OV ENSG00000248703 RP11-495K9.3 path:04620_92 Toll-like receptor signaling pathway 11 -3.68768521414718 0.000272815010843681 0.00403159960468996
OV ENSG00000248703 RP11-495K9.3 path:04621_22 NOD-like receptor signaling pathway 28 -3.56242133219777 0.000459011953907694 0.00610485898697233
OV ENSG00000248703 RP11-495K9.3 path:04650_115 Natural killer cell mediated cytotoxicity 5 3.07806296884031 0.00241289279941829 0.0165990383959982
OV ENSG00000248703 RP11-495K9.3 path:04650_139 Natural killer cell mediated cytotoxicity 2 2.62503191152082 0.00943651777580246 0.0448234594350617
OV ENSG00000248703 RP11-495K9.3 path:04664_71 Fc epsilon RI signaling pathway 10 -2.88446918562689 0.00422029964971252 0.0251328292572432
OV ENSG00000248703 RP11-495K9.3 path:04664_75 Fc epsilon RI signaling pathway 9 -3.10196806259234 0.00211869966466686 0.0150957351107514
OV ENSG00000248703 RP11-495K9.3 path:04720_79 Long-term potentiation 3 -2.84815354163694 0.00475981953789948 0.0279289411120867
OV ENSG00000248703 RP11-495K9.3 path:04725_86 Cholinergic synapse 18 -3.61769902166959 0.000354084081461203 0.00504569816082214
OV ENSG00000248703 RP11-495K9.3 path:04742_1 Taste transduction 14 -3.86517650098333 0.000144612443532088 0.00263209741541561
OV ENSG00000248703 RP11-495K9.3 path:04750_14 Inflammatory mediator regulation of TRP channels 66 -2.74281128951694 0.00658071331609294 0.0341000599106634
OV ENSG00000248703 RP11-495K9.3 path:04810_241 Regulation of actin cytoskeleton 4 -4.61819856226101 6.0593664547292e-06 0.000302210901929619
OV ENSG00000248703 RP11-495K9.3 path:04810_68 Regulation of actin cytoskeleton 69 -4.07293279710435 6.30752588798371e-05 0.00157293926831594
OV ENSG00000248703 RP11-495K9.3 path:04916_128 Melanogenesis 6 -3.40425810365379 0.000774938465897607 0.00822425601212504
OV ENSG00000248703 RP11-495K9.3 path:04916_139 Melanogenesis 2 -3.86352667007126 0.000138847638500708 0.00263209741541561
OV ENSG00000248703 RP11-495K9.3 path:04916_75 Melanogenesis 23 -3.3090740432862 0.00109890963342479 0.0101968591566626
OV ENSG00000248703 RP11-495K9.3 path:04917_119 Prolactin signaling pathway 10 -3.27341396161591 0.00119883782237831 0.0108712793438397
OV ENSG00000248703 RP11-495K9.3 path:04919_50 Thyroid hormone signaling pathway 33 -2.94907893606408 0.00352388352098436 0.0226778955624639
OV ENSG00000248703 RP11-495K9.3 path:04919_84 Thyroid hormone signaling pathway 5 -3.18886976931956 0.00160780467665611 0.0133648763747039
OV ENSG00000248703 RP11-495K9.3 path:04940_2 Type I diabetes mellitus 2 3.38228500323422 0.000888481328752173 0.00844057262314564
OV ENSG00000248703 RP11-495K9.3 path:04960_8 Aldosterone-regulated sodium reabsorption 14 -4.46439606357177 1.15280705361286e-05 0.000511077793768367
OV ENSG00000248703 RP11-495K9.3 path:04973_1 Carbohydrate digestion and absorption 12 -3.02490325990897 0.00271878920061749 0.0183863879838369
OV ENSG00000248703 RP11-495K9.3 path:05132_39 Salmonella infection 8 -2.76799298558023 0.00620636458906177 0.0325834140925743
OV ENSG00000248703 RP11-495K9.3 path:05140_54 Leishmaniasis 15 3.1517755359412 0.00189693537895389 0.0148460631116439
OV ENSG00000248703 RP11-495K9.3 path:05140_84 Leishmaniasis 3 3.52954603074327 0.000540815520424486 0.00674329352029281
OV ENSG00000248703 RP11-495K9.3 path:05206_109 MicroRNAs in cancer 14 -5.27607739621093 2.60648361992811e-07 2.07997392870263e-05
OV ENSG00000248703 RP11-495K9.3 path:05206_112 MicroRNAs in cancer 11 -3.11691693773615 0.00203510430389959 0.0150957351107514
OV ENSG00000248703 RP11-495K9.3 path:05211_9 Renal cell carcinoma 14 -2.94719970357589 0.0035078466085981 0.0226778955624639
OV ENSG00000248703 RP11-495K9.3 path:05212_61 Pancreatic cancer 2 -2.58525746773174 0.0103734915565737 0.0486943897773283
OV ENSG00000248703 RP11-495K9.3 path:05215_50 Prostate cancer 35 -3.99823634431151 8.13081258779376e-05 0.00190834954266454
OV ENSG00000248703 RP11-495K9.3 path:05215_83 Prostate cancer 9 -3.76812336031104 0.000216897652290398 0.00360592346932787
OV ENSG00000248703 RP11-495K9.3 path:05218_1 Melanoma 63 -2.84492827400633 0.00484838020722444 0.0280362855461239
OV ENSG00000248703 RP11-495K9.3 path:05221_7 Acute myeloid leukemia 49 -3.86894072918504 0.000143040479793953 0.00263209741541561
OV ENSG00000248703 RP11-495K9.3 path:05231_31 Choline metabolism in cancer 35 -3.51042876838787 0.000531503254458367 0.00674329352029281
OV ENSG00000248703 RP11-495K9.3 path:05231_42 Choline metabolism in cancer 26 -3.11602334017061 0.00209977785307876 0.0150957351107514
OV ENSG00000248703 RP11-495K9.3 path:05320_2 Autoimmune thyroid disease 2 3.38228500323422 0.000888481328752173 0.00844057262314564
OV ENSG00000248703 RP11-495K9.3 path:05330_2 Allograft rejection 2 3.38228500323422 0.000888481328752173 0.00844057262314564
OV ENSG00000248703 RP11-495K9.3 path:05332_5 Graft-versus-host disease 2 3.38228500323422 0.000888481328752173 0.00844057262314564
OV ENSG00000248703 RP11-495K9.3 path:05414_26 Dilated cardiomyopathy 6 -2.62137358565214 0.00922168391744859 0.0443307455790601
OV ENSG00000255933 RP11-495K9.5 path:00120_5 Primary bile acid biosynthesis 4 4.35581306744189 2.08617645162511e-05 0.000756713094725835
OV ENSG00000255933 RP11-495K9.5 path:00140_7 Steroid hormone biosynthesis 23 2.72985781468462 0.00696628870292606 0.0347443649058437
OV ENSG00000255933 RP11-495K9.5 path:00232_1 Caffeine metabolism 3 2.97637922152278 0.00331598060287064 0.0208562543667041
OV ENSG00000255933 RP11-495K9.5 path:00270_17 Cysteine and methionine metabolism 19 -3.39408135948966 0.000795074634167574 0.00813422510340672
OV ENSG00000255933 RP11-495K9.5 path:00270_51 Cysteine and methionine metabolism 8 -2.67322264742238 0.00793999255671832 0.0381693618088025
OV ENSG00000255933 RP11-495K9.5 path:00310_9 Lysine degradation 23 -4.8082690772173 2.62565885048366e-06 0.000174606313557163
OV ENSG00000255933 RP11-495K9.5 path:00450_8 Selenocompound metabolism 3 -5.91675373551536 1.04135567704126e-08 1.38500305046488e-06
OV ENSG00000255933 RP11-495K9.5 path:00562_2 Inositol phosphate metabolism 44 -2.96224570194814 0.00334536410894502 0.0208562543667041
OV ENSG00000255933 RP11-495K9.5 path:00562_70 Inositol phosphate metabolism 7 -4.01194464480691 7.71475301469333e-05 0.00181069791344861
OV ENSG00000255933 RP11-495K9.5 path:00564_106 Glycerophospholipid metabolism 3 2.66740678640714 0.0082709574620013 0.0390121181540839
OV ENSG00000255933 RP11-495K9.5 path:00565_22 Ether lipid metabolism 13 2.96449676527866 0.00349179024795463 0.0211094592262712
OV ENSG00000255933 RP11-495K9.5 path:00591_12 Linoleic acid metabolism 16 3.2175469315235 0.00156268811398306 0.0132662246272179
OV ENSG00000255933 RP11-495K9.5 path:00600_45 Sphingolipid metabolism 6 2.75409446924775 0.00651656010412404 0.0332804771087021
OV ENSG00000255933 RP11-495K9.5 path:00601_16 Glycosphingolipid biosynthesis - lacto and neolacto series 12 3.47129379688456 0.00063861626926508 0.00670547082728334
OV ENSG00000255933 RP11-495K9.5 path:00603_1 Glycosphingolipid biosynthesis - globo series 9 3.5122827278837 0.000527030531418795 0.00584125505655831
OV ENSG00000255933 RP11-495K9.5 path:00604_1 Glycosphingolipid biosynthesis - ganglio series 9 3.71866952126678 0.000259779168755854 0.00367949535169317
OV ENSG00000255933 RP11-495K9.5 path:00750_1 Vitamin B6 metabolism 3 2.56815542827064 0.0109840706864314 0.046133096883012
OV ENSG00000255933 RP11-495K9.5 path:00760_1 Nicotinate and nicotinamide metabolism 20 4.10216577741263 5.82916471903354e-05 0.00155055781526292
OV ENSG00000255933 RP11-495K9.5 path:00770_1 Pantothenate and CoA biosynthesis 6 2.77809720812254 0.00598451567075187 0.0314187072714473
OV ENSG00000255933 RP11-495K9.5 path:00830_7 Retinol metabolism 27 2.65955552300258 0.00840862697055443 0.0390121181540839
OV ENSG00000255933 RP11-495K9.5 path:00860_2 Porphyrin and chlorophyll metabolism 10 2.62233459155879 0.0093987224030223 0.0413116829894908
OV ENSG00000255933 RP11-495K9.5 path:00983_2 Drug metabolism - other enzymes 16 4.01568061934572 8.75791802319713e-05 0.00194133849514203
OV ENSG00000255933 RP11-495K9.5 path:03320_1 PPAR signaling pathway 48 -3.1787415990692 0.00171485482227813 0.013888868749244
OV ENSG00000255933 RP11-495K9.5 path:04012_22 ErbB signaling pathway 65 -3.13146121144253 0.00192386780790501 0.0147263525786394
OV ENSG00000255933 RP11-495K9.5 path:04014_12 Ras signaling pathway 180 -3.66827023991915 0.000295097371564364 0.00367949535169317
OV ENSG00000255933 RP11-495K9.5 path:04014_139 Ras signaling pathway 15 -2.78557497658331 0.00578537591787671 0.0308888118816418
OV ENSG00000255933 RP11-495K9.5 path:04024_110 cAMP signaling pathway 29 -2.61417791773421 0.00952550083968208 0.0413116829894908
OV ENSG00000255933 RP11-495K9.5 path:04024_125 cAMP signaling pathway 23 -4.29728156698625 2.36870718574015e-05 0.000787595139258601
OV ENSG00000255933 RP11-495K9.5 path:04062_228 Chemokine signaling pathway 13 2.79100668605037 0.00580616764692516 0.0308888118816418
OV ENSG00000255933 RP11-495K9.5 path:04062_26 Chemokine signaling pathway 106 -3.49029082663025 0.000576451207033827 0.00621632517855397
OV ENSG00000255933 RP11-495K9.5 path:04064_1 NF-kappa B signaling pathway 69 2.83807011195079 0.00498892557783622 0.0276469625771757
OV ENSG00000255933 RP11-495K9.5 path:04066_94 HIF-1 signaling pathway 15 -2.62948849135985 0.00909400539759436 0.0413116829894908
OV ENSG00000255933 RP11-495K9.5 path:04070_22 Phosphatidylinositol signaling system 29 -3.67189415860055 0.000291058240570234 0.00367949535169317
OV ENSG00000255933 RP11-495K9.5 path:04122_1 Sulfur relay system 5 3.01684231891248 0.00285646331923743 0.0189954810729289
OV ENSG00000255933 RP11-495K9.5 path:04140_2 Regulation of autophagy 4 -7.24391035095285 4.00383643048545e-12 1.59753073576369e-09
OV ENSG00000255933 RP11-495K9.5 path:04145_13 Phagosome 10 -3.04955074679875 0.00257642776139613 0.0183570477999474
OV ENSG00000255933 RP11-495K9.5 path:04151_67 PI3K-Akt signaling pathway 164 -3.68920902013903 0.000294374603504966 0.00367949535169317
OV ENSG00000255933 RP11-495K9.5 path:04152_50 AMPK signaling pathway 21 -5.46335279475935 1.19835236363991e-07 1.19535648273081e-05
OV ENSG00000255933 RP11-495K9.5 path:04210_36 Apoptosis 36 -3.1264821179335 0.00195613204678668 0.0147263525786394
OV ENSG00000255933 RP11-495K9.5 path:04261_51 Adrenergic signaling in cardiomyocytes 66 -4.15526521071378 4.56524141029226e-05 0.00140117794054355
OV ENSG00000255933 RP11-495K9.5 path:04310_144 Wnt signaling pathway 11 -2.53534947202103 0.0119011606655051 0.0494641990160055
OV ENSG00000255933 RP11-495K9.5 path:04330_22 Notch signaling pathway 24 -4.40106806254762 1.56771338322905e-05 0.00062551763990839
OV ENSG00000255933 RP11-495K9.5 path:04330_24 Notch signaling pathway 16 -6.09143450859242 3.90326817882254e-09 7.78702001675097e-07
OV ENSG00000255933 RP11-495K9.5 path:04360_145 Axon guidance 8 -2.99509845587686 0.00301672143425344 0.0194140621333407
OV ENSG00000255933 RP11-495K9.5 path:04370_42 VEGF signaling pathway 22 -3.52740948178571 0.000501972142689621 0.00572248242666168
OV ENSG00000255933 RP11-495K9.5 path:04370_66 VEGF signaling pathway 14 -3.16108296435621 0.00174244148592139 0.013888868749244
OV ENSG00000255933 RP11-495K9.5 path:04510_126 Focal adhesion 38 -3.17615964172877 0.00166379169111505 0.0138302684323939
OV ENSG00000255933 RP11-495K9.5 path:04510_137 Focal adhesion 32 -3.2813077410242 0.00119614448531097 0.0108943396841893
OV ENSG00000255933 RP11-495K9.5 path:04510_283 Focal adhesion 10 -3.27604557690964 0.00120138081730408 0.0108943396841893
OV ENSG00000255933 RP11-495K9.5 path:04512_79 ECM-receptor interaction 8 -2.62902774751174 0.00921315591979941 0.0413116829894908
OV ENSG00000255933 RP11-495K9.5 path:04611_164 Platelet activation 15 -2.79140541234007 0.00572210546084667 0.0308888118816418
OV ENSG00000255933 RP11-495K9.5 path:04611_279 Platelet activation 2 3.01880002212946 0.00291092261040566 0.0190402970746207
OV ENSG00000255933 RP11-495K9.5 path:04620_60 Toll-like receptor signaling pathway 22 4.68458887099692 5.28031170784503e-06 0.000300977767347167
OV ENSG00000255933 RP11-495K9.5 path:04620_92 Toll-like receptor signaling pathway 11 -3.78037585513744 0.000191521794329036 0.00332248677988197
OV ENSG00000255933 RP11-495K9.5 path:04621_22 NOD-like receptor signaling pathway 28 -3.54940034621023 0.000476661644412557 0.00559376459178265
OV ENSG00000255933 RP11-495K9.5 path:04650_115 Natural killer cell mediated cytotoxicity 5 3.32910282941878 0.00105745288159595 0.0102908219452874
OV ENSG00000255933 RP11-495K9.5 path:04650_139 Natural killer cell mediated cytotoxicity 2 2.91212918313792 0.00406002579016243 0.0238227983863943
OV ENSG00000255933 RP11-495K9.5 path:04660_105 T cell receptor signaling pathway 13 -2.61457646275494 0.00944348911579212 0.0413116829894908
OV ENSG00000255933 RP11-495K9.5 path:04664_71 Fc epsilon RI signaling pathway 10 -2.95108134441196 0.00342809044145045 0.0210432013252112
OV ENSG00000255933 RP11-495K9.5 path:04664_75 Fc epsilon RI signaling pathway 9 -3.20050345235695 0.00153168440713142 0.0132662246272179
OV ENSG00000255933 RP11-495K9.5 path:04720_79 Long-term potentiation 3 -2.87340600801831 0.00439596493480291 0.0250570001283766
OV ENSG00000255933 RP11-495K9.5 path:04725_86 Cholinergic synapse 18 -3.74266696566655 0.000221332690296082 0.00367949535169317
OV ENSG00000255933 RP11-495K9.5 path:04742_1 Taste transduction 14 -3.80917619147136 0.000177847510327263 0.00332248677988197
OV ENSG00000255933 RP11-495K9.5 path:04750_14 Inflammatory mediator regulation of TRP channels 66 -2.68824234434932 0.00770715794130397 0.0375019026656132
OV ENSG00000255933 RP11-495K9.5 path:04810_241 Regulation of actin cytoskeleton 4 -4.54324341681814 8.39288745669846e-06 0.000418595261902836
OV ENSG00000255933 RP11-495K9.5 path:04810_68 Regulation of actin cytoskeleton 69 -4.10469196703834 5.49955492735813e-05 0.00155055781526292
OV ENSG00000255933 RP11-495K9.5 path:04910_9 Insulin signaling pathway 120 -2.6190619294798 0.00940544858751121 0.0413116829894908
OV ENSG00000255933 RP11-495K9.5 path:04916_128 Melanogenesis 6 -3.35381839838861 0.000925327911413037 0.00923014591634504
OV ENSG00000255933 RP11-495K9.5 path:04916_139 Melanogenesis 2 -3.78351607344789 0.000188585048201887 0.00332248677988197
OV ENSG00000255933 RP11-495K9.5 path:04916_75 Melanogenesis 23 -3.2568222229991 0.0013021102497359 0.0115453775476583
OV ENSG00000255933 RP11-495K9.5 path:04917_119 Prolactin signaling pathway 10 -3.27813068223159 0.00118166573156669 0.0108943396841893
OV ENSG00000255933 RP11-495K9.5 path:04919_50 Thyroid hormone signaling pathway 33 -2.89333211415453 0.0041685779170741 0.0241052549117763
OV ENSG00000255933 RP11-495K9.5 path:04919_84 Thyroid hormone signaling pathway 5 -3.15954295619475 0.00177526893787329 0.013888868749244
OV ENSG00000255933 RP11-495K9.5 path:04940_2 Type I diabetes mellitus 2 3.69300236999867 0.000294518386999632 0.00367949535169317
OV ENSG00000255933 RP11-495K9.5 path:04950_1 Maturity onset diabetes of the young 22 2.57683665444625 0.0107591641398429 0.0456692179978438
OV ENSG00000255933 RP11-495K9.5 path:04960_8 Aldosterone-regulated sodium reabsorption 14 -4.44249781326048 1.26791158179844e-05 0.000562107467930644
OV ENSG00000255933 RP11-495K9.5 path:04961_12 Endocrine and other factor-regulated calcium reabsorption 11 2.57858193360567 0.0106700760408734 0.0456692179978438
OV ENSG00000255933 RP11-495K9.5 path:04973_1 Carbohydrate digestion and absorption 12 -3.06737856274753 0.00236835163166019 0.0171813145642257
OV ENSG00000255933 RP11-495K9.5 path:04976_8 Bile secretion 8 2.66611242015063 0.00837707423983334 0.0390121181540839
OV ENSG00000255933 RP11-495K9.5 path:05132_39 Salmonella infection 8 -2.87207500222985 0.00452911050570049 0.0254523252362605
OV ENSG00000255933 RP11-495K9.5 path:05140_54 Leishmaniasis 15 3.0338948136214 0.00275226630730101 0.0186127840103916
OV ENSG00000255933 RP11-495K9.5 path:05140_84 Leishmaniasis 3 3.04034200146857 0.00270551604628901 0.0186127840103916
OV ENSG00000255933 RP11-495K9.5 path:05206_109 MicroRNAs in cancer 14 -5.13525227878429 5.19383080713922e-07 4.1446769840971e-05
OV ENSG00000255933 RP11-495K9.5 path:05206_112 MicroRNAs in cancer 11 -3.12268070057918 0.00199315485544698 0.0147271997652471
OV ENSG00000255933 RP11-495K9.5 path:05211_9 Renal cell carcinoma 14 -2.69994357295553 0.00739138591199347 0.0364094194924123
OV ENSG00000255933 RP11-495K9.5 path:05212_61 Pancreatic cancer 2 -3.03030754410051 0.00272169016947142 0.0186127840103916
OV ENSG00000255933 RP11-495K9.5 path:05215_50 Prostate cancer 35 -4.03592201211073 7.0057657708601e-05 0.00174706283910824
OV ENSG00000255933 RP11-495K9.5 path:05215_83 Prostate cancer 9 -3.82540731399767 0.000173124186973461 0.00332248677988197
OV ENSG00000255933 RP11-495K9.5 path:05218_1 Melanoma 63 -2.75384639318547 0.00634950121739787 0.0329019608537889
OV ENSG00000255933 RP11-495K9.5 path:05221_7 Acute myeloid leukemia 49 -3.85169818364124 0.000151866235141714 0.00318919093797599
OV ENSG00000255933 RP11-495K9.5 path:05231_31 Choline metabolism in cancer 35 -3.54250695699482 0.00047102165310689 0.00559376459178265
OV ENSG00000255933 RP11-495K9.5 path:05231_42 Choline metabolism in cancer 26 -2.93607736331692 0.00369712317292032 0.0220171962088837
OV ENSG00000255933 RP11-495K9.5 path:05320_2 Autoimmune thyroid disease 2 3.69300236999867 0.000294518386999632 0.00367949535169317
OV ENSG00000255933 RP11-495K9.5 path:05330_2 Allograft rejection 2 3.69300236999867 0.000294518386999632 0.00367949535169317
OV ENSG00000255933 RP11-495K9.5 path:05332_5 Graft-versus-host disease 2 3.69300236999867 0.000294518386999632 0.00367949535169317
OV ENSG00000255933 RP11-495K9.5 path:05414_26 Dilated cardiomyopathy 6 -2.73684424428412 0.00658936764808888 0.0332804771087021
OV ENSG00000234768 RP11-503C24.1 path:00120_6 Primary bile acid biosynthesis 3 3.18535658928001 0.00165788465840394 0.0309543292303518
OV ENSG00000234768 RP11-503C24.1 path:00330_90 Arginine and proline metabolism 6 3.96375495313566 9.42295561785887e-05 0.00694680101925293
OV ENSG00000234768 RP11-503C24.1 path:00561_55 Glycerolipid metabolism 7 3.42911855411097 0.000710060255826291 0.0176031602709445
OV ENSG00000234768 RP11-503C24.1 path:00565_8 Ether lipid metabolism 23 -3.13878614893191 0.00206304046816838 0.0348997679198484
OV ENSG00000234768 RP11-503C24.1 path:00760_14 Nicotinate and nicotinamide metabolism 15 3.04874989841356 0.00256092170374297 0.0399897773738325
OV ENSG00000234768 RP11-503C24.1 path:00983_2 Drug metabolism - other enzymes 16 3.00219547419417 0.00294155179202089 0.0442322232429807
OV ENSG00000234768 RP11-503C24.1 path:04068_37 FoxO signaling pathway 42 -4.80612289700125 3.2769338922829e-06 0.000665217580133429
OV ENSG00000234768 RP11-503C24.1 path:04140_1 Regulation of autophagy 10 -3.5047474955029 0.000562082204905186 0.0166030394707407
OV ENSG00000234768 RP11-503C24.1 path:04330_24 Notch signaling pathway 16 -3.5219030469935 0.000534233572296435 0.0166030394707407
OV ENSG00000234768 RP11-503C24.1 path:04360_145 Axon guidance 8 -3.18109905200329 0.00168047022364146 0.0309543292303518
OV ENSG00000234768 RP11-503C24.1 path:04510_310 Focal adhesion 7 -4.04510021824649 7.2690942738889e-05 0.00694680101925293
OV ENSG00000234768 RP11-503C24.1 path:04510_63 Focal adhesion 76 -3.18550052112093 0.00175357037511845 0.0309543292303518
OV ENSG00000234768 RP11-503C24.1 path:04550_2 Signaling pathways regulating pluripotency of stem cells 91 -3.41493390716594 0.00078043567703695 0.0176031602709445
OV ENSG00000234768 RP11-503C24.1 path:04621_50 NOD-like receptor signaling pathway 7 -6.92752096188275 5.40021786737194e-11 2.19248845415301e-08
OV ENSG00000234768 RP11-503C24.1 path:04623_19 Cytosolic DNA-sensing pathway 3 3.10218079489719 0.00216248720607672 0.035118792226686
OV ENSG00000234768 RP11-503C24.1 path:04666_159 Fc gamma R-mediated phagocytosis 19 -3.52129249322459 0.000550530934565086 0.0166030394707407
OV ENSG00000234768 RP11-503C24.1 path:04670_105 Leukocyte transendothelial migration 16 3.23861546253146 0.00135832133437783 0.02757392308787
OV ENSG00000234768 RP11-503C24.1 path:04670_163 Leukocyte transendothelial migration 4 -3.7922983342269 0.000198174702130028 0.0112077821550028
OV ENSG00000234768 RP11-503C24.1 path:04720_55 Long-term potentiation 18 4.19011622680633 3.72788790685877e-05 0.0050450749672822
OV ENSG00000234768 RP11-503C24.1 path:04723_39 Retrograde endocannabinoid signaling 14 3.65238104851373 0.000318443128835207 0.0143653233674549
OV ENSG00000234768 RP11-503C24.1 path:04932_84 Non-alcoholic fatty liver disease (NAFLD) 11 -3.47733475662725 0.000613412788327859 0.0166030394707407
OV ENSG00000234768 RP11-503C24.1 path:05033_8 Nicotine addiction 9 3.29797181356696 0.00111366369926839 0.0237972348369983
OV ENSG00000234768 RP11-503C24.1 path:05131_27 Shigellosis 2 -3.49264909618988 0.000574812339876785 0.0166030394707407
OV ENSG00000234768 RP11-503C24.1 path:05143_1 African trypanosomiasis 9 3.95180282508953 0.000102662084028368 0.00694680101925293
OV ENSG00000234768 RP11-503C24.1 path:05206_22 MicroRNAs in cancer 98 -3.78291492791227 0.000220842998128135 0.0112077821550028
OV ENSG00000234768 RP11-503C24.1 path:05211_17 Renal cell carcinoma 6 -3.59136233410258 0.00040762955968946 0.0165497601233921
OV ENSG00000234768 RP11-503C24.1 path:05212_5 Pancreatic cancer 46 -3.43821231229403 0.000772283036547218 0.0176031602709445
OV ENSG00000237987 RP11-503C24.2 path:00120_6 Primary bile acid biosynthesis 3 3.18535658928001 0.00165788465840394 0.0309543292303518
OV ENSG00000237987 RP11-503C24.2 path:00330_90 Arginine and proline metabolism 6 3.96375495313566 9.42295561785887e-05 0.00694680101925293
OV ENSG00000237987 RP11-503C24.2 path:00561_55 Glycerolipid metabolism 7 3.42911855411097 0.000710060255826291 0.0176031602709445
OV ENSG00000237987 RP11-503C24.2 path:00565_8 Ether lipid metabolism 23 -3.13878614893191 0.00206304046816838 0.0348997679198484
OV ENSG00000237987 RP11-503C24.2 path:00760_14 Nicotinate and nicotinamide metabolism 15 3.04874989841356 0.00256092170374297 0.0399897773738325
OV ENSG00000237987 RP11-503C24.2 path:00983_2 Drug metabolism - other enzymes 16 3.00219547419417 0.00294155179202089 0.0442322232429807
OV ENSG00000237987 RP11-503C24.2 path:04068_37 FoxO signaling pathway 42 -4.80612289700125 3.2769338922829e-06 0.000665217580133429
OV ENSG00000237987 RP11-503C24.2 path:04140_1 Regulation of autophagy 10 -3.5047474955029 0.000562082204905186 0.0166030394707407
OV ENSG00000237987 RP11-503C24.2 path:04330_24 Notch signaling pathway 16 -3.5219030469935 0.000534233572296435 0.0166030394707407
OV ENSG00000237987 RP11-503C24.2 path:04360_145 Axon guidance 8 -3.18109905200329 0.00168047022364146 0.0309543292303518
OV ENSG00000237987 RP11-503C24.2 path:04510_310 Focal adhesion 7 -4.04510021824649 7.2690942738889e-05 0.00694680101925293
OV ENSG00000237987 RP11-503C24.2 path:04510_63 Focal adhesion 76 -3.18550052112093 0.00175357037511845 0.0309543292303518
OV ENSG00000237987 RP11-503C24.2 path:04550_2 Signaling pathways regulating pluripotency of stem cells 91 -3.41493390716594 0.00078043567703695 0.0176031602709445
OV ENSG00000237987 RP11-503C24.2 path:04621_50 NOD-like receptor signaling pathway 7 -6.92752096188275 5.40021786737194e-11 2.19248845415301e-08
OV ENSG00000237987 RP11-503C24.2 path:04623_19 Cytosolic DNA-sensing pathway 3 3.10218079489719 0.00216248720607672 0.035118792226686
OV ENSG00000237987 RP11-503C24.2 path:04666_159 Fc gamma R-mediated phagocytosis 19 -3.52129249322459 0.000550530934565086 0.0166030394707407
OV ENSG00000237987 RP11-503C24.2 path:04670_105 Leukocyte transendothelial migration 16 3.23861546253146 0.00135832133437783 0.02757392308787
OV ENSG00000237987 RP11-503C24.2 path:04670_163 Leukocyte transendothelial migration 4 -3.7922983342269 0.000198174702130028 0.0112077821550028
OV ENSG00000237987 RP11-503C24.2 path:04720_55 Long-term potentiation 18 4.19011622680633 3.72788790685877e-05 0.0050450749672822
OV ENSG00000237987 RP11-503C24.2 path:04723_39 Retrograde endocannabinoid signaling 14 3.65238104851373 0.000318443128835207 0.0143653233674549
OV ENSG00000237987 RP11-503C24.2 path:04932_84 Non-alcoholic fatty liver disease (NAFLD) 11 -3.47733475662725 0.000613412788327859 0.0166030394707407
OV ENSG00000237987 RP11-503C24.2 path:05033_8 Nicotine addiction 9 3.29797181356696 0.00111366369926839 0.0237972348369983
OV ENSG00000237987 RP11-503C24.2 path:05131_27 Shigellosis 2 -3.49264909618988 0.000574812339876785 0.0166030394707407
OV ENSG00000237987 RP11-503C24.2 path:05143_1 African trypanosomiasis 9 3.95180282508953 0.000102662084028368 0.00694680101925293
OV ENSG00000237987 RP11-503C24.2 path:05206_22 MicroRNAs in cancer 98 -3.78291492791227 0.000220842998128135 0.0112077821550028
OV ENSG00000237987 RP11-503C24.2 path:05211_17 Renal cell carcinoma 6 -3.59136233410258 0.00040762955968946 0.0165497601233921
OV ENSG00000237987 RP11-503C24.2 path:05212_5 Pancreatic cancer 46 -3.43821231229403 0.000772283036547218 0.0176031602709445
OV ENSG00000228361 RP11-503C24.3 path:00120_6 Primary bile acid biosynthesis 3 3.18535658928001 0.00165788465840394 0.0309543292303518
OV ENSG00000228361 RP11-503C24.3 path:00330_90 Arginine and proline metabolism 6 3.96375495313566 9.42295561785887e-05 0.00694680101925293
OV ENSG00000228361 RP11-503C24.3 path:00561_55 Glycerolipid metabolism 7 3.42911855411097 0.000710060255826291 0.0176031602709445
OV ENSG00000228361 RP11-503C24.3 path:00565_8 Ether lipid metabolism 23 -3.13878614893191 0.00206304046816838 0.0348997679198484
OV ENSG00000228361 RP11-503C24.3 path:00760_14 Nicotinate and nicotinamide metabolism 15 3.04874989841356 0.00256092170374297 0.0399897773738325
OV ENSG00000228361 RP11-503C24.3 path:00983_2 Drug metabolism - other enzymes 16 3.00219547419417 0.00294155179202089 0.0442322232429807
OV ENSG00000228361 RP11-503C24.3 path:04068_37 FoxO signaling pathway 42 -4.80612289700125 3.2769338922829e-06 0.000665217580133429
OV ENSG00000228361 RP11-503C24.3 path:04140_1 Regulation of autophagy 10 -3.5047474955029 0.000562082204905186 0.0166030394707407
OV ENSG00000228361 RP11-503C24.3 path:04330_24 Notch signaling pathway 16 -3.5219030469935 0.000534233572296435 0.0166030394707407
OV ENSG00000228361 RP11-503C24.3 path:04360_145 Axon guidance 8 -3.18109905200329 0.00168047022364146 0.0309543292303518
OV ENSG00000228361 RP11-503C24.3 path:04510_310 Focal adhesion 7 -4.04510021824649 7.2690942738889e-05 0.00694680101925293
OV ENSG00000228361 RP11-503C24.3 path:04510_63 Focal adhesion 76 -3.18550052112093 0.00175357037511845 0.0309543292303518
OV ENSG00000228361 RP11-503C24.3 path:04550_2 Signaling pathways regulating pluripotency of stem cells 91 -3.41493390716594 0.00078043567703695 0.0176031602709445
OV ENSG00000228361 RP11-503C24.3 path:04621_50 NOD-like receptor signaling pathway 7 -6.92752096188275 5.40021786737194e-11 2.19248845415301e-08
OV ENSG00000228361 RP11-503C24.3 path:04623_19 Cytosolic DNA-sensing pathway 3 3.10218079489719 0.00216248720607672 0.035118792226686
OV ENSG00000228361 RP11-503C24.3 path:04666_159 Fc gamma R-mediated phagocytosis 19 -3.52129249322459 0.000550530934565086 0.0166030394707407
OV ENSG00000228361 RP11-503C24.3 path:04670_105 Leukocyte transendothelial migration 16 3.23861546253146 0.00135832133437783 0.02757392308787
OV ENSG00000228361 RP11-503C24.3 path:04670_163 Leukocyte transendothelial migration 4 -3.7922983342269 0.000198174702130028 0.0112077821550028
OV ENSG00000228361 RP11-503C24.3 path:04720_55 Long-term potentiation 18 4.19011622680633 3.72788790685877e-05 0.0050450749672822
OV ENSG00000228361 RP11-503C24.3 path:04723_39 Retrograde endocannabinoid signaling 14 3.65238104851373 0.000318443128835207 0.0143653233674549
OV ENSG00000228361 RP11-503C24.3 path:04932_84 Non-alcoholic fatty liver disease (NAFLD) 11 -3.47733475662725 0.000613412788327859 0.0166030394707407
OV ENSG00000228361 RP11-503C24.3 path:05033_8 Nicotine addiction 9 3.29797181356696 0.00111366369926839 0.0237972348369983
OV ENSG00000228361 RP11-503C24.3 path:05131_27 Shigellosis 2 -3.49264909618988 0.000574812339876785 0.0166030394707407
OV ENSG00000228361 RP11-503C24.3 path:05143_1 African trypanosomiasis 9 3.95180282508953 0.000102662084028368 0.00694680101925293
OV ENSG00000228361 RP11-503C24.3 path:05206_22 MicroRNAs in cancer 98 -3.78291492791227 0.000220842998128135 0.0112077821550028
OV ENSG00000228361 RP11-503C24.3 path:05211_17 Renal cell carcinoma 6 -3.59136233410258 0.00040762955968946 0.0165497601233921
OV ENSG00000228361 RP11-503C24.3 path:05212_5 Pancreatic cancer 46 -3.43821231229403 0.000772283036547218 0.0176031602709445
OV ENSG00000234647 RP11-503C24.4 path:00120_6 Primary bile acid biosynthesis 3 3.18535658928001 0.00165788465840394 0.0309543292303518
OV ENSG00000234647 RP11-503C24.4 path:00330_90 Arginine and proline metabolism 6 3.96375495313566 9.42295561785887e-05 0.00694680101925293
OV ENSG00000234647 RP11-503C24.4 path:00561_55 Glycerolipid metabolism 7 3.42911855411097 0.000710060255826291 0.0176031602709445
OV ENSG00000234647 RP11-503C24.4 path:00565_8 Ether lipid metabolism 23 -3.13878614893191 0.00206304046816838 0.0348997679198484
OV ENSG00000234647 RP11-503C24.4 path:00760_14 Nicotinate and nicotinamide metabolism 15 3.04874989841356 0.00256092170374297 0.0399897773738325
OV ENSG00000234647 RP11-503C24.4 path:00983_2 Drug metabolism - other enzymes 16 3.00219547419417 0.00294155179202089 0.0442322232429807
OV ENSG00000234647 RP11-503C24.4 path:04068_37 FoxO signaling pathway 42 -4.80612289700125 3.2769338922829e-06 0.000665217580133429
OV ENSG00000234647 RP11-503C24.4 path:04140_1 Regulation of autophagy 10 -3.5047474955029 0.000562082204905186 0.0166030394707407
OV ENSG00000234647 RP11-503C24.4 path:04330_24 Notch signaling pathway 16 -3.5219030469935 0.000534233572296435 0.0166030394707407
OV ENSG00000234647 RP11-503C24.4 path:04360_145 Axon guidance 8 -3.18109905200329 0.00168047022364146 0.0309543292303518
OV ENSG00000234647 RP11-503C24.4 path:04510_310 Focal adhesion 7 -4.04510021824649 7.2690942738889e-05 0.00694680101925293
OV ENSG00000234647 RP11-503C24.4 path:04510_63 Focal adhesion 76 -3.18550052112093 0.00175357037511845 0.0309543292303518
OV ENSG00000234647 RP11-503C24.4 path:04550_2 Signaling pathways regulating pluripotency of stem cells 91 -3.41493390716594 0.00078043567703695 0.0176031602709445
OV ENSG00000234647 RP11-503C24.4 path:04621_50 NOD-like receptor signaling pathway 7 -6.92752096188275 5.40021786737194e-11 2.19248845415301e-08
OV ENSG00000234647 RP11-503C24.4 path:04623_19 Cytosolic DNA-sensing pathway 3 3.10218079489719 0.00216248720607672 0.035118792226686
OV ENSG00000234647 RP11-503C24.4 path:04666_159 Fc gamma R-mediated phagocytosis 19 -3.52129249322459 0.000550530934565086 0.0166030394707407
OV ENSG00000234647 RP11-503C24.4 path:04670_105 Leukocyte transendothelial migration 16 3.23861546253146 0.00135832133437783 0.02757392308787
OV ENSG00000234647 RP11-503C24.4 path:04670_163 Leukocyte transendothelial migration 4 -3.7922983342269 0.000198174702130028 0.0112077821550028
OV ENSG00000234647 RP11-503C24.4 path:04720_55 Long-term potentiation 18 4.19011622680633 3.72788790685877e-05 0.0050450749672822
OV ENSG00000234647 RP11-503C24.4 path:04723_39 Retrograde endocannabinoid signaling 14 3.65238104851373 0.000318443128835207 0.0143653233674549
OV ENSG00000234647 RP11-503C24.4 path:04932_84 Non-alcoholic fatty liver disease (NAFLD) 11 -3.47733475662725 0.000613412788327859 0.0166030394707407
OV ENSG00000234647 RP11-503C24.4 path:05033_8 Nicotine addiction 9 3.29797181356696 0.00111366369926839 0.0237972348369983
OV ENSG00000234647 RP11-503C24.4 path:05131_27 Shigellosis 2 -3.49264909618988 0.000574812339876785 0.0166030394707407
OV ENSG00000234647 RP11-503C24.4 path:05143_1 African trypanosomiasis 9 3.95180282508953 0.000102662084028368 0.00694680101925293
OV ENSG00000234647 RP11-503C24.4 path:05206_22 MicroRNAs in cancer 98 -3.78291492791227 0.000220842998128135 0.0112077821550028
OV ENSG00000234647 RP11-503C24.4 path:05211_17 Renal cell carcinoma 6 -3.59136233410258 0.00040762955968946 0.0165497601233921
OV ENSG00000234647 RP11-503C24.4 path:05212_5 Pancreatic cancer 46 -3.43821231229403 0.000772283036547218 0.0176031602709445
OV ENSG00000224417 RP11-503C24.6 path:00120_6 Primary bile acid biosynthesis 3 3.18535658928001 0.00165788465840394 0.0309543292303518
OV ENSG00000224417 RP11-503C24.6 path:00330_90 Arginine and proline metabolism 6 3.96375495313566 9.42295561785887e-05 0.00694680101925293
OV ENSG00000224417 RP11-503C24.6 path:00561_55 Glycerolipid metabolism 7 3.42911855411097 0.000710060255826291 0.0176031602709445
OV ENSG00000224417 RP11-503C24.6 path:00565_8 Ether lipid metabolism 23 -3.13878614893191 0.00206304046816838 0.0348997679198484
OV ENSG00000224417 RP11-503C24.6 path:00760_14 Nicotinate and nicotinamide metabolism 15 3.04874989841356 0.00256092170374297 0.0399897773738325
OV ENSG00000224417 RP11-503C24.6 path:00983_2 Drug metabolism - other enzymes 16 3.00219547419417 0.00294155179202089 0.0442322232429807
OV ENSG00000224417 RP11-503C24.6 path:04068_37 FoxO signaling pathway 42 -4.80612289700125 3.2769338922829e-06 0.000665217580133429
OV ENSG00000224417 RP11-503C24.6 path:04140_1 Regulation of autophagy 10 -3.5047474955029 0.000562082204905186 0.0166030394707407
OV ENSG00000224417 RP11-503C24.6 path:04330_24 Notch signaling pathway 16 -3.5219030469935 0.000534233572296435 0.0166030394707407
OV ENSG00000224417 RP11-503C24.6 path:04360_145 Axon guidance 8 -3.18109905200329 0.00168047022364146 0.0309543292303518
OV ENSG00000224417 RP11-503C24.6 path:04510_310 Focal adhesion 7 -4.04510021824649 7.2690942738889e-05 0.00694680101925293
OV ENSG00000224417 RP11-503C24.6 path:04510_63 Focal adhesion 76 -3.18550052112093 0.00175357037511845 0.0309543292303518
OV ENSG00000224417 RP11-503C24.6 path:04550_2 Signaling pathways regulating pluripotency of stem cells 91 -3.41493390716594 0.00078043567703695 0.0176031602709445
OV ENSG00000224417 RP11-503C24.6 path:04621_50 NOD-like receptor signaling pathway 7 -6.92752096188275 5.40021786737194e-11 2.19248845415301e-08
OV ENSG00000224417 RP11-503C24.6 path:04623_19 Cytosolic DNA-sensing pathway 3 3.10218079489719 0.00216248720607672 0.035118792226686
OV ENSG00000224417 RP11-503C24.6 path:04666_159 Fc gamma R-mediated phagocytosis 19 -3.52129249322459 0.000550530934565086 0.0166030394707407
OV ENSG00000224417 RP11-503C24.6 path:04670_105 Leukocyte transendothelial migration 16 3.23861546253146 0.00135832133437783 0.02757392308787
OV ENSG00000224417 RP11-503C24.6 path:04670_163 Leukocyte transendothelial migration 4 -3.7922983342269 0.000198174702130028 0.0112077821550028
OV ENSG00000224417 RP11-503C24.6 path:04720_55 Long-term potentiation 18 4.19011622680633 3.72788790685877e-05 0.0050450749672822
OV ENSG00000224417 RP11-503C24.6 path:04723_39 Retrograde endocannabinoid signaling 14 3.65238104851373 0.000318443128835207 0.0143653233674549
OV ENSG00000224417 RP11-503C24.6 path:04932_84 Non-alcoholic fatty liver disease (NAFLD) 11 -3.47733475662725 0.000613412788327859 0.0166030394707407
OV ENSG00000224417 RP11-503C24.6 path:05033_8 Nicotine addiction 9 3.29797181356696 0.00111366369926839 0.0237972348369983
OV ENSG00000224417 RP11-503C24.6 path:05131_27 Shigellosis 2 -3.49264909618988 0.000574812339876785 0.0166030394707407
OV ENSG00000224417 RP11-503C24.6 path:05143_1 African trypanosomiasis 9 3.95180282508953 0.000102662084028368 0.00694680101925293
OV ENSG00000224417 RP11-503C24.6 path:05206_22 MicroRNAs in cancer 98 -3.78291492791227 0.000220842998128135 0.0112077821550028
OV ENSG00000224417 RP11-503C24.6 path:05211_17 Renal cell carcinoma 6 -3.59136233410258 0.00040762955968946 0.0165497601233921
OV ENSG00000224417 RP11-503C24.6 path:05212_5 Pancreatic cancer 46 -3.43821231229403 0.000772283036547218 0.0176031602709445
OV ENSG00000256783 RP11-503G7.1 path:00120_5 Primary bile acid biosynthesis 4 4.51000176465236 1.10080674679919e-05 0.000590525530660006
OV ENSG00000256783 RP11-503G7.1 path:00140_7 Steroid hormone biosynthesis 23 2.75141764965753 0.00656819009102006 0.0340351668352857
OV ENSG00000256783 RP11-503G7.1 path:00232_1 Caffeine metabolism 3 3.18134556988151 0.00173452388177145 0.0147250006133364
OV ENSG00000256783 RP11-503G7.1 path:00270_17 Cysteine and methionine metabolism 19 -3.30444323846443 0.00108827139327654 0.0108555071479335
OV ENSG00000256783 RP11-503G7.1 path:00270_51 Cysteine and methionine metabolism 8 -2.60833981196217 0.00957155537041206 0.0441620557496843
OV ENSG00000256783 RP11-503G7.1 path:00310_9 Lysine degradation 23 -4.64770693084661 5.4783034517304e-06 0.000364307179540071
OV ENSG00000256783 RP11-503G7.1 path:00410_21 beta-Alanine metabolism 5 -2.55279552240192 0.0113309798971532 0.0491419671626535
OV ENSG00000256783 RP11-503G7.1 path:00450_8 Selenocompound metabolism 3 -5.59390891547333 5.73693287097967e-08 7.63012071840297e-06
OV ENSG00000256783 RP11-503G7.1 path:00562_2 Inositol phosphate metabolism 44 -3.0607241835454 0.00244918176578597 0.0177677004463382
OV ENSG00000256783 RP11-503G7.1 path:00562_70 Inositol phosphate metabolism 7 -3.33241311411182 0.000983050998060281 0.0103220354796329
OV ENSG00000256783 RP11-503G7.1 path:00565_22 Ether lipid metabolism 13 3.12572017484232 0.00211662686136984 0.0164569031961431
OV ENSG00000256783 RP11-503G7.1 path:00591_12 Linoleic acid metabolism 16 3.39198403818117 0.000879526184303337 0.00974808187602865
OV ENSG00000256783 RP11-503G7.1 path:00601_16 Glycosphingolipid biosynthesis - lacto and neolacto series 12 3.675429437307 0.000308687228155791 0.00439879300122002
OV ENSG00000256783 RP11-503G7.1 path:00603_1 Glycosphingolipid biosynthesis - globo series 9 3.74276505679405 0.000226501136496751 0.00352856033062826
OV ENSG00000256783 RP11-503G7.1 path:00604_1 Glycosphingolipid biosynthesis - ganglio series 9 3.84574327513626 0.000161995569796033 0.00269317634785904
OV ENSG00000256783 RP11-503G7.1 path:00670_12 One carbon pool by folate 5 -2.76078404627536 0.00622028434798556 0.0329672903561243
OV ENSG00000256783 RP11-503G7.1 path:00760_1 Nicotinate and nicotinamide metabolism 20 4.28330091029452 2.79403248553306e-05 0.00112013275535015
OV ENSG00000256783 RP11-503G7.1 path:00770_1 Pantothenate and CoA biosynthesis 6 2.5763006196592 0.0107214811999006 0.0475318999862258
OV ENSG00000256783 RP11-503G7.1 path:00830_7 Retinol metabolism 27 2.93063143943858 0.00375284275412654 0.0226876402863105
OV ENSG00000256783 RP11-503G7.1 path:00860_2 Porphyrin and chlorophyll metabolism 10 2.83352147850273 0.00508034232919387 0.0292150792681276
OV ENSG00000256783 RP11-503G7.1 path:00983_2 Drug metabolism - other enzymes 16 4.02781672804496 8.32195751601507e-05 0.00174761107836316
OV ENSG00000256783 RP11-503G7.1 path:03320_1 PPAR signaling pathway 48 -3.07436561329727 0.00240905336163302 0.0177677004463382
OV ENSG00000256783 RP11-503G7.1 path:04012_22 ErbB signaling pathway 65 -3.00189562888883 0.00292241916315995 0.0202507688297115
OV ENSG00000256783 RP11-503G7.1 path:04014_12 Ras signaling pathway 180 -3.36836288010451 0.000870796257083678 0.00974808187602865
OV ENSG00000256783 RP11-503G7.1 path:04014_139 Ras signaling pathway 15 -2.55492525813419 0.011271951039878 0.0491419671626535
OV ENSG00000256783 RP11-503G7.1 path:04024_125 cAMP signaling pathway 23 -4.25735493735336 2.80735026403545e-05 0.00112013275535015
OV ENSG00000256783 RP11-503G7.1 path:04062_228 Chemokine signaling pathway 13 3.01072667063783 0.00298285997377301 0.0202507688297115
OV ENSG00000256783 RP11-503G7.1 path:04062_26 Chemokine signaling pathway 106 -3.09912380493101 0.00218600468520196 0.0164569031961431
OV ENSG00000256783 RP11-503G7.1 path:04062_94 Chemokine signaling pathway 51 2.62535998762477 0.00927497768705778 0.0435378364368948
OV ENSG00000256783 RP11-503G7.1 path:04064_1 NF-kappa B signaling pathway 69 3.15455803328309 0.00185179587425291 0.0150789092617737
OV ENSG00000256783 RP11-503G7.1 path:04066_94 HIF-1 signaling pathway 15 -2.66214916989077 0.00827176780296758 0.0402492116266349
OV ENSG00000256783 RP11-503G7.1 path:04070_22 Phosphatidylinositol signaling system 29 -3.52864772386505 0.000493880376970113 0.00597146273972954
OV ENSG00000256783 RP11-503G7.1 path:04140_2 Regulation of autophagy 4 -6.88875407594402 3.52277396531729e-11 1.4055868121616e-08
OV ENSG00000256783 RP11-503G7.1 path:04141_3 Protein processing in endoplasmic reticulum 20 -2.6506472331072 0.00856638301715892 0.0411805641427278
OV ENSG00000256783 RP11-503G7.1 path:04145_13 Phagosome 10 -3.63646417004417 0.000341783181217088 0.00470246514846959
OV ENSG00000256783 RP11-503G7.1 path:04151_233 PI3K-Akt signaling pathway 26 2.94971811353712 0.00356165863609272 0.0218631045507845
OV ENSG00000256783 RP11-503G7.1 path:04151_67 PI3K-Akt signaling pathway 164 -3.90435466463765 0.000131610800464841 0.00239215827497838
OV ENSG00000256783 RP11-503G7.1 path:04152_50 AMPK signaling pathway 21 -5.34711091954349 2.14685149128752e-07 2.08613528897491e-05
OV ENSG00000256783 RP11-503G7.1 path:04210_36 Apoptosis 36 -2.75406796387777 0.00627948387735701 0.0329672903561243
OV ENSG00000256783 RP11-503G7.1 path:04261_51 Adrenergic signaling in cardiomyocytes 66 -4.08743058134037 6.04497925659543e-05 0.00150746670211349
OV ENSG00000256783 RP11-503G7.1 path:04330_22 Notch signaling pathway 24 -3.93709885145048 0.00010734171190194 0.0021414671524437
OV ENSG00000256783 RP11-503G7.1 path:04330_24 Notch signaling pathway 16 -5.9116595975731 1.08048115437142e-08 2.15555990297099e-06
OV ENSG00000256783 RP11-503G7.1 path:04370_42 VEGF signaling pathway 22 -3.2901478452742 0.00115495477388028 0.0112396818238594
OV ENSG00000256783 RP11-503G7.1 path:04370_66 VEGF signaling pathway 14 -3.22937582783755 0.00138783541445903 0.0128352195842968
OV ENSG00000256783 RP11-503G7.1 path:04510_126 Focal adhesion 38 -2.98942525048395 0.00304522839544533 0.0202507688297115
OV ENSG00000256783 RP11-503G7.1 path:04510_137 Focal adhesion 32 -3.32173241335214 0.00104018803140467 0.0106419237059094
OV ENSG00000256783 RP11-503G7.1 path:04510_283 Focal adhesion 10 -2.94987206974197 0.00348694071898694 0.0217592645553635
OV ENSG00000256783 RP11-503G7.1 path:04540_12 Gap junction 71 -2.61571720905987 0.00962932042662289 0.0441620557496843
OV ENSG00000256783 RP11-503G7.1 path:04611_279 Platelet activation 2 3.22752363668332 0.00149655118717204 0.0132694205262588
OV ENSG00000256783 RP11-503G7.1 path:04620_60 Toll-like receptor signaling pathway 22 5.334961208509 2.61420462277557e-07 2.08613528897491e-05
OV ENSG00000256783 RP11-503G7.1 path:04620_92 Toll-like receptor signaling pathway 11 -3.73300836388262 0.000229931249614874 0.00352856033062826
OV ENSG00000256783 RP11-503G7.1 path:04621_22 NOD-like receptor signaling pathway 28 -3.56763298792995 0.000449097604698887 0.00562652187819879
OV ENSG00000256783 RP11-503G7.1 path:04650_115 Natural killer cell mediated cytotoxicity 5 3.61939322099692 0.000386760426508066 0.00514391367255728
OV ENSG00000256783 RP11-503G7.1 path:04650_139 Natural killer cell mediated cytotoxicity 2 3.13399007519802 0.0020358669009318 0.0162462178694358
OV ENSG00000256783 RP11-503G7.1 path:04664_71 Fc epsilon RI signaling pathway 10 -3.1829470912896 0.00161929890181555 0.0140456578657479
OV ENSG00000256783 RP11-503G7.1 path:04664_75 Fc epsilon RI signaling pathway 9 -2.95323404037863 0.00340761344300669 0.0217592645553635
OV ENSG00000256783 RP11-503G7.1 path:04666_244 Fc gamma R-mediated phagocytosis 7 2.68732561124211 0.00778007596543703 0.0389460681065881
OV ENSG00000256783 RP11-503G7.1 path:04720_79 Long-term potentiation 3 -2.67051253064723 0.00806540844279822 0.0397296045515616
OV ENSG00000256783 RP11-503G7.1 path:04722_7 Neurotrophin signaling pathway 107 -2.68428949535569 0.00780873545996753 0.0389460681065881
OV ENSG00000256783 RP11-503G7.1 path:04725_86 Cholinergic synapse 18 -3.33593253126721 0.000971947136628586 0.0103220354796329
OV ENSG00000256783 RP11-503G7.1 path:04742_1 Taste transduction 14 -3.44159300947635 0.000686826202086613 0.0080601074891929
OV ENSG00000256783 RP11-503G7.1 path:04810_241 Regulation of actin cytoskeleton 4 -4.46653173474529 1.18401108904262e-05 0.000590525530660006
OV ENSG00000256783 RP11-503G7.1 path:04810_68 Regulation of actin cytoskeleton 69 -3.69714178971662 0.000271189897787423 0.00400758404508081
OV ENSG00000256783 RP11-503G7.1 path:04910_9 Insulin signaling pathway 120 -2.58839976002241 0.0102797495489981 0.0460856187646093
OV ENSG00000256783 RP11-503G7.1 path:04916_128 Melanogenesis 6 -2.78587644201108 0.0057239875514078 0.0308631220677259
OV ENSG00000256783 RP11-503G7.1 path:04916_139 Melanogenesis 2 -3.55072410430232 0.000451249874943261 0.00562652187819879
OV ENSG00000256783 RP11-503G7.1 path:04916_75 Melanogenesis 23 -2.81448330309427 0.00534511475331657 0.0292150792681276
OV ENSG00000256783 RP11-503G7.1 path:04917_119 Prolactin signaling pathway 10 -2.80833976138489 0.00532761313131726 0.0292150792681276
OV ENSG00000256783 RP11-503G7.1 path:04919_50 Thyroid hormone signaling pathway 33 -2.91958414765043 0.00384821380054463 0.0229169747226464
OV ENSG00000256783 RP11-503G7.1 path:04919_84 Thyroid hormone signaling pathway 5 -2.63385892001617 0.00893122838239294 0.0424233348163665
OV ENSG00000256783 RP11-503G7.1 path:04940_2 Type I diabetes mellitus 2 4.20075428535092 4.22920677407837e-05 0.00112496900190485
OV ENSG00000256783 RP11-503G7.1 path:04950_1 Maturity onset diabetes of the young 22 2.82061133996118 0.00534203981453259 0.0292150792681276
OV ENSG00000256783 RP11-503G7.1 path:04960_8 Aldosterone-regulated sodium reabsorption 14 -3.83675463192949 0.000153347714511069 0.00266024948217028
OV ENSG00000256783 RP11-503G7.1 path:04961_12 Endocrine and other factor-regulated calcium reabsorption 11 2.95830535851067 0.00349020784847936 0.0217592645553635
OV ENSG00000256783 RP11-503G7.1 path:04973_1 Carbohydrate digestion and absorption 12 -3.09291212693519 0.00218182151941671 0.0164569031961431
OV ENSG00000256783 RP11-503G7.1 path:04976_8 Bile secretion 8 2.97996355777916 0.0032980857519611 0.021572724836598
OV ENSG00000256783 RP11-503G7.1 path:05132_39 Salmonella infection 8 -2.84374722692605 0.00495333314792979 0.0290644106768233
OV ENSG00000256783 RP11-503G7.1 path:05140_54 Leishmaniasis 15 3.29178515607181 0.00119031510486084 0.011307993496178
OV ENSG00000256783 RP11-503G7.1 path:05140_84 Leishmaniasis 3 3.00575889913724 0.00303257237162561 0.0202507688297115
OV ENSG00000256783 RP11-503G7.1 path:05206_109 MicroRNAs in cancer 14 -4.20111190647406 3.60789643935302e-05 0.00112496900190485
OV ENSG00000256783 RP11-503G7.1 path:05206_112 MicroRNAs in cancer 11 -2.81546782981109 0.00526249362666958 0.0292150792681276
OV ENSG00000256783 RP11-503G7.1 path:05211_9 Renal cell carcinoma 14 -3.00490072294432 0.00291967889536316 0.0202507688297115
OV ENSG00000256783 RP11-503G7.1 path:05212_61 Pancreatic cancer 2 -2.73336915544695 0.00676572890882166 0.0346093055720492
OV ENSG00000256783 RP11-503G7.1 path:05215_50 Prostate cancer 35 -4.03139610982187 7.1295709268632e-05 0.0016733522351873
OV ENSG00000256783 RP11-503G7.1 path:05215_83 Prostate cancer 9 -3.89901425682466 0.000131898451251941 0.00239215827497838
OV ENSG00000256783 RP11-503G7.1 path:05218_1 Melanoma 63 -3.14847866260563 0.00183117241381397 0.0150789092617737
OV ENSG00000256783 RP11-503G7.1 path:05221_7 Acute myeloid leukemia 49 -4.01879584786709 7.88451371788988e-05 0.00174761107836316
OV ENSG00000256783 RP11-503G7.1 path:05231_31 Choline metabolism in cancer 35 -3.22781643072269 0.00141541268598762 0.0128352195842968
OV ENSG00000256783 RP11-503G7.1 path:05231_42 Choline metabolism in cancer 26 -2.59216415422234 0.0102449868924832 0.0460856187646093
OV ENSG00000256783 RP11-503G7.1 path:05320_2 Autoimmune thyroid disease 2 4.20075428535092 4.22920677407837e-05 0.00112496900190485
OV ENSG00000256783 RP11-503G7.1 path:05330_2 Allograft rejection 2 4.20075428535092 4.22920677407837e-05 0.00112496900190485
OV ENSG00000256783 RP11-503G7.1 path:05332_5 Graft-versus-host disease 2 4.20075428535092 4.22920677407837e-05 0.00112496900190485
OV ENSG00000256875 RP11-503G7.2 path:00120_5 Primary bile acid biosynthesis 4 4.51000176465236 1.10080674679919e-05 0.000590525530660006
OV ENSG00000256875 RP11-503G7.2 path:00140_7 Steroid hormone biosynthesis 23 2.75141764965753 0.00656819009102006 0.0340351668352857
OV ENSG00000256875 RP11-503G7.2 path:00232_1 Caffeine metabolism 3 3.18134556988151 0.00173452388177145 0.0147250006133364
OV ENSG00000256875 RP11-503G7.2 path:00270_17 Cysteine and methionine metabolism 19 -3.30444323846443 0.00108827139327654 0.0108555071479335
OV ENSG00000256875 RP11-503G7.2 path:00270_51 Cysteine and methionine metabolism 8 -2.60833981196217 0.00957155537041206 0.0441620557496843
OV ENSG00000256875 RP11-503G7.2 path:00310_9 Lysine degradation 23 -4.64770693084661 5.4783034517304e-06 0.000364307179540071
OV ENSG00000256875 RP11-503G7.2 path:00410_21 beta-Alanine metabolism 5 -2.55279552240192 0.0113309798971532 0.0491419671626535
OV ENSG00000256875 RP11-503G7.2 path:00450_8 Selenocompound metabolism 3 -5.59390891547333 5.73693287097967e-08 7.63012071840297e-06
OV ENSG00000256875 RP11-503G7.2 path:00562_2 Inositol phosphate metabolism 44 -3.0607241835454 0.00244918176578597 0.0177677004463382
OV ENSG00000256875 RP11-503G7.2 path:00562_70 Inositol phosphate metabolism 7 -3.33241311411182 0.000983050998060281 0.0103220354796329
OV ENSG00000256875 RP11-503G7.2 path:00565_22 Ether lipid metabolism 13 3.12572017484232 0.00211662686136984 0.0164569031961431
OV ENSG00000256875 RP11-503G7.2 path:00591_12 Linoleic acid metabolism 16 3.39198403818117 0.000879526184303337 0.00974808187602865
OV ENSG00000256875 RP11-503G7.2 path:00601_16 Glycosphingolipid biosynthesis - lacto and neolacto series 12 3.675429437307 0.000308687228155791 0.00439879300122002
OV ENSG00000256875 RP11-503G7.2 path:00603_1 Glycosphingolipid biosynthesis - globo series 9 3.74276505679405 0.000226501136496751 0.00352856033062826
OV ENSG00000256875 RP11-503G7.2 path:00604_1 Glycosphingolipid biosynthesis - ganglio series 9 3.84574327513626 0.000161995569796033 0.00269317634785904
OV ENSG00000256875 RP11-503G7.2 path:00670_12 One carbon pool by folate 5 -2.76078404627536 0.00622028434798556 0.0329672903561243
OV ENSG00000256875 RP11-503G7.2 path:00760_1 Nicotinate and nicotinamide metabolism 20 4.28330091029452 2.79403248553306e-05 0.00112013275535015
OV ENSG00000256875 RP11-503G7.2 path:00770_1 Pantothenate and CoA biosynthesis 6 2.5763006196592 0.0107214811999006 0.0475318999862258
OV ENSG00000256875 RP11-503G7.2 path:00830_7 Retinol metabolism 27 2.93063143943858 0.00375284275412654 0.0226876402863105
OV ENSG00000256875 RP11-503G7.2 path:00860_2 Porphyrin and chlorophyll metabolism 10 2.83352147850273 0.00508034232919387 0.0292150792681276
OV ENSG00000256875 RP11-503G7.2 path:00983_2 Drug metabolism - other enzymes 16 4.02781672804496 8.32195751601507e-05 0.00174761107836316
OV ENSG00000256875 RP11-503G7.2 path:03320_1 PPAR signaling pathway 48 -3.07436561329727 0.00240905336163302 0.0177677004463382
OV ENSG00000256875 RP11-503G7.2 path:04012_22 ErbB signaling pathway 65 -3.00189562888883 0.00292241916315995 0.0202507688297115
OV ENSG00000256875 RP11-503G7.2 path:04014_12 Ras signaling pathway 180 -3.36836288010451 0.000870796257083678 0.00974808187602865
OV ENSG00000256875 RP11-503G7.2 path:04014_139 Ras signaling pathway 15 -2.55492525813419 0.011271951039878 0.0491419671626535
OV ENSG00000256875 RP11-503G7.2 path:04024_125 cAMP signaling pathway 23 -4.25735493735336 2.80735026403545e-05 0.00112013275535015
OV ENSG00000256875 RP11-503G7.2 path:04062_228 Chemokine signaling pathway 13 3.01072667063783 0.00298285997377301 0.0202507688297115
OV ENSG00000256875 RP11-503G7.2 path:04062_26 Chemokine signaling pathway 106 -3.09912380493101 0.00218600468520196 0.0164569031961431
OV ENSG00000256875 RP11-503G7.2 path:04062_94 Chemokine signaling pathway 51 2.62535998762477 0.00927497768705778 0.0435378364368948
OV ENSG00000256875 RP11-503G7.2 path:04064_1 NF-kappa B signaling pathway 69 3.15455803328309 0.00185179587425291 0.0150789092617737
OV ENSG00000256875 RP11-503G7.2 path:04066_94 HIF-1 signaling pathway 15 -2.66214916989077 0.00827176780296758 0.0402492116266349
OV ENSG00000256875 RP11-503G7.2 path:04070_22 Phosphatidylinositol signaling system 29 -3.52864772386505 0.000493880376970113 0.00597146273972954
OV ENSG00000256875 RP11-503G7.2 path:04140_2 Regulation of autophagy 4 -6.88875407594402 3.52277396531729e-11 1.4055868121616e-08
OV ENSG00000256875 RP11-503G7.2 path:04141_3 Protein processing in endoplasmic reticulum 20 -2.6506472331072 0.00856638301715892 0.0411805641427278
OV ENSG00000256875 RP11-503G7.2 path:04145_13 Phagosome 10 -3.63646417004417 0.000341783181217088 0.00470246514846959
OV ENSG00000256875 RP11-503G7.2 path:04151_233 PI3K-Akt signaling pathway 26 2.94971811353712 0.00356165863609272 0.0218631045507845
OV ENSG00000256875 RP11-503G7.2 path:04151_67 PI3K-Akt signaling pathway 164 -3.90435466463765 0.000131610800464841 0.00239215827497838
OV ENSG00000256875 RP11-503G7.2 path:04152_50 AMPK signaling pathway 21 -5.34711091954349 2.14685149128752e-07 2.08613528897491e-05
OV ENSG00000256875 RP11-503G7.2 path:04210_36 Apoptosis 36 -2.75406796387777 0.00627948387735701 0.0329672903561243
OV ENSG00000256875 RP11-503G7.2 path:04261_51 Adrenergic signaling in cardiomyocytes 66 -4.08743058134037 6.04497925659543e-05 0.00150746670211349
OV ENSG00000256875 RP11-503G7.2 path:04330_22 Notch signaling pathway 24 -3.93709885145048 0.00010734171190194 0.0021414671524437
OV ENSG00000256875 RP11-503G7.2 path:04330_24 Notch signaling pathway 16 -5.9116595975731 1.08048115437142e-08 2.15555990297099e-06
OV ENSG00000256875 RP11-503G7.2 path:04370_42 VEGF signaling pathway 22 -3.2901478452742 0.00115495477388028 0.0112396818238594
OV ENSG00000256875 RP11-503G7.2 path:04370_66 VEGF signaling pathway 14 -3.22937582783755 0.00138783541445903 0.0128352195842968
OV ENSG00000256875 RP11-503G7.2 path:04510_126 Focal adhesion 38 -2.98942525048395 0.00304522839544533 0.0202507688297115
OV ENSG00000256875 RP11-503G7.2 path:04510_137 Focal adhesion 32 -3.32173241335214 0.00104018803140467 0.0106419237059094
OV ENSG00000256875 RP11-503G7.2 path:04510_283 Focal adhesion 10 -2.94987206974197 0.00348694071898694 0.0217592645553635
OV ENSG00000256875 RP11-503G7.2 path:04540_12 Gap junction 71 -2.61571720905987 0.00962932042662289 0.0441620557496843
OV ENSG00000256875 RP11-503G7.2 path:04611_279 Platelet activation 2 3.22752363668332 0.00149655118717204 0.0132694205262588
OV ENSG00000256875 RP11-503G7.2 path:04620_60 Toll-like receptor signaling pathway 22 5.334961208509 2.61420462277557e-07 2.08613528897491e-05
OV ENSG00000256875 RP11-503G7.2 path:04620_92 Toll-like receptor signaling pathway 11 -3.73300836388262 0.000229931249614874 0.00352856033062826
OV ENSG00000256875 RP11-503G7.2 path:04621_22 NOD-like receptor signaling pathway 28 -3.56763298792995 0.000449097604698887 0.00562652187819879
OV ENSG00000256875 RP11-503G7.2 path:04650_115 Natural killer cell mediated cytotoxicity 5 3.61939322099692 0.000386760426508066 0.00514391367255728
OV ENSG00000256875 RP11-503G7.2 path:04650_139 Natural killer cell mediated cytotoxicity 2 3.13399007519802 0.0020358669009318 0.0162462178694358
OV ENSG00000256875 RP11-503G7.2 path:04664_71 Fc epsilon RI signaling pathway 10 -3.1829470912896 0.00161929890181555 0.0140456578657479
OV ENSG00000256875 RP11-503G7.2 path:04664_75 Fc epsilon RI signaling pathway 9 -2.95323404037863 0.00340761344300669 0.0217592645553635
OV ENSG00000256875 RP11-503G7.2 path:04666_244 Fc gamma R-mediated phagocytosis 7 2.68732561124211 0.00778007596543703 0.0389460681065881
OV ENSG00000256875 RP11-503G7.2 path:04720_79 Long-term potentiation 3 -2.67051253064723 0.00806540844279822 0.0397296045515616
OV ENSG00000256875 RP11-503G7.2 path:04722_7 Neurotrophin signaling pathway 107 -2.68428949535569 0.00780873545996753 0.0389460681065881
OV ENSG00000256875 RP11-503G7.2 path:04725_86 Cholinergic synapse 18 -3.33593253126721 0.000971947136628586 0.0103220354796329
OV ENSG00000256875 RP11-503G7.2 path:04742_1 Taste transduction 14 -3.44159300947635 0.000686826202086613 0.0080601074891929
OV ENSG00000256875 RP11-503G7.2 path:04810_241 Regulation of actin cytoskeleton 4 -4.46653173474529 1.18401108904262e-05 0.000590525530660006
OV ENSG00000256875 RP11-503G7.2 path:04810_68 Regulation of actin cytoskeleton 69 -3.69714178971662 0.000271189897787423 0.00400758404508081
OV ENSG00000256875 RP11-503G7.2 path:04910_9 Insulin signaling pathway 120 -2.58839976002241 0.0102797495489981 0.0460856187646093
OV ENSG00000256875 RP11-503G7.2 path:04916_128 Melanogenesis 6 -2.78587644201108 0.0057239875514078 0.0308631220677259
OV ENSG00000256875 RP11-503G7.2 path:04916_139 Melanogenesis 2 -3.55072410430232 0.000451249874943261 0.00562652187819879
OV ENSG00000256875 RP11-503G7.2 path:04916_75 Melanogenesis 23 -2.81448330309427 0.00534511475331657 0.0292150792681276
OV ENSG00000256875 RP11-503G7.2 path:04917_119 Prolactin signaling pathway 10 -2.80833976138489 0.00532761313131726 0.0292150792681276
OV ENSG00000256875 RP11-503G7.2 path:04919_50 Thyroid hormone signaling pathway 33 -2.91958414765043 0.00384821380054463 0.0229169747226464
OV ENSG00000256875 RP11-503G7.2 path:04919_84 Thyroid hormone signaling pathway 5 -2.63385892001617 0.00893122838239294 0.0424233348163665
OV ENSG00000256875 RP11-503G7.2 path:04940_2 Type I diabetes mellitus 2 4.20075428535092 4.22920677407837e-05 0.00112496900190485
OV ENSG00000256875 RP11-503G7.2 path:04950_1 Maturity onset diabetes of the young 22 2.82061133996118 0.00534203981453259 0.0292150792681276
OV ENSG00000256875 RP11-503G7.2 path:04960_8 Aldosterone-regulated sodium reabsorption 14 -3.83675463192949 0.000153347714511069 0.00266024948217028
OV ENSG00000256875 RP11-503G7.2 path:04961_12 Endocrine and other factor-regulated calcium reabsorption 11 2.95830535851067 0.00349020784847936 0.0217592645553635
OV ENSG00000256875 RP11-503G7.2 path:04973_1 Carbohydrate digestion and absorption 12 -3.09291212693519 0.00218182151941671 0.0164569031961431
OV ENSG00000256875 RP11-503G7.2 path:04976_8 Bile secretion 8 2.97996355777916 0.0032980857519611 0.021572724836598
OV ENSG00000256875 RP11-503G7.2 path:05132_39 Salmonella infection 8 -2.84374722692605 0.00495333314792979 0.0290644106768233
OV ENSG00000256875 RP11-503G7.2 path:05140_54 Leishmaniasis 15 3.29178515607181 0.00119031510486084 0.011307993496178
OV ENSG00000256875 RP11-503G7.2 path:05140_84 Leishmaniasis 3 3.00575889913724 0.00303257237162561 0.0202507688297115
OV ENSG00000256875 RP11-503G7.2 path:05206_109 MicroRNAs in cancer 14 -4.20111190647406 3.60789643935302e-05 0.00112496900190485
OV ENSG00000256875 RP11-503G7.2 path:05206_112 MicroRNAs in cancer 11 -2.81546782981109 0.00526249362666958 0.0292150792681276
OV ENSG00000256875 RP11-503G7.2 path:05211_9 Renal cell carcinoma 14 -3.00490072294432 0.00291967889536316 0.0202507688297115
OV ENSG00000256875 RP11-503G7.2 path:05212_61 Pancreatic cancer 2 -2.73336915544695 0.00676572890882166 0.0346093055720492
OV ENSG00000256875 RP11-503G7.2 path:05215_50 Prostate cancer 35 -4.03139610982187 7.1295709268632e-05 0.0016733522351873
OV ENSG00000256875 RP11-503G7.2 path:05215_83 Prostate cancer 9 -3.89901425682466 0.000131898451251941 0.00239215827497838
OV ENSG00000256875 RP11-503G7.2 path:05218_1 Melanoma 63 -3.14847866260563 0.00183117241381397 0.0150789092617737
OV ENSG00000256875 RP11-503G7.2 path:05221_7 Acute myeloid leukemia 49 -4.01879584786709 7.88451371788988e-05 0.00174761107836316
OV ENSG00000256875 RP11-503G7.2 path:05231_31 Choline metabolism in cancer 35 -3.22781643072269 0.00141541268598762 0.0128352195842968
OV ENSG00000256875 RP11-503G7.2 path:05231_42 Choline metabolism in cancer 26 -2.59216415422234 0.0102449868924832 0.0460856187646093
OV ENSG00000256875 RP11-503G7.2 path:05320_2 Autoimmune thyroid disease 2 4.20075428535092 4.22920677407837e-05 0.00112496900190485
OV ENSG00000256875 RP11-503G7.2 path:05330_2 Allograft rejection 2 4.20075428535092 4.22920677407837e-05 0.00112496900190485
OV ENSG00000256875 RP11-503G7.2 path:05332_5 Graft-versus-host disease 2 4.20075428535092 4.22920677407837e-05 0.00112496900190485
OV ENSG00000244260 RP11-521D12.2 path:00740_1 Riboflavin metabolism 8 -5.10848416556755 2.12024164393961e-06 0.000824773999492506
OV ENSG00000244260 RP11-521D12.2 path:04115_9 p53 signaling pathway 57 -4.36622914828505 3.38500558736253e-05 0.00658383586742011
OV ENSG00000228648 RP11-568A7.2 path:00100_10 Steroid biosynthesis 10 2.87093377530285 0.00443378392554821 0.0493797044840981
OV ENSG00000228648 RP11-568A7.2 path:00120_6 Primary bile acid biosynthesis 3 3.37791928562181 0.000859237595362444 0.0193805813176196
OV ENSG00000228648 RP11-568A7.2 path:00330_90 Arginine and proline metabolism 6 3.88897008617019 0.000126318115246594 0.00732645068430247
OV ENSG00000228648 RP11-568A7.2 path:00524_1 Butirosin and neomycin biosynthesis 4 -3.01399467102562 0.00293993647339391 0.0438824722970206
OV ENSG00000228648 RP11-568A7.2 path:00561_55 Glycerolipid metabolism 7 3.22113303481992 0.00145062586365298 0.0268320792106822
OV ENSG00000228648 RP11-568A7.2 path:00565_8 Ether lipid metabolism 23 -3.15851475914324 0.00193161154985689 0.031369371569676
OV ENSG00000228648 RP11-568A7.2 path:00983_2 Drug metabolism - other enzymes 16 3.1600516243159 0.00175918638689991 0.0297595697117236
OV ENSG00000228648 RP11-568A7.2 path:04014_21 Ras signaling pathway 155 -2.96629604298501 0.00334171874807055 0.0441790540033559
OV ENSG00000228648 RP11-568A7.2 path:04068_37 FoxO signaling pathway 42 -4.72348422240979 4.66625725851313e-06 0.000947250223478165
OV ENSG00000228648 RP11-568A7.2 path:04140_1 Regulation of autophagy 10 -3.26934537046421 0.00126344187383331 0.0256478700388162
OV ENSG00000228648 RP11-568A7.2 path:04330_24 Notch signaling pathway 16 -3.59852024270707 0.000404105287323363 0.0145227295077435
OV ENSG00000228648 RP11-568A7.2 path:04360_143 Axon guidance 9 -2.89065044091061 0.00421838613673413 0.0493797044840981
OV ENSG00000228648 RP11-568A7.2 path:04360_145 Axon guidance 8 -3.4445832856097 0.000683915278849054 0.0163335060713362
OV ENSG00000228648 RP11-568A7.2 path:04390_125 Hippo signaling pathway 10 -2.95399813803269 0.00348209292637288 0.0441790540033559
OV ENSG00000228648 RP11-568A7.2 path:04510_310 Focal adhesion 7 -4.09316761353922 5.95817311350318e-05 0.00498560980608799
OV ENSG00000228648 RP11-568A7.2 path:04510_63 Focal adhesion 76 -3.35206044427342 0.00100770664867631 0.0215330999664517
OV ENSG00000228648 RP11-568A7.2 path:04550_2 Signaling pathways regulating pluripotency of stem cells 91 -3.64923005659467 0.000337794308078854 0.0144491932827961
OV ENSG00000228648 RP11-568A7.2 path:04621_50 NOD-like receptor signaling pathway 7 -7.51700111475503 1.65061591341748e-12 6.70150060847497e-10
OV ENSG00000228648 RP11-568A7.2 path:04623_19 Cytosolic DNA-sensing pathway 3 3.2216086658782 0.00145395503112071 0.0268320792106822
OV ENSG00000228648 RP11-568A7.2 path:04666_159 Fc gamma R-mediated phagocytosis 19 -3.55208299860538 0.000491411977129663 0.0153471740549725
OV ENSG00000228648 RP11-568A7.2 path:04670_105 Leukocyte transendothelial migration 16 3.18555722231736 0.0016201776836279 0.0285996582414317
OV ENSG00000228648 RP11-568A7.2 path:04670_163 Leukocyte transendothelial migration 4 -3.82119532026206 0.000177156063901317 0.00899067024299186
OV ENSG00000228648 RP11-568A7.2 path:04720_55 Long-term potentiation 18 4.06825075287858 6.13991355429556e-05 0.00498560980608799
OV ENSG00000228648 RP11-568A7.2 path:04720_60 Long-term potentiation 16 -2.96360519332466 0.00345761918879733 0.0441790540033559
OV ENSG00000228648 RP11-568A7.2 path:04723_39 Retrograde endocannabinoid signaling 14 3.62173583001926 0.000355891460167391 0.0144491932827961
OV ENSG00000228648 RP11-568A7.2 path:04932_84 Non-alcoholic fatty liver disease (NAFLD) 11 -3.47837649319126 0.000609687967999611 0.0163335060713362
OV ENSG00000228648 RP11-568A7.2 path:05033_8 Nicotine addiction 9 3.07144934384726 0.00236221222400283 0.0368868524209673
OV ENSG00000228648 RP11-568A7.2 path:05131_27 Shigellosis 2 -3.47229754069797 0.00061634900633344 0.0163335060713362
OV ENSG00000228648 RP11-568A7.2 path:05134_11 Legionellosis 7 2.91032414211015 0.00395062380125599 0.0486046443427252
OV ENSG00000228648 RP11-568A7.2 path:05143_1 African trypanosomiasis 9 4.0852600418552 6.02306071056266e-05 0.00498560980608799
OV ENSG00000228648 RP11-568A7.2 path:05164_41 Influenza A 6 2.87422410800824 0.00442435120464645 0.0493797044840981
OV ENSG00000228648 RP11-568A7.2 path:05206_22 MicroRNAs in cancer 98 -4.02626993689228 8.77461921120874e-05 0.00593749233291792
OV ENSG00000228648 RP11-568A7.2 path:05211_17 Renal cell carcinoma 6 -3.575982431959 0.000429243236682073 0.0145227295077435
OV ENSG00000228648 RP11-568A7.2 path:05212_5 Pancreatic cancer 46 -3.48476678161276 0.00065559834240241 0.0163335060713362
OV ENSG00000228648 RP11-568A7.2 path:05214_7 Glioma 50 -2.98977152878203 0.00313446230693004 0.0438824722970206
OV ENSG00000228648 RP11-568A7.2 path:05215_53 Prostate cancer 30 -3.0164845840865 0.00309640582064933 0.0438824722970206
OV ENSG00000228648 RP11-568A7.2 path:05221_34 Acute myeloid leukemia 23 -2.88107945441955 0.00450012085199909 0.0493797044840981
OV ENSG00000231720 RP11-568A7.3 path:00100_10 Steroid biosynthesis 10 2.87093377530285 0.00443378392554821 0.0493797044840981
OV ENSG00000231720 RP11-568A7.3 path:00120_6 Primary bile acid biosynthesis 3 3.37791928562181 0.000859237595362444 0.0193805813176196
OV ENSG00000231720 RP11-568A7.3 path:00330_90 Arginine and proline metabolism 6 3.88897008617019 0.000126318115246594 0.00732645068430247
OV ENSG00000231720 RP11-568A7.3 path:00524_1 Butirosin and neomycin biosynthesis 4 -3.01399467102562 0.00293993647339391 0.0438824722970206
OV ENSG00000231720 RP11-568A7.3 path:00561_55 Glycerolipid metabolism 7 3.22113303481992 0.00145062586365298 0.0268320792106822
OV ENSG00000231720 RP11-568A7.3 path:00565_8 Ether lipid metabolism 23 -3.15851475914324 0.00193161154985689 0.031369371569676
OV ENSG00000231720 RP11-568A7.3 path:00983_2 Drug metabolism - other enzymes 16 3.1600516243159 0.00175918638689991 0.0297595697117236
OV ENSG00000231720 RP11-568A7.3 path:04014_21 Ras signaling pathway 155 -2.96629604298501 0.00334171874807055 0.0441790540033559
OV ENSG00000231720 RP11-568A7.3 path:04068_37 FoxO signaling pathway 42 -4.72348422240979 4.66625725851313e-06 0.000947250223478165
OV ENSG00000231720 RP11-568A7.3 path:04140_1 Regulation of autophagy 10 -3.26934537046421 0.00126344187383331 0.0256478700388162
OV ENSG00000231720 RP11-568A7.3 path:04330_24 Notch signaling pathway 16 -3.59852024270707 0.000404105287323363 0.0145227295077435
OV ENSG00000231720 RP11-568A7.3 path:04360_143 Axon guidance 9 -2.89065044091061 0.00421838613673413 0.0493797044840981
OV ENSG00000231720 RP11-568A7.3 path:04360_145 Axon guidance 8 -3.4445832856097 0.000683915278849054 0.0163335060713362
OV ENSG00000231720 RP11-568A7.3 path:04390_125 Hippo signaling pathway 10 -2.95399813803269 0.00348209292637288 0.0441790540033559
OV ENSG00000231720 RP11-568A7.3 path:04510_310 Focal adhesion 7 -4.09316761353922 5.95817311350318e-05 0.00498560980608799
OV ENSG00000231720 RP11-568A7.3 path:04510_63 Focal adhesion 76 -3.35206044427342 0.00100770664867631 0.0215330999664517
OV ENSG00000231720 RP11-568A7.3 path:04550_2 Signaling pathways regulating pluripotency of stem cells 91 -3.64923005659467 0.000337794308078854 0.0144491932827961
OV ENSG00000231720 RP11-568A7.3 path:04621_50 NOD-like receptor signaling pathway 7 -7.51700111475503 1.65061591341748e-12 6.70150060847497e-10
OV ENSG00000231720 RP11-568A7.3 path:04623_19 Cytosolic DNA-sensing pathway 3 3.2216086658782 0.00145395503112071 0.0268320792106822
OV ENSG00000231720 RP11-568A7.3 path:04666_159 Fc gamma R-mediated phagocytosis 19 -3.55208299860538 0.000491411977129663 0.0153471740549725
OV ENSG00000231720 RP11-568A7.3 path:04670_105 Leukocyte transendothelial migration 16 3.18555722231736 0.0016201776836279 0.0285996582414317
OV ENSG00000231720 RP11-568A7.3 path:04670_163 Leukocyte transendothelial migration 4 -3.82119532026206 0.000177156063901317 0.00899067024299186
OV ENSG00000231720 RP11-568A7.3 path:04720_55 Long-term potentiation 18 4.06825075287858 6.13991355429556e-05 0.00498560980608799
OV ENSG00000231720 RP11-568A7.3 path:04720_60 Long-term potentiation 16 -2.96360519332466 0.00345761918879733 0.0441790540033559
OV ENSG00000231720 RP11-568A7.3 path:04723_39 Retrograde endocannabinoid signaling 14 3.62173583001926 0.000355891460167391 0.0144491932827961
OV ENSG00000231720 RP11-568A7.3 path:04932_84 Non-alcoholic fatty liver disease (NAFLD) 11 -3.47837649319126 0.000609687967999611 0.0163335060713362
OV ENSG00000231720 RP11-568A7.3 path:05033_8 Nicotine addiction 9 3.07144934384726 0.00236221222400283 0.0368868524209673
OV ENSG00000231720 RP11-568A7.3 path:05131_27 Shigellosis 2 -3.47229754069797 0.00061634900633344 0.0163335060713362
OV ENSG00000231720 RP11-568A7.3 path:05134_11 Legionellosis 7 2.91032414211015 0.00395062380125599 0.0486046443427252
OV ENSG00000231720 RP11-568A7.3 path:05143_1 African trypanosomiasis 9 4.0852600418552 6.02306071056266e-05 0.00498560980608799
OV ENSG00000231720 RP11-568A7.3 path:05164_41 Influenza A 6 2.87422410800824 0.00442435120464645 0.0493797044840981
OV ENSG00000231720 RP11-568A7.3 path:05206_22 MicroRNAs in cancer 98 -4.02626993689228 8.77461921120874e-05 0.00593749233291792
OV ENSG00000231720 RP11-568A7.3 path:05211_17 Renal cell carcinoma 6 -3.575982431959 0.000429243236682073 0.0145227295077435
OV ENSG00000231720 RP11-568A7.3 path:05212_5 Pancreatic cancer 46 -3.48476678161276 0.00065559834240241 0.0163335060713362
OV ENSG00000231720 RP11-568A7.3 path:05214_7 Glioma 50 -2.98977152878203 0.00313446230693004 0.0438824722970206
OV ENSG00000231720 RP11-568A7.3 path:05215_53 Prostate cancer 30 -3.0164845840865 0.00309640582064933 0.0438824722970206
OV ENSG00000231720 RP11-568A7.3 path:05221_34 Acute myeloid leukemia 23 -2.88107945441955 0.00450012085199909 0.0493797044840981
OV ENSG00000257009 RP11-685B13.2 path:00010_31 Glycolysis / Gluconeogenesis 25 3.41685289164535 0.00080338955357898 0.0228966022770009
OV ENSG00000257009 RP11-685B13.2 path:00280_80 Valine, leucine and isoleucine degradation 4 3.41980775261843 0.000724609483730399 0.0222399372314176
OV ENSG00000257009 RP11-685B13.2 path:00630_1 Glyoxylate and dicarboxylate metabolism 7 4.06264657076638 7.39585363533156e-05 0.0036904901447769
OV ENSG00000257009 RP11-685B13.2 path:00790_1 Folate biosynthesis 10 3.53737929887806 0.000470618338737101 0.0156480597630086
OV ENSG00000257009 RP11-685B13.2 path:04015_117 Rap1 signaling pathway 26 3.35044719604079 0.000964929520926971 0.0240629299281163
OV ENSG00000257009 RP11-685B13.2 path:04062_328 Chemokine signaling pathway 2 3.97787171998972 9.24934873377668e-05 0.0036904901447769
OV ENSG00000257009 RP11-685B13.2 path:04068_74 FoxO signaling pathway 2 3.97787171998972 9.24934873377668e-05 0.0036904901447769
OV ENSG00000257009 RP11-685B13.2 path:04146_1 Peroxisome 4 4.34525328019452 2.43935914034689e-05 0.00324434765666136
OV ENSG00000257009 RP11-685B13.2 path:04510_330 Focal adhesion 5 3.17619375319533 0.00173341614686723 0.0406842966235308
OV ENSG00000257009 RP11-685B13.2 path:04662_95 B cell receptor signaling pathway 2 3.97787171998972 9.24934873377668e-05 0.0036904901447769
OV ENSG00000257009 RP11-685B13.2 path:04912_78 GnRH signaling pathway 3 3.79854715488632 0.00017773092378347 0.00644678532632769
OV ENSG00000257009 RP11-685B13.2 path:04960_9 Aldosterone-regulated sodium reabsorption 7 5.18621009535422 4.96091705677215e-07 0.000197940590565209
OV ENSG00000257009 RP11-685B13.2 path:05200_219 Pathways in cancer 6 4.74839147351551 3.63821977048157e-06 0.000725824844211072
OV ENSG00000257009 RP11-685B13.2 path:05200_245 Pathways in cancer 2 4.13201627547024 5.11988657353953e-05 0.0036904901447769
OV ENSG00000257009 RP11-685B13.2 path:05214_58 Glioma 2 3.97787171998972 9.24934873377668e-05 0.0036904901447769
OV ENSG00000257009 RP11-685B13.2 path:05216_18 Thyroid cancer 2 4.13201627547024 5.11988657353953e-05 0.0036904901447769
OV ENSG00000257009 RP11-685B13.2 path:05218_84 Melanoma 6 3.35158328784767 0.000939351347863229 0.0240629299281163
OV ENSG00000258471 RP11-84C10.4 path:03460_61 Fanconi anemia pathway 2 -4.16348447955931 4.20546481888573e-05 0.0180834987212086
OV ENSG00000178107 RP11-998D10.4 path:03460_61 Fanconi anemia pathway 2 -4.60119415723038 6.42586644633312e-06 0.00276312257192324
OV ENSG00000178107 RP11-998D10.4 path:04530_221 Tight junction 2 3.75039737925368 0.00021589088269476 0.0464165397793734
OV ENSG00000257000 RP13-820C6.2 path:00120_5 Primary bile acid biosynthesis 4 4.34195377550443 2.24692188447678e-05 0.000956710118782273
OV ENSG00000257000 RP13-820C6.2 path:00140_7 Steroid hormone biosynthesis 23 2.71756167579368 0.00724880506373806 0.0399737701779041
OV ENSG00000257000 RP13-820C6.2 path:00232_1 Caffeine metabolism 3 2.99291126009978 0.00316683811912061 0.0216706131152794
OV ENSG00000257000 RP13-820C6.2 path:00270_17 Cysteine and methionine metabolism 19 -3.31891766346046 0.00103562787826463 0.0108740927217787
OV ENSG00000257000 RP13-820C6.2 path:00270_51 Cysteine and methionine metabolism 8 -2.68604352386049 0.00764873507990748 0.0402551056806751
OV ENSG00000257000 RP13-820C6.2 path:00310_9 Lysine degradation 23 -4.58167639833063 7.35244594320513e-06 0.000419089418762692
OV ENSG00000257000 RP13-820C6.2 path:00450_8 Selenocompound metabolism 3 -5.9146809411007 1.07060841612419e-08 1.42390919344518e-06
OV ENSG00000257000 RP13-820C6.2 path:00562_2 Inositol phosphate metabolism 44 -2.89904466608991 0.0040807199076784 0.0262614071478013
OV ENSG00000257000 RP13-820C6.2 path:00562_70 Inositol phosphate metabolism 7 -3.84316635366397 0.000150424289233826 0.00300641527210726
OV ENSG00000257000 RP13-820C6.2 path:00565_22 Ether lipid metabolism 13 2.90954336503297 0.00415318485572434 0.0263035040862542
OV ENSG00000257000 RP13-820C6.2 path:00591_12 Linoleic acid metabolism 16 3.19250660972243 0.00170840475512197 0.0151478554954148
OV ENSG00000257000 RP13-820C6.2 path:00601_16 Glycosphingolipid biosynthesis - lacto and neolacto series 12 3.50223893044274 0.000577082215921537 0.00677222953390274
OV ENSG00000257000 RP13-820C6.2 path:00603_1 Glycosphingolipid biosynthesis - globo series 9 3.66676896681137 0.000300918779853197 0.00431749364504043
OV ENSG00000257000 RP13-820C6.2 path:00604_1 Glycosphingolipid biosynthesis - ganglio series 9 3.88994809282333 0.000136907749391259 0.00300641527210726
OV ENSG00000257000 RP13-820C6.2 path:00760_1 Nicotinate and nicotinamide metabolism 20 4.11803493070203 5.53161180458461e-05 0.00169777931540712
OV ENSG00000257000 RP13-820C6.2 path:00983_2 Drug metabolism - other enzymes 16 3.82633637079882 0.000180837008848557 0.00300641527210726
OV ENSG00000257000 RP13-820C6.2 path:03320_1 PPAR signaling pathway 48 -3.2104428658955 0.00154599336298451 0.0140522278796805
OV ENSG00000257000 RP13-820C6.2 path:04012_22 ErbB signaling pathway 65 -3.05797073101882 0.00244193126821179 0.0194866115203301
OV ENSG00000257000 RP13-820C6.2 path:04014_12 Ras signaling pathway 180 -3.39431969226969 0.00079506667106656 0.00906376005015879
OV ENSG00000257000 RP13-820C6.2 path:04024_125 cAMP signaling pathway 23 -4.13648344206064 4.64130116750283e-05 0.00154323263819469
OV ENSG00000257000 RP13-820C6.2 path:04062_228 Chemokine signaling pathway 13 2.85683063390582 0.00479057643323499 0.0289612120736479
OV ENSG00000257000 RP13-820C6.2 path:04062_26 Chemokine signaling pathway 106 -3.21092767809999 0.00151293974060751 0.0140522278796805
OV ENSG00000257000 RP13-820C6.2 path:04064_1 NF-kappa B signaling pathway 69 3.04585452090235 0.00263038076896721 0.0201831139772677
OV ENSG00000257000 RP13-820C6.2 path:04070_22 Phosphatidylinositol signaling system 29 -3.51295089580531 0.000522678414439849 0.00631965719277272
OV ENSG00000257000 RP13-820C6.2 path:04122_1 Sulfur relay system 5 2.64693683957269 0.00871840324241918 0.0440334543509526
OV ENSG00000257000 RP13-820C6.2 path:04140_2 Regulation of autophagy 4 -7.18583149713795 5.71384299224867e-12 2.27982335390722e-09
OV ENSG00000257000 RP13-820C6.2 path:04145_13 Phagosome 10 -3.21241210542898 0.00152329978669899 0.0140522278796805
OV ENSG00000257000 RP13-820C6.2 path:04151_233 PI3K-Akt signaling pathway 26 2.71042738747593 0.00731487011124955 0.0399737701779041
OV ENSG00000257000 RP13-820C6.2 path:04151_67 PI3K-Akt signaling pathway 164 -3.56563987250422 0.000463401704139851 0.00577803999849376
OV ENSG00000257000 RP13-820C6.2 path:04152_50 AMPK signaling pathway 21 -5.22498039643753 3.95885513904348e-07 3.94895800119587e-05
OV ENSG00000257000 RP13-820C6.2 path:04210_36 Apoptosis 36 -2.86701093661245 0.0044633532771611 0.0273981224244197
OV ENSG00000257000 RP13-820C6.2 path:04261_51 Adrenergic signaling in cardiomyocytes 66 -3.88941153161631 0.000132069225672664 0.00300641527210726
OV ENSG00000257000 RP13-820C6.2 path:04330_22 Notch signaling pathway 24 -4.30333237977485 2.39776972125883e-05 0.000956710118782273
OV ENSG00000257000 RP13-820C6.2 path:04330_24 Notch signaling pathway 16 -6.05801749429401 4.8276791595908e-09 9.63121992338366e-07
OV ENSG00000257000 RP13-820C6.2 path:04360_145 Axon guidance 8 -2.80436649576071 0.00544385361571119 0.0324193670547577
OV ENSG00000257000 RP13-820C6.2 path:04370_42 VEGF signaling pathway 22 -3.29429900760846 0.00113874131092459 0.0116501995656132
OV ENSG00000257000 RP13-820C6.2 path:04370_66 VEGF signaling pathway 14 -3.13324587637491 0.00191189649607257 0.0162307808921905
OV ENSG00000257000 RP13-820C6.2 path:04510_126 Focal adhesion 38 -3.09974293968889 0.00213686744421092 0.0174237381395233
OV ENSG00000257000 RP13-820C6.2 path:04510_137 Focal adhesion 32 -3.01611294564293 0.00285982808854827 0.0211309519876067
OV ENSG00000257000 RP13-820C6.2 path:04510_283 Focal adhesion 10 -3.04388261578839 0.00259063371524695 0.0201831139772677
OV ENSG00000257000 RP13-820C6.2 path:04611_279 Platelet activation 2 3.00704159998309 0.00303746554120097 0.0216419419810569
OV ENSG00000257000 RP13-820C6.2 path:04620_60 Toll-like receptor signaling pathway 22 4.93633660779526 1.73779632766323e-06 0.000115563455789605
OV ENSG00000257000 RP13-820C6.2 path:04620_92 Toll-like receptor signaling pathway 11 -3.65390007639631 0.000309334889436814 0.00431749364504043
OV ENSG00000257000 RP13-820C6.2 path:04621_22 NOD-like receptor signaling pathway 28 -3.631717877703 0.000356149164438062 0.00473678388702622
OV ENSG00000257000 RP13-820C6.2 path:04650_115 Natural killer cell mediated cytotoxicity 5 3.35696234360302 0.000969995048539834 0.0104602168747944
OV ENSG00000257000 RP13-820C6.2 path:04650_139 Natural killer cell mediated cytotoxicity 2 2.89792855491181 0.00426111133244916 0.0265653659632378
OV ENSG00000257000 RP13-820C6.2 path:04664_71 Fc epsilon RI signaling pathway 10 -2.90576225364913 0.00395191909440296 0.0258494380109309
OV ENSG00000257000 RP13-820C6.2 path:04664_75 Fc epsilon RI signaling pathway 9 -3.09890749262546 0.00213975731538006 0.0174237381395233
OV ENSG00000257000 RP13-820C6.2 path:04720_79 Long-term potentiation 3 -2.69941117471501 0.00741368168713008 0.0399737701779041
OV ENSG00000257000 RP13-820C6.2 path:04725_86 Cholinergic synapse 18 -3.65052643682297 0.000313802796256071 0.00431749364504043
OV ENSG00000257000 RP13-820C6.2 path:04742_1 Taste transduction 14 -3.57253669789689 0.000430801495481054 0.00554483215151421
OV ENSG00000257000 RP13-820C6.2 path:04810_241 Regulation of actin cytoskeleton 4 -4.40249896092598 1.56177639100603e-05 0.000778935975014256
OV ENSG00000257000 RP13-820C6.2 path:04810_68 Regulation of actin cytoskeleton 69 -3.86495257424228 0.000142704515453312 0.00300641527210726
OV ENSG00000257000 RP13-820C6.2 path:04916_128 Melanogenesis 6 -3.20123283579129 0.00154961911455123 0.0140522278796805
OV ENSG00000257000 RP13-820C6.2 path:04916_139 Melanogenesis 2 -3.68997918016985 0.000269384365644165 0.00413401391892392
OV ENSG00000257000 RP13-820C6.2 path:04916_75 Melanogenesis 23 -2.98549644547524 0.00315526451006006 0.0216706131152794
OV ENSG00000257000 RP13-820C6.2 path:04917_119 Prolactin signaling pathway 10 -3.13851815858974 0.00188371333840654 0.0162307808921905
OV ENSG00000257000 RP13-820C6.2 path:04919_50 Thyroid hormone signaling pathway 33 -2.64852768017977 0.00864353415722225 0.0440334543509526
OV ENSG00000257000 RP13-820C6.2 path:04919_84 Thyroid hormone signaling pathway 5 -3.00453798657641 0.00292713411214106 0.0212350274680779
OV ENSG00000257000 RP13-820C6.2 path:04940_2 Type I diabetes mellitus 2 3.82985124115553 0.000179541911893609 0.00300641527210726
OV ENSG00000257000 RP13-820C6.2 path:04960_8 Aldosterone-regulated sodium reabsorption 14 -4.20684209158807 3.45929632977722e-05 0.00125478112325555
OV ENSG00000257000 RP13-820C6.2 path:04961_12 Endocrine and other factor-regulated calcium reabsorption 11 2.73148685206949 0.00691599377293584 0.0388659368366395
OV ENSG00000257000 RP13-820C6.2 path:04973_1 Carbohydrate digestion and absorption 12 -3.01506650065409 0.00280457143784636 0.021113660447183
OV ENSG00000257000 RP13-820C6.2 path:04976_8 Bile secretion 8 2.67935241341786 0.00809326064487638 0.041937805159814
OV ENSG00000257000 RP13-820C6.2 path:05132_39 Salmonella infection 8 -2.77088542880957 0.00615364240598926 0.0361074017645546
OV ENSG00000257000 RP13-820C6.2 path:05140_54 Leishmaniasis 15 3.25116027133203 0.00136347217526574 0.0136006349482758
OV ENSG00000257000 RP13-820C6.2 path:05140_84 Leishmaniasis 3 2.98817746745875 0.0032044265007556 0.0216706131152794
OV ENSG00000257000 RP13-820C6.2 path:05206_109 MicroRNAs in cancer 14 -5.00464007024165 9.77630018465642e-07 7.80148754735582e-05
OV ENSG00000257000 RP13-820C6.2 path:05206_112 MicroRNAs in cancer 11 -2.94470712378743 0.00353064299206078 0.0234787758972042
OV ENSG00000257000 RP13-820C6.2 path:05211_9 Renal cell carcinoma 14 -2.68779325039084 0.00766763917727145 0.0402551056806751
OV ENSG00000257000 RP13-820C6.2 path:05212_61 Pancreatic cancer 2 -2.72636656538376 0.00690620060306928 0.0388659368366395
OV ENSG00000257000 RP13-820C6.2 path:05215_50 Prostate cancer 35 -3.93668847076429 0.000103860644977709 0.0029600283818647
OV ENSG00000257000 RP13-820C6.2 path:05215_83 Prostate cancer 9 -3.9141070531498 0.000124447931276524 0.00300641527210726
OV ENSG00000257000 RP13-820C6.2 path:05218_1 Melanoma 63 -2.61499925508358 0.00951655832233571 0.0474638346326494
OV ENSG00000257000 RP13-820C6.2 path:05221_7 Acute myeloid leukemia 49 -3.72298220959101 0.000248729764025945 0.00396972703385408
OV ENSG00000257000 RP13-820C6.2 path:05231_31 Choline metabolism in cancer 35 -3.34963183039395 0.000933585509813083 0.0103472394004283
OV ENSG00000257000 RP13-820C6.2 path:05231_42 Choline metabolism in cancer 26 -2.74461863558082 0.00660695743407369 0.0382054495100783
OV ENSG00000257000 RP13-820C6.2 path:05320_2 Autoimmune thyroid disease 2 3.82985124115553 0.000179541911893609 0.00300641527210726
OV ENSG00000257000 RP13-820C6.2 path:05330_2 Allograft rejection 2 3.82985124115553 0.000179541911893609 0.00300641527210726
OV ENSG00000257000 RP13-820C6.2 path:05332_5 Graft-versus-host disease 2 3.82985124115553 0.000179541911893609 0.00300641527210726
OV ENSG00000256943 RP13-895J2.2 path:00100_1 Steroid biosynthesis 13 2.60228951743014 0.0101423341141269 0.0439421889225508
OV ENSG00000256943 RP13-895J2.2 path:00120_5 Primary bile acid biosynthesis 4 4.49439405858721 1.18949012289458e-05 0.000493741415377017
OV ENSG00000256943 RP13-895J2.2 path:00140_7 Steroid hormone biosynthesis 23 2.76769479553527 0.00627622868092228 0.0325222758920518
OV ENSG00000256943 RP13-895J2.2 path:00232_1 Caffeine metabolism 3 3.14360703553865 0.00196735095988888 0.0142722369635575
OV ENSG00000256943 RP13-895J2.2 path:00270_17 Cysteine and methionine metabolism 19 -3.29862009650208 0.00111249074376079 0.00986408459467898
OV ENSG00000256943 RP13-895J2.2 path:00270_51 Cysteine and methionine metabolism 8 -2.71658678573836 0.00699408153869485 0.0342051206268332
OV ENSG00000256943 RP13-895J2.2 path:00310_9 Lysine degradation 23 -4.69372470374386 4.49441723904539e-06 0.000256181782625587
OV ENSG00000256943 RP13-895J2.2 path:00450_8 Selenocompound metabolism 3 -5.74509564341831 2.64155756516516e-08 2.63495367125225e-06
OV ENSG00000256943 RP13-895J2.2 path:00562_2 Inositol phosphate metabolism 44 -3.09659161157344 0.00218487962452119 0.0149433350555552
OV ENSG00000256943 RP13-895J2.2 path:00562_70 Inositol phosphate metabolism 7 -3.84359974216614 0.000150452648245952 0.00240122426600539
OV ENSG00000256943 RP13-895J2.2 path:00565_22 Ether lipid metabolism 13 3.0455283758664 0.00273674122345334 0.0172050105669626
OV ENSG00000256943 RP13-895J2.2 path:00591_12 Linoleic acid metabolism 16 3.32911675328674 0.00109197521912744 0.00986408459467898
OV ENSG00000256943 RP13-895J2.2 path:00601_16 Glycosphingolipid biosynthesis - lacto and neolacto series 12 3.73687518456696 0.000247540350594157 0.00331669336931518
OV ENSG00000256943 RP13-895J2.2 path:00603_1 Glycosphingolipid biosynthesis - globo series 9 3.70664880993929 0.000260300062523332 0.0033503137079616
OV ENSG00000256943 RP13-895J2.2 path:00604_1 Glycosphingolipid biosynthesis - ganglio series 9 3.8342063989555 0.000170294818471259 0.00251657898407527
OV ENSG00000256943 RP13-895J2.2 path:00670_12 One carbon pool by folate 5 -2.71912698276967 0.00704223651908822 0.0342051206268332
OV ENSG00000256943 RP13-895J2.2 path:00760_1 Nicotinate and nicotinamide metabolism 20 4.5106070675745 1.07217432492167e-05 0.000493741415377017
OV ENSG00000256943 RP13-895J2.2 path:00770_1 Pantothenate and CoA biosynthesis 6 2.6107609886297 0.00974731940190605 0.0433802889045002
OV ENSG00000256943 RP13-895J2.2 path:00830_7 Retinol metabolism 27 2.68378564544924 0.00784848963470375 0.0365653574212313
OV ENSG00000256943 RP13-895J2.2 path:00860_2 Porphyrin and chlorophyll metabolism 10 2.75285487893177 0.00646832869269434 0.0330879890818595
OV ENSG00000256943 RP13-895J2.2 path:00983_2 Drug metabolism - other enzymes 16 4.06447152706543 7.2690485995369e-05 0.00138111923391201
OV ENSG00000256943 RP13-895J2.2 path:03320_1 PPAR signaling pathway 48 -3.20931148665437 0.00155692266341446 0.0124242428540474
OV ENSG00000256943 RP13-895J2.2 path:04012_22 ErbB signaling pathway 65 -3.08865697309306 0.00220966608590916 0.0149433350555552
OV ENSG00000256943 RP13-895J2.2 path:04014_12 Ras signaling pathway 180 -3.69072970146771 0.000271703099730903 0.00338779802476969
OV ENSG00000256943 RP13-895J2.2 path:04024_125 cAMP signaling pathway 23 -4.22797789499566 3.17974352624091e-05 0.000923001976751965
OV ENSG00000256943 RP13-895J2.2 path:04062_228 Chemokine signaling pathway 13 3.00743504234665 0.003022532217686 0.0185536977670264
OV ENSG00000256943 RP13-895J2.2 path:04062_26 Chemokine signaling pathway 106 -3.24507288881208 0.00135330112390862 0.0112493155924904
OV ENSG00000256943 RP13-895J2.2 path:04062_94 Chemokine signaling pathway 51 2.60699162413058 0.00978502757244366 0.0433802889045002
OV ENSG00000256943 RP13-895J2.2 path:04064_1 NF-kappa B signaling pathway 69 3.16177648165995 0.00181412323291729 0.0139161782172068
OV ENSG00000256943 RP13-895J2.2 path:04066_94 HIF-1 signaling pathway 15 -2.64510364414812 0.00868276486678411 0.0398209561131823
OV ENSG00000256943 RP13-895J2.2 path:04070_22 Phosphatidylinositol signaling system 29 -3.65123468544539 0.00031612321344358 0.00370979888717613
OV ENSG00000256943 RP13-895J2.2 path:04140_2 Regulation of autophagy 4 -7.03512229990188 1.44626656738175e-11 5.77060360385319e-09
OV ENSG00000256943 RP13-895J2.2 path:04141_3 Protein processing in endoplasmic reticulum 20 -2.58948394204094 0.01020792131398 0.0439421889225508
OV ENSG00000256943 RP13-895J2.2 path:04145_13 Phagosome 10 -3.78477137554249 0.000197235232877645 0.00281060206850644
OV ENSG00000256943 RP13-895J2.2 path:04151_233 PI3K-Akt signaling pathway 26 2.89822209103207 0.00418285324528429 0.0236353108771237
OV ENSG00000256943 RP13-895J2.2 path:04151_67 PI3K-Akt signaling pathway 164 -3.85548716128347 0.000159554121410144 0.00244854209394799
OV ENSG00000256943 RP13-895J2.2 path:04152_50 AMPK signaling pathway 21 -5.78683233530924 2.25405184710183e-08 2.63495367125225e-06
OV ENSG00000256943 RP13-895J2.2 path:04210_36 Apoptosis 36 -2.90585710208152 0.00396254970373128 0.0232508431145409
OV ENSG00000256943 RP13-895J2.2 path:04261_51 Adrenergic signaling in cardiomyocytes 66 -4.01728219878105 8.04069868358209e-05 0.00145829035215875
OV ENSG00000256943 RP13-895J2.2 path:04310_144 Wnt signaling pathway 11 -2.58954363975762 0.0102421643353314 0.0439421889225508
OV ENSG00000256943 RP13-895J2.2 path:04330_22 Notch signaling pathway 24 -4.29866114910335 2.45854184153318e-05 0.000891780177065217
OV ENSG00000256943 RP13-895J2.2 path:04330_24 Notch signaling pathway 16 -6.23580647680062 1.82740151120049e-09 3.64566601484497e-07
OV ENSG00000256943 RP13-895J2.2 path:04360_145 Axon guidance 8 -2.78708834026281 0.00574078435929291 0.0305409727914383
OV ENSG00000256943 RP13-895J2.2 path:04370_42 VEGF signaling pathway 22 -3.35593348422674 0.000924429141504019 0.00878207684428818
OV ENSG00000256943 RP13-895J2.2 path:04370_66 VEGF signaling pathway 14 -3.2148066522002 0.0014588578479376 0.0118792710474919
OV ENSG00000256943 RP13-895J2.2 path:04510_126 Focal adhesion 38 -3.1340842325741 0.00190824075439014 0.0140997789074383
OV ENSG00000256943 RP13-895J2.2 path:04510_137 Focal adhesion 32 -3.37413405670264 0.000871094227224639 0.00847723406494221
OV ENSG00000256943 RP13-895J2.2 path:04510_283 Focal adhesion 10 -2.95803560842298 0.00340462719426181 0.0205825189471282
OV ENSG00000256943 RP13-895J2.2 path:04540_12 Gap junction 71 -2.73535497934253 0.00683929220051194 0.0341109698500533
OV ENSG00000256943 RP13-895J2.2 path:04611_279 Platelet activation 2 3.13399671342101 0.00203565705286304 0.0145040565016491
OV ENSG00000256943 RP13-895J2.2 path:04620_60 Toll-like receptor signaling pathway 22 5.29213800726849 3.27398660395715e-07 2.61264130995781e-05
OV ENSG00000256943 RP13-895J2.2 path:04620_92 Toll-like receptor signaling pathway 11 -3.71200746582972 0.000249375441301893 0.00331669336931518
OV ENSG00000256943 RP13-895J2.2 path:04621_22 NOD-like receptor signaling pathway 28 -3.60857086764186 0.000389252752450385 0.00443748137793439
OV ENSG00000256943 RP13-895J2.2 path:04650_115 Natural killer cell mediated cytotoxicity 5 3.54873396797697 0.000500092947216272 0.00554269683164701
OV ENSG00000256943 RP13-895J2.2 path:04650_139 Natural killer cell mediated cytotoxicity 2 3.03921989305843 0.00275970094307169 0.0172050105669626
OV ENSG00000256943 RP13-895J2.2 path:04664_71 Fc epsilon RI signaling pathway 10 -3.07208583952372 0.00233224744887524 0.0155094455350203
OV ENSG00000256943 RP13-895J2.2 path:04664_75 Fc epsilon RI signaling pathway 9 -3.30611910840611 0.00106966815461868 0.00986408459467898
OV ENSG00000256943 RP13-895J2.2 path:04666_244 Fc gamma R-mediated phagocytosis 7 2.62911895605521 0.00920751163599138 0.0417476948040973
OV ENSG00000256943 RP13-895J2.2 path:04720_79 Long-term potentiation 3 -2.90037845741709 0.0040549350178003 0.0234481024942365
OV ENSG00000256943 RP13-895J2.2 path:04722_7 Neurotrophin signaling pathway 107 -2.76197107945446 0.00622816862807314 0.0325222758920518
OV ENSG00000256943 RP13-895J2.2 path:04725_86 Cholinergic synapse 18 -3.67599100039595 0.000286025224134787 0.00345830498272061
OV ENSG00000256943 RP13-895J2.2 path:04742_1 Taste transduction 14 -3.46994054573377 0.000623574639644011 0.00654753371626212
OV ENSG00000256943 RP13-895J2.2 path:04810_241 Regulation of actin cytoskeleton 4 -4.45762747828286 1.23744715633338e-05 0.000493741415377017
OV ENSG00000256943 RP13-895J2.2 path:04810_68 Regulation of actin cytoskeleton 69 -4.09540409814346 5.74542697494894e-05 0.00129206777812241
OV ENSG00000256943 RP13-895J2.2 path:04916_128 Melanogenesis 6 -3.25927881778985 0.00127426759406624 0.0110528863050528
OV ENSG00000256943 RP13-895J2.2 path:04916_139 Melanogenesis 2 -3.89573352713576 0.000122479134190625 0.00203621560591915
OV ENSG00000256943 RP13-895J2.2 path:04916_75 Melanogenesis 23 -3.11081204498855 0.00211916650219375 0.0148341655153563
OV ENSG00000256943 RP13-895J2.2 path:04917_119 Prolactin signaling pathway 10 -3.18405107200329 0.00161889003193659 0.0126654337792686
OV ENSG00000256943 RP13-895J2.2 path:04919_50 Thyroid hormone signaling pathway 33 -2.84052059895758 0.00490928389588219 0.026884904723021
OV ENSG00000256943 RP13-895J2.2 path:04919_84 Thyroid hormone signaling pathway 5 -3.06230750033102 0.00243170965719621 0.0156492282777627
OV ENSG00000256943 RP13-895J2.2 path:04940_2 Type I diabetes mellitus 2 4.09543013578257 6.47653021615246e-05 0.00129206777812241
OV ENSG00000256943 RP13-895J2.2 path:04950_1 Maturity onset diabetes of the young 22 2.68826444620679 0.00788125498302228 0.0365653574212313
OV ENSG00000256943 RP13-895J2.2 path:04960_8 Aldosterone-regulated sodium reabsorption 14 -4.22271306422235 3.23860342719988e-05 0.000923001976751965
OV ENSG00000256943 RP13-895J2.2 path:04961_12 Endocrine and other factor-regulated calcium reabsorption 11 2.947913707609 0.00361363986918087 0.0215200344448234
OV ENSG00000256943 RP13-895J2.2 path:04973_1 Carbohydrate digestion and absorption 12 -3.06547149512793 0.00238689687394195 0.0156126533229973
OV ENSG00000256943 RP13-895J2.2 path:04976_8 Bile secretion 8 2.84956614951635 0.00491879209218179 0.026884904723021
OV ENSG00000256943 RP13-895J2.2 path:05132_39 Salmonella infection 8 -2.80271653500542 0.00561198225089311 0.0302592015960318
OV ENSG00000256943 RP13-895J2.2 path:05140_54 Leishmaniasis 15 3.25671596805525 0.00134342801744696 0.0112493155924904
OV ENSG00000256943 RP13-895J2.2 path:05140_84 Leishmaniasis 3 3.16161859730166 0.00184851490103249 0.0139161782172068
OV ENSG00000256943 RP13-895J2.2 path:05206_109 MicroRNAs in cancer 14 -4.93517236608292 1.36227014325145e-06 9.05909645262217e-05
OV ENSG00000256943 RP13-895J2.2 path:05206_112 MicroRNAs in cancer 11 -3.4384758457242 0.000678480463647874 0.00691605539358514
OV ENSG00000256943 RP13-895J2.2 path:05206_42 MicroRNAs in cancer 71 -2.67896362030171 0.00780823754322106 0.0365653574212313
OV ENSG00000256943 RP13-895J2.2 path:05211_9 Renal cell carcinoma 14 -2.88844814083664 0.00420578213602954 0.0236353108771237
OV ENSG00000256943 RP13-895J2.2 path:05212_61 Pancreatic cancer 2 -2.71669211678347 0.00711535090733623 0.0342051206268332
OV ENSG00000256943 RP13-895J2.2 path:05215_50 Prostate cancer 35 -4.25050649042072 2.89913785368523e-05 0.000923001976751965
OV ENSG00000256943 RP13-895J2.2 path:05215_83 Prostate cancer 9 -3.93824050496351 0.000114138181353253 0.00198004931999774
OV ENSG00000256943 RP13-895J2.2 path:05218_1 Melanoma 63 -3.49923250838646 0.000546580778167958 0.00589420893213555
OV ENSG00000256943 RP13-895J2.2 path:05221_7 Acute myeloid leukemia 49 -4.09419821046503 5.86163616341071e-05 0.00129206777812241
OV ENSG00000256943 RP13-895J2.2 path:05231_31 Choline metabolism in cancer 35 -3.43549434221425 0.000693338886574952 0.00691605539358514
OV ENSG00000256943 RP13-895J2.2 path:05231_42 Choline metabolism in cancer 26 -2.74076173027846 0.00669466969291559 0.0338123190819408
OV ENSG00000256943 RP13-895J2.2 path:05320_2 Autoimmune thyroid disease 2 4.09543013578257 6.47653021615246e-05 0.00129206777812241
OV ENSG00000256943 RP13-895J2.2 path:05330_2 Allograft rejection 2 4.09543013578257 6.47653021615246e-05 0.00129206777812241
OV ENSG00000256943 RP13-895J2.2 path:05332_5 Graft-versus-host disease 2 4.09543013578257 6.47653021615246e-05 0.00129206777812241
OV ENSG00000256943 RP13-895J2.2 path:05414_26 Dilated cardiomyopathy 6 -2.57440740773892 0.0105393114621507 0.0447360135467887
OV ENSG00000256542 RP13-895J2.3 path:00100_1 Steroid biosynthesis 13 2.60228951743014 0.0101423341141269 0.0439421889225508
OV ENSG00000256542 RP13-895J2.3 path:00120_5 Primary bile acid biosynthesis 4 4.49439405858721 1.18949012289458e-05 0.000493741415377017
OV ENSG00000256542 RP13-895J2.3 path:00140_7 Steroid hormone biosynthesis 23 2.76769479553527 0.00627622868092228 0.0325222758920518
OV ENSG00000256542 RP13-895J2.3 path:00232_1 Caffeine metabolism 3 3.14360703553865 0.00196735095988888 0.0142722369635575
OV ENSG00000256542 RP13-895J2.3 path:00270_17 Cysteine and methionine metabolism 19 -3.29862009650208 0.00111249074376079 0.00986408459467898
OV ENSG00000256542 RP13-895J2.3 path:00270_51 Cysteine and methionine metabolism 8 -2.71658678573836 0.00699408153869485 0.0342051206268332
OV ENSG00000256542 RP13-895J2.3 path:00310_9 Lysine degradation 23 -4.69372470374386 4.49441723904539e-06 0.000256181782625587
OV ENSG00000256542 RP13-895J2.3 path:00450_8 Selenocompound metabolism 3 -5.74509564341831 2.64155756516516e-08 2.63495367125225e-06
OV ENSG00000256542 RP13-895J2.3 path:00562_2 Inositol phosphate metabolism 44 -3.09659161157344 0.00218487962452119 0.0149433350555552
OV ENSG00000256542 RP13-895J2.3 path:00562_70 Inositol phosphate metabolism 7 -3.84359974216614 0.000150452648245952 0.00240122426600539
OV ENSG00000256542 RP13-895J2.3 path:00565_22 Ether lipid metabolism 13 3.0455283758664 0.00273674122345334 0.0172050105669626
OV ENSG00000256542 RP13-895J2.3 path:00591_12 Linoleic acid metabolism 16 3.32911675328674 0.00109197521912744 0.00986408459467898
OV ENSG00000256542 RP13-895J2.3 path:00601_16 Glycosphingolipid biosynthesis - lacto and neolacto series 12 3.73687518456696 0.000247540350594157 0.00331669336931518
OV ENSG00000256542 RP13-895J2.3 path:00603_1 Glycosphingolipid biosynthesis - globo series 9 3.70664880993929 0.000260300062523332 0.0033503137079616
OV ENSG00000256542 RP13-895J2.3 path:00604_1 Glycosphingolipid biosynthesis - ganglio series 9 3.8342063989555 0.000170294818471259 0.00251657898407527
OV ENSG00000256542 RP13-895J2.3 path:00670_12 One carbon pool by folate 5 -2.71912698276967 0.00704223651908822 0.0342051206268332
OV ENSG00000256542 RP13-895J2.3 path:00760_1 Nicotinate and nicotinamide metabolism 20 4.5106070675745 1.07217432492167e-05 0.000493741415377017
OV ENSG00000256542 RP13-895J2.3 path:00770_1 Pantothenate and CoA biosynthesis 6 2.6107609886297 0.00974731940190605 0.0433802889045002
OV ENSG00000256542 RP13-895J2.3 path:00830_7 Retinol metabolism 27 2.68378564544924 0.00784848963470375 0.0365653574212313
OV ENSG00000256542 RP13-895J2.3 path:00860_2 Porphyrin and chlorophyll metabolism 10 2.75285487893177 0.00646832869269434 0.0330879890818595
OV ENSG00000256542 RP13-895J2.3 path:00983_2 Drug metabolism - other enzymes 16 4.06447152706543 7.2690485995369e-05 0.00138111923391201
OV ENSG00000256542 RP13-895J2.3 path:03320_1 PPAR signaling pathway 48 -3.20931148665437 0.00155692266341446 0.0124242428540474
OV ENSG00000256542 RP13-895J2.3 path:04012_22 ErbB signaling pathway 65 -3.08865697309306 0.00220966608590916 0.0149433350555552
OV ENSG00000256542 RP13-895J2.3 path:04014_12 Ras signaling pathway 180 -3.69072970146771 0.000271703099730903 0.00338779802476969
OV ENSG00000256542 RP13-895J2.3 path:04024_125 cAMP signaling pathway 23 -4.22797789499566 3.17974352624091e-05 0.000923001976751965
OV ENSG00000256542 RP13-895J2.3 path:04062_228 Chemokine signaling pathway 13 3.00743504234665 0.003022532217686 0.0185536977670264
OV ENSG00000256542 RP13-895J2.3 path:04062_26 Chemokine signaling pathway 106 -3.24507288881208 0.00135330112390862 0.0112493155924904
OV ENSG00000256542 RP13-895J2.3 path:04062_94 Chemokine signaling pathway 51 2.60699162413058 0.00978502757244366 0.0433802889045002
OV ENSG00000256542 RP13-895J2.3 path:04064_1 NF-kappa B signaling pathway 69 3.16177648165995 0.00181412323291729 0.0139161782172068
OV ENSG00000256542 RP13-895J2.3 path:04066_94 HIF-1 signaling pathway 15 -2.64510364414812 0.00868276486678411 0.0398209561131823
OV ENSG00000256542 RP13-895J2.3 path:04070_22 Phosphatidylinositol signaling system 29 -3.65123468544539 0.00031612321344358 0.00370979888717613
OV ENSG00000256542 RP13-895J2.3 path:04140_2 Regulation of autophagy 4 -7.03512229990188 1.44626656738175e-11 5.77060360385319e-09
OV ENSG00000256542 RP13-895J2.3 path:04141_3 Protein processing in endoplasmic reticulum 20 -2.58948394204094 0.01020792131398 0.0439421889225508
OV ENSG00000256542 RP13-895J2.3 path:04145_13 Phagosome 10 -3.78477137554249 0.000197235232877645 0.00281060206850644
OV ENSG00000256542 RP13-895J2.3 path:04151_233 PI3K-Akt signaling pathway 26 2.89822209103207 0.00418285324528429 0.0236353108771237
OV ENSG00000256542 RP13-895J2.3 path:04151_67 PI3K-Akt signaling pathway 164 -3.85548716128347 0.000159554121410144 0.00244854209394799
OV ENSG00000256542 RP13-895J2.3 path:04152_50 AMPK signaling pathway 21 -5.78683233530924 2.25405184710183e-08 2.63495367125225e-06
OV ENSG00000256542 RP13-895J2.3 path:04210_36 Apoptosis 36 -2.90585710208152 0.00396254970373128 0.0232508431145409
OV ENSG00000256542 RP13-895J2.3 path:04261_51 Adrenergic signaling in cardiomyocytes 66 -4.01728219878105 8.04069868358209e-05 0.00145829035215875
OV ENSG00000256542 RP13-895J2.3 path:04310_144 Wnt signaling pathway 11 -2.58954363975762 0.0102421643353314 0.0439421889225508
OV ENSG00000256542 RP13-895J2.3 path:04330_22 Notch signaling pathway 24 -4.29866114910335 2.45854184153318e-05 0.000891780177065217
OV ENSG00000256542 RP13-895J2.3 path:04330_24 Notch signaling pathway 16 -6.23580647680062 1.82740151120049e-09 3.64566601484497e-07
OV ENSG00000256542 RP13-895J2.3 path:04360_145 Axon guidance 8 -2.78708834026281 0.00574078435929291 0.0305409727914383
OV ENSG00000256542 RP13-895J2.3 path:04370_42 VEGF signaling pathway 22 -3.35593348422674 0.000924429141504019 0.00878207684428818
OV ENSG00000256542 RP13-895J2.3 path:04370_66 VEGF signaling pathway 14 -3.2148066522002 0.0014588578479376 0.0118792710474919
OV ENSG00000256542 RP13-895J2.3 path:04510_126 Focal adhesion 38 -3.1340842325741 0.00190824075439014 0.0140997789074383
OV ENSG00000256542 RP13-895J2.3 path:04510_137 Focal adhesion 32 -3.37413405670264 0.000871094227224639 0.00847723406494221
OV ENSG00000256542 RP13-895J2.3 path:04510_283 Focal adhesion 10 -2.95803560842298 0.00340462719426181 0.0205825189471282
OV ENSG00000256542 RP13-895J2.3 path:04540_12 Gap junction 71 -2.73535497934253 0.00683929220051194 0.0341109698500533
OV ENSG00000256542 RP13-895J2.3 path:04611_279 Platelet activation 2 3.13399671342101 0.00203565705286304 0.0145040565016491
OV ENSG00000256542 RP13-895J2.3 path:04620_60 Toll-like receptor signaling pathway 22 5.29213800726849 3.27398660395715e-07 2.61264130995781e-05
OV ENSG00000256542 RP13-895J2.3 path:04620_92 Toll-like receptor signaling pathway 11 -3.71200746582972 0.000249375441301893 0.00331669336931518
OV ENSG00000256542 RP13-895J2.3 path:04621_22 NOD-like receptor signaling pathway 28 -3.60857086764186 0.000389252752450385 0.00443748137793439
OV ENSG00000256542 RP13-895J2.3 path:04650_115 Natural killer cell mediated cytotoxicity 5 3.54873396797697 0.000500092947216272 0.00554269683164701
OV ENSG00000256542 RP13-895J2.3 path:04650_139 Natural killer cell mediated cytotoxicity 2 3.03921989305843 0.00275970094307169 0.0172050105669626
OV ENSG00000256542 RP13-895J2.3 path:04664_71 Fc epsilon RI signaling pathway 10 -3.07208583952372 0.00233224744887524 0.0155094455350203
OV ENSG00000256542 RP13-895J2.3 path:04664_75 Fc epsilon RI signaling pathway 9 -3.30611910840611 0.00106966815461868 0.00986408459467898
OV ENSG00000256542 RP13-895J2.3 path:04666_244 Fc gamma R-mediated phagocytosis 7 2.62911895605521 0.00920751163599138 0.0417476948040973
OV ENSG00000256542 RP13-895J2.3 path:04720_79 Long-term potentiation 3 -2.90037845741709 0.0040549350178003 0.0234481024942365
OV ENSG00000256542 RP13-895J2.3 path:04722_7 Neurotrophin signaling pathway 107 -2.76197107945446 0.00622816862807314 0.0325222758920518
OV ENSG00000256542 RP13-895J2.3 path:04725_86 Cholinergic synapse 18 -3.67599100039595 0.000286025224134787 0.00345830498272061
OV ENSG00000256542 RP13-895J2.3 path:04742_1 Taste transduction 14 -3.46994054573377 0.000623574639644011 0.00654753371626212
OV ENSG00000256542 RP13-895J2.3 path:04810_241 Regulation of actin cytoskeleton 4 -4.45762747828286 1.23744715633338e-05 0.000493741415377017
OV ENSG00000256542 RP13-895J2.3 path:04810_68 Regulation of actin cytoskeleton 69 -4.09540409814346 5.74542697494894e-05 0.00129206777812241
OV ENSG00000256542 RP13-895J2.3 path:04916_128 Melanogenesis 6 -3.25927881778985 0.00127426759406624 0.0110528863050528
OV ENSG00000256542 RP13-895J2.3 path:04916_139 Melanogenesis 2 -3.89573352713576 0.000122479134190625 0.00203621560591915
OV ENSG00000256542 RP13-895J2.3 path:04916_75 Melanogenesis 23 -3.11081204498855 0.00211916650219375 0.0148341655153563
OV ENSG00000256542 RP13-895J2.3 path:04917_119 Prolactin signaling pathway 10 -3.18405107200329 0.00161889003193659 0.0126654337792686
OV ENSG00000256542 RP13-895J2.3 path:04919_50 Thyroid hormone signaling pathway 33 -2.84052059895758 0.00490928389588219 0.026884904723021
OV ENSG00000256542 RP13-895J2.3 path:04919_84 Thyroid hormone signaling pathway 5 -3.06230750033102 0.00243170965719621 0.0156492282777627
OV ENSG00000256542 RP13-895J2.3 path:04940_2 Type I diabetes mellitus 2 4.09543013578257 6.47653021615246e-05 0.00129206777812241
OV ENSG00000256542 RP13-895J2.3 path:04950_1 Maturity onset diabetes of the young 22 2.68826444620679 0.00788125498302228 0.0365653574212313
OV ENSG00000256542 RP13-895J2.3 path:04960_8 Aldosterone-regulated sodium reabsorption 14 -4.22271306422235 3.23860342719988e-05 0.000923001976751965
OV ENSG00000256542 RP13-895J2.3 path:04961_12 Endocrine and other factor-regulated calcium reabsorption 11 2.947913707609 0.00361363986918087 0.0215200344448234
OV ENSG00000256542 RP13-895J2.3 path:04973_1 Carbohydrate digestion and absorption 12 -3.06547149512793 0.00238689687394195 0.0156126533229973
OV ENSG00000256542 RP13-895J2.3 path:04976_8 Bile secretion 8 2.84956614951635 0.00491879209218179 0.026884904723021
OV ENSG00000256542 RP13-895J2.3 path:05132_39 Salmonella infection 8 -2.80271653500542 0.00561198225089311 0.0302592015960318
OV ENSG00000256542 RP13-895J2.3 path:05140_54 Leishmaniasis 15 3.25671596805525 0.00134342801744696 0.0112493155924904
OV ENSG00000256542 RP13-895J2.3 path:05140_84 Leishmaniasis 3 3.16161859730166 0.00184851490103249 0.0139161782172068
OV ENSG00000256542 RP13-895J2.3 path:05206_109 MicroRNAs in cancer 14 -4.93517236608292 1.36227014325145e-06 9.05909645262217e-05
OV ENSG00000256542 RP13-895J2.3 path:05206_112 MicroRNAs in cancer 11 -3.4384758457242 0.000678480463647874 0.00691605539358514
OV ENSG00000256542 RP13-895J2.3 path:05206_42 MicroRNAs in cancer 71 -2.67896362030171 0.00780823754322106 0.0365653574212313
OV ENSG00000256542 RP13-895J2.3 path:05211_9 Renal cell carcinoma 14 -2.88844814083664 0.00420578213602954 0.0236353108771237
OV ENSG00000256542 RP13-895J2.3 path:05212_61 Pancreatic cancer 2 -2.71669211678347 0.00711535090733623 0.0342051206268332
OV ENSG00000256542 RP13-895J2.3 path:05215_50 Prostate cancer 35 -4.25050649042072 2.89913785368523e-05 0.000923001976751965
OV ENSG00000256542 RP13-895J2.3 path:05215_83 Prostate cancer 9 -3.93824050496351 0.000114138181353253 0.00198004931999774
OV ENSG00000256542 RP13-895J2.3 path:05218_1 Melanoma 63 -3.49923250838646 0.000546580778167958 0.00589420893213555
OV ENSG00000256542 RP13-895J2.3 path:05221_7 Acute myeloid leukemia 49 -4.09419821046503 5.86163616341071e-05 0.00129206777812241
OV ENSG00000256542 RP13-895J2.3 path:05231_31 Choline metabolism in cancer 35 -3.43549434221425 0.000693338886574952 0.00691605539358514
OV ENSG00000256542 RP13-895J2.3 path:05231_42 Choline metabolism in cancer 26 -2.74076173027846 0.00669466969291559 0.0338123190819408
OV ENSG00000256542 RP13-895J2.3 path:05320_2 Autoimmune thyroid disease 2 4.09543013578257 6.47653021615246e-05 0.00129206777812241
OV ENSG00000256542 RP13-895J2.3 path:05330_2 Allograft rejection 2 4.09543013578257 6.47653021615246e-05 0.00129206777812241
OV ENSG00000256542 RP13-895J2.3 path:05332_5 Graft-versus-host disease 2 4.09543013578257 6.47653021615246e-05 0.00129206777812241
OV ENSG00000256542 RP13-895J2.3 path:05414_26 Dilated cardiomyopathy 6 -2.57440740773892 0.0105393114621507 0.0447360135467887
OV ENSG00000255916 RP13-895J2.7 path:00100_1 Steroid biosynthesis 13 2.60228951743014 0.0101423341141269 0.0439421889225508
OV ENSG00000255916 RP13-895J2.7 path:00120_5 Primary bile acid biosynthesis 4 4.49439405858721 1.18949012289458e-05 0.000493741415377017
OV ENSG00000255916 RP13-895J2.7 path:00140_7 Steroid hormone biosynthesis 23 2.76769479553527 0.00627622868092228 0.0325222758920518
OV ENSG00000255916 RP13-895J2.7 path:00232_1 Caffeine metabolism 3 3.14360703553865 0.00196735095988888 0.0142722369635575
OV ENSG00000255916 RP13-895J2.7 path:00270_17 Cysteine and methionine metabolism 19 -3.29862009650208 0.00111249074376079 0.00986408459467898
OV ENSG00000255916 RP13-895J2.7 path:00270_51 Cysteine and methionine metabolism 8 -2.71658678573836 0.00699408153869485 0.0342051206268332
OV ENSG00000255916 RP13-895J2.7 path:00310_9 Lysine degradation 23 -4.69372470374386 4.49441723904539e-06 0.000256181782625587
OV ENSG00000255916 RP13-895J2.7 path:00450_8 Selenocompound metabolism 3 -5.74509564341831 2.64155756516516e-08 2.63495367125225e-06
OV ENSG00000255916 RP13-895J2.7 path:00562_2 Inositol phosphate metabolism 44 -3.09659161157344 0.00218487962452119 0.0149433350555552
OV ENSG00000255916 RP13-895J2.7 path:00562_70 Inositol phosphate metabolism 7 -3.84359974216614 0.000150452648245952 0.00240122426600539
OV ENSG00000255916 RP13-895J2.7 path:00565_22 Ether lipid metabolism 13 3.0455283758664 0.00273674122345334 0.0172050105669626
OV ENSG00000255916 RP13-895J2.7 path:00591_12 Linoleic acid metabolism 16 3.32911675328674 0.00109197521912744 0.00986408459467898
OV ENSG00000255916 RP13-895J2.7 path:00601_16 Glycosphingolipid biosynthesis - lacto and neolacto series 12 3.73687518456696 0.000247540350594157 0.00331669336931518
OV ENSG00000255916 RP13-895J2.7 path:00603_1 Glycosphingolipid biosynthesis - globo series 9 3.70664880993929 0.000260300062523332 0.0033503137079616
OV ENSG00000255916 RP13-895J2.7 path:00604_1 Glycosphingolipid biosynthesis - ganglio series 9 3.8342063989555 0.000170294818471259 0.00251657898407527
OV ENSG00000255916 RP13-895J2.7 path:00670_12 One carbon pool by folate 5 -2.71912698276967 0.00704223651908822 0.0342051206268332
OV ENSG00000255916 RP13-895J2.7 path:00760_1 Nicotinate and nicotinamide metabolism 20 4.5106070675745 1.07217432492167e-05 0.000493741415377017
OV ENSG00000255916 RP13-895J2.7 path:00770_1 Pantothenate and CoA biosynthesis 6 2.6107609886297 0.00974731940190605 0.0433802889045002
OV ENSG00000255916 RP13-895J2.7 path:00830_7 Retinol metabolism 27 2.68378564544924 0.00784848963470375 0.0365653574212313
OV ENSG00000255916 RP13-895J2.7 path:00860_2 Porphyrin and chlorophyll metabolism 10 2.75285487893177 0.00646832869269434 0.0330879890818595
OV ENSG00000255916 RP13-895J2.7 path:00983_2 Drug metabolism - other enzymes 16 4.06447152706543 7.2690485995369e-05 0.00138111923391201
OV ENSG00000255916 RP13-895J2.7 path:03320_1 PPAR signaling pathway 48 -3.20931148665437 0.00155692266341446 0.0124242428540474
OV ENSG00000255916 RP13-895J2.7 path:04012_22 ErbB signaling pathway 65 -3.08865697309306 0.00220966608590916 0.0149433350555552
OV ENSG00000255916 RP13-895J2.7 path:04014_12 Ras signaling pathway 180 -3.69072970146771 0.000271703099730903 0.00338779802476969
OV ENSG00000255916 RP13-895J2.7 path:04024_125 cAMP signaling pathway 23 -4.22797789499566 3.17974352624091e-05 0.000923001976751965
OV ENSG00000255916 RP13-895J2.7 path:04062_228 Chemokine signaling pathway 13 3.00743504234665 0.003022532217686 0.0185536977670264
OV ENSG00000255916 RP13-895J2.7 path:04062_26 Chemokine signaling pathway 106 -3.24507288881208 0.00135330112390862 0.0112493155924904
OV ENSG00000255916 RP13-895J2.7 path:04062_94 Chemokine signaling pathway 51 2.60699162413058 0.00978502757244366 0.0433802889045002
OV ENSG00000255916 RP13-895J2.7 path:04064_1 NF-kappa B signaling pathway 69 3.16177648165995 0.00181412323291729 0.0139161782172068
OV ENSG00000255916 RP13-895J2.7 path:04066_94 HIF-1 signaling pathway 15 -2.64510364414812 0.00868276486678411 0.0398209561131823
OV ENSG00000255916 RP13-895J2.7 path:04070_22 Phosphatidylinositol signaling system 29 -3.65123468544539 0.00031612321344358 0.00370979888717613
OV ENSG00000255916 RP13-895J2.7 path:04140_2 Regulation of autophagy 4 -7.03512229990188 1.44626656738175e-11 5.77060360385319e-09
OV ENSG00000255916 RP13-895J2.7 path:04141_3 Protein processing in endoplasmic reticulum 20 -2.58948394204094 0.01020792131398 0.0439421889225508
OV ENSG00000255916 RP13-895J2.7 path:04145_13 Phagosome 10 -3.78477137554249 0.000197235232877645 0.00281060206850644
OV ENSG00000255916 RP13-895J2.7 path:04151_233 PI3K-Akt signaling pathway 26 2.89822209103207 0.00418285324528429 0.0236353108771237
OV ENSG00000255916 RP13-895J2.7 path:04151_67 PI3K-Akt signaling pathway 164 -3.85548716128347 0.000159554121410144 0.00244854209394799
OV ENSG00000255916 RP13-895J2.7 path:04152_50 AMPK signaling pathway 21 -5.78683233530924 2.25405184710183e-08 2.63495367125225e-06
OV ENSG00000255916 RP13-895J2.7 path:04210_36 Apoptosis 36 -2.90585710208152 0.00396254970373128 0.0232508431145409
OV ENSG00000255916 RP13-895J2.7 path:04261_51 Adrenergic signaling in cardiomyocytes 66 -4.01728219878105 8.04069868358209e-05 0.00145829035215875
OV ENSG00000255916 RP13-895J2.7 path:04310_144 Wnt signaling pathway 11 -2.58954363975762 0.0102421643353314 0.0439421889225508
OV ENSG00000255916 RP13-895J2.7 path:04330_22 Notch signaling pathway 24 -4.29866114910335 2.45854184153318e-05 0.000891780177065217
OV ENSG00000255916 RP13-895J2.7 path:04330_24 Notch signaling pathway 16 -6.23580647680062 1.82740151120049e-09 3.64566601484497e-07
OV ENSG00000255916 RP13-895J2.7 path:04360_145 Axon guidance 8 -2.78708834026281 0.00574078435929291 0.0305409727914383
OV ENSG00000255916 RP13-895J2.7 path:04370_42 VEGF signaling pathway 22 -3.35593348422674 0.000924429141504019 0.00878207684428818
OV ENSG00000255916 RP13-895J2.7 path:04370_66 VEGF signaling pathway 14 -3.2148066522002 0.0014588578479376 0.0118792710474919
OV ENSG00000255916 RP13-895J2.7 path:04510_126 Focal adhesion 38 -3.1340842325741 0.00190824075439014 0.0140997789074383
OV ENSG00000255916 RP13-895J2.7 path:04510_137 Focal adhesion 32 -3.37413405670264 0.000871094227224639 0.00847723406494221
OV ENSG00000255916 RP13-895J2.7 path:04510_283 Focal adhesion 10 -2.95803560842298 0.00340462719426181 0.0205825189471282
OV ENSG00000255916 RP13-895J2.7 path:04540_12 Gap junction 71 -2.73535497934253 0.00683929220051194 0.0341109698500533
OV ENSG00000255916 RP13-895J2.7 path:04611_279 Platelet activation 2 3.13399671342101 0.00203565705286304 0.0145040565016491
OV ENSG00000255916 RP13-895J2.7 path:04620_60 Toll-like receptor signaling pathway 22 5.29213800726849 3.27398660395715e-07 2.61264130995781e-05
OV ENSG00000255916 RP13-895J2.7 path:04620_92 Toll-like receptor signaling pathway 11 -3.71200746582972 0.000249375441301893 0.00331669336931518
OV ENSG00000255916 RP13-895J2.7 path:04621_22 NOD-like receptor signaling pathway 28 -3.60857086764186 0.000389252752450385 0.00443748137793439
OV ENSG00000255916 RP13-895J2.7 path:04650_115 Natural killer cell mediated cytotoxicity 5 3.54873396797697 0.000500092947216272 0.00554269683164701
OV ENSG00000255916 RP13-895J2.7 path:04650_139 Natural killer cell mediated cytotoxicity 2 3.03921989305843 0.00275970094307169 0.0172050105669626
OV ENSG00000255916 RP13-895J2.7 path:04664_71 Fc epsilon RI signaling pathway 10 -3.07208583952372 0.00233224744887524 0.0155094455350203
OV ENSG00000255916 RP13-895J2.7 path:04664_75 Fc epsilon RI signaling pathway 9 -3.30611910840611 0.00106966815461868 0.00986408459467898
OV ENSG00000255916 RP13-895J2.7 path:04666_244 Fc gamma R-mediated phagocytosis 7 2.62911895605521 0.00920751163599138 0.0417476948040973
OV ENSG00000255916 RP13-895J2.7 path:04720_79 Long-term potentiation 3 -2.90037845741709 0.0040549350178003 0.0234481024942365
OV ENSG00000255916 RP13-895J2.7 path:04722_7 Neurotrophin signaling pathway 107 -2.76197107945446 0.00622816862807314 0.0325222758920518
OV ENSG00000255916 RP13-895J2.7 path:04725_86 Cholinergic synapse 18 -3.67599100039595 0.000286025224134787 0.00345830498272061
OV ENSG00000255916 RP13-895J2.7 path:04742_1 Taste transduction 14 -3.46994054573377 0.000623574639644011 0.00654753371626212
OV ENSG00000255916 RP13-895J2.7 path:04810_241 Regulation of actin cytoskeleton 4 -4.45762747828286 1.23744715633338e-05 0.000493741415377017
OV ENSG00000255916 RP13-895J2.7 path:04810_68 Regulation of actin cytoskeleton 69 -4.09540409814346 5.74542697494894e-05 0.00129206777812241
OV ENSG00000255916 RP13-895J2.7 path:04916_128 Melanogenesis 6 -3.25927881778985 0.00127426759406624 0.0110528863050528
OV ENSG00000255916 RP13-895J2.7 path:04916_139 Melanogenesis 2 -3.89573352713576 0.000122479134190625 0.00203621560591915
OV ENSG00000255916 RP13-895J2.7 path:04916_75 Melanogenesis 23 -3.11081204498855 0.00211916650219375 0.0148341655153563
OV ENSG00000255916 RP13-895J2.7 path:04917_119 Prolactin signaling pathway 10 -3.18405107200329 0.00161889003193659 0.0126654337792686
OV ENSG00000255916 RP13-895J2.7 path:04919_50 Thyroid hormone signaling pathway 33 -2.84052059895758 0.00490928389588219 0.026884904723021
OV ENSG00000255916 RP13-895J2.7 path:04919_84 Thyroid hormone signaling pathway 5 -3.06230750033102 0.00243170965719621 0.0156492282777627
OV ENSG00000255916 RP13-895J2.7 path:04940_2 Type I diabetes mellitus 2 4.09543013578257 6.47653021615246e-05 0.00129206777812241
OV ENSG00000255916 RP13-895J2.7 path:04950_1 Maturity onset diabetes of the young 22 2.68826444620679 0.00788125498302228 0.0365653574212313
OV ENSG00000255916 RP13-895J2.7 path:04960_8 Aldosterone-regulated sodium reabsorption 14 -4.22271306422235 3.23860342719988e-05 0.000923001976751965
OV ENSG00000255916 RP13-895J2.7 path:04961_12 Endocrine and other factor-regulated calcium reabsorption 11 2.947913707609 0.00361363986918087 0.0215200344448234
OV ENSG00000255916 RP13-895J2.7 path:04973_1 Carbohydrate digestion and absorption 12 -3.06547149512793 0.00238689687394195 0.0156126533229973
OV ENSG00000255916 RP13-895J2.7 path:04976_8 Bile secretion 8 2.84956614951635 0.00491879209218179 0.026884904723021
OV ENSG00000255916 RP13-895J2.7 path:05132_39 Salmonella infection 8 -2.80271653500542 0.00561198225089311 0.0302592015960318
OV ENSG00000255916 RP13-895J2.7 path:05140_54 Leishmaniasis 15 3.25671596805525 0.00134342801744696 0.0112493155924904
OV ENSG00000255916 RP13-895J2.7 path:05140_84 Leishmaniasis 3 3.16161859730166 0.00184851490103249 0.0139161782172068
OV ENSG00000255916 RP13-895J2.7 path:05206_109 MicroRNAs in cancer 14 -4.93517236608292 1.36227014325145e-06 9.05909645262217e-05
OV ENSG00000255916 RP13-895J2.7 path:05206_112 MicroRNAs in cancer 11 -3.4384758457242 0.000678480463647874 0.00691605539358514
OV ENSG00000255916 RP13-895J2.7 path:05206_42 MicroRNAs in cancer 71 -2.67896362030171 0.00780823754322106 0.0365653574212313
OV ENSG00000255916 RP13-895J2.7 path:05211_9 Renal cell carcinoma 14 -2.88844814083664 0.00420578213602954 0.0236353108771237
OV ENSG00000255916 RP13-895J2.7 path:05212_61 Pancreatic cancer 2 -2.71669211678347 0.00711535090733623 0.0342051206268332
OV ENSG00000255916 RP13-895J2.7 path:05215_50 Prostate cancer 35 -4.25050649042072 2.89913785368523e-05 0.000923001976751965
OV ENSG00000255916 RP13-895J2.7 path:05215_83 Prostate cancer 9 -3.93824050496351 0.000114138181353253 0.00198004931999774
OV ENSG00000255916 RP13-895J2.7 path:05218_1 Melanoma 63 -3.49923250838646 0.000546580778167958 0.00589420893213555
OV ENSG00000255916 RP13-895J2.7 path:05221_7 Acute myeloid leukemia 49 -4.09419821046503 5.86163616341071e-05 0.00129206777812241
OV ENSG00000255916 RP13-895J2.7 path:05231_31 Choline metabolism in cancer 35 -3.43549434221425 0.000693338886574952 0.00691605539358514
OV ENSG00000255916 RP13-895J2.7 path:05231_42 Choline metabolism in cancer 26 -2.74076173027846 0.00669466969291559 0.0338123190819408
OV ENSG00000255916 RP13-895J2.7 path:05320_2 Autoimmune thyroid disease 2 4.09543013578257 6.47653021615246e-05 0.00129206777812241
OV ENSG00000255916 RP13-895J2.7 path:05330_2 Allograft rejection 2 4.09543013578257 6.47653021615246e-05 0.00129206777812241
OV ENSG00000255916 RP13-895J2.7 path:05332_5 Graft-versus-host disease 2 4.09543013578257 6.47653021615246e-05 0.00129206777812241
OV ENSG00000255916 RP13-895J2.7 path:05414_26 Dilated cardiomyopathy 6 -2.57440740773892 0.0105393114621507 0.0447360135467887
OV ENSG00000256576 RP13-977J11.2 path:00100_1 Steroid biosynthesis 13 2.60228951743014 0.0101423341141269 0.0439421889225508
OV ENSG00000256576 RP13-977J11.2 path:00120_5 Primary bile acid biosynthesis 4 4.49439405858721 1.18949012289458e-05 0.000493741415377017
OV ENSG00000256576 RP13-977J11.2 path:00140_7 Steroid hormone biosynthesis 23 2.76769479553527 0.00627622868092228 0.0325222758920518
OV ENSG00000256576 RP13-977J11.2 path:00232_1 Caffeine metabolism 3 3.14360703553865 0.00196735095988888 0.0142722369635575
OV ENSG00000256576 RP13-977J11.2 path:00270_17 Cysteine and methionine metabolism 19 -3.29862009650208 0.00111249074376079 0.00986408459467898
OV ENSG00000256576 RP13-977J11.2 path:00270_51 Cysteine and methionine metabolism 8 -2.71658678573836 0.00699408153869485 0.0342051206268332
OV ENSG00000256576 RP13-977J11.2 path:00310_9 Lysine degradation 23 -4.69372470374386 4.49441723904539e-06 0.000256181782625587
OV ENSG00000256576 RP13-977J11.2 path:00450_8 Selenocompound metabolism 3 -5.74509564341831 2.64155756516516e-08 2.63495367125225e-06
OV ENSG00000256576 RP13-977J11.2 path:00562_2 Inositol phosphate metabolism 44 -3.09659161157344 0.00218487962452119 0.0149433350555552
OV ENSG00000256576 RP13-977J11.2 path:00562_70 Inositol phosphate metabolism 7 -3.84359974216614 0.000150452648245952 0.00240122426600539
OV ENSG00000256576 RP13-977J11.2 path:00565_22 Ether lipid metabolism 13 3.0455283758664 0.00273674122345334 0.0172050105669626
OV ENSG00000256576 RP13-977J11.2 path:00591_12 Linoleic acid metabolism 16 3.32911675328674 0.00109197521912744 0.00986408459467898
OV ENSG00000256576 RP13-977J11.2 path:00601_16 Glycosphingolipid biosynthesis - lacto and neolacto series 12 3.73687518456696 0.000247540350594157 0.00331669336931518
OV ENSG00000256576 RP13-977J11.2 path:00603_1 Glycosphingolipid biosynthesis - globo series 9 3.70664880993929 0.000260300062523332 0.0033503137079616
OV ENSG00000256576 RP13-977J11.2 path:00604_1 Glycosphingolipid biosynthesis - ganglio series 9 3.8342063989555 0.000170294818471259 0.00251657898407527
OV ENSG00000256576 RP13-977J11.2 path:00670_12 One carbon pool by folate 5 -2.71912698276967 0.00704223651908822 0.0342051206268332
OV ENSG00000256576 RP13-977J11.2 path:00760_1 Nicotinate and nicotinamide metabolism 20 4.5106070675745 1.07217432492167e-05 0.000493741415377017
OV ENSG00000256576 RP13-977J11.2 path:00770_1 Pantothenate and CoA biosynthesis 6 2.6107609886297 0.00974731940190605 0.0433802889045002
OV ENSG00000256576 RP13-977J11.2 path:00830_7 Retinol metabolism 27 2.68378564544924 0.00784848963470375 0.0365653574212313
OV ENSG00000256576 RP13-977J11.2 path:00860_2 Porphyrin and chlorophyll metabolism 10 2.75285487893177 0.00646832869269434 0.0330879890818595
OV ENSG00000256576 RP13-977J11.2 path:00983_2 Drug metabolism - other enzymes 16 4.06447152706543 7.2690485995369e-05 0.00138111923391201
OV ENSG00000256576 RP13-977J11.2 path:03320_1 PPAR signaling pathway 48 -3.20931148665437 0.00155692266341446 0.0124242428540474
OV ENSG00000256576 RP13-977J11.2 path:04012_22 ErbB signaling pathway 65 -3.08865697309306 0.00220966608590916 0.0149433350555552
OV ENSG00000256576 RP13-977J11.2 path:04014_12 Ras signaling pathway 180 -3.69072970146771 0.000271703099730903 0.00338779802476969
OV ENSG00000256576 RP13-977J11.2 path:04024_125 cAMP signaling pathway 23 -4.22797789499566 3.17974352624091e-05 0.000923001976751965
OV ENSG00000256576 RP13-977J11.2 path:04062_228 Chemokine signaling pathway 13 3.00743504234665 0.003022532217686 0.0185536977670264
OV ENSG00000256576 RP13-977J11.2 path:04062_26 Chemokine signaling pathway 106 -3.24507288881208 0.00135330112390862 0.0112493155924904
OV ENSG00000256576 RP13-977J11.2 path:04062_94 Chemokine signaling pathway 51 2.60699162413058 0.00978502757244366 0.0433802889045002
OV ENSG00000256576 RP13-977J11.2 path:04064_1 NF-kappa B signaling pathway 69 3.16177648165995 0.00181412323291729 0.0139161782172068
OV ENSG00000256576 RP13-977J11.2 path:04066_94 HIF-1 signaling pathway 15 -2.64510364414812 0.00868276486678411 0.0398209561131823
OV ENSG00000256576 RP13-977J11.2 path:04070_22 Phosphatidylinositol signaling system 29 -3.65123468544539 0.00031612321344358 0.00370979888717613
OV ENSG00000256576 RP13-977J11.2 path:04140_2 Regulation of autophagy 4 -7.03512229990188 1.44626656738175e-11 5.77060360385319e-09
OV ENSG00000256576 RP13-977J11.2 path:04141_3 Protein processing in endoplasmic reticulum 20 -2.58948394204094 0.01020792131398 0.0439421889225508
OV ENSG00000256576 RP13-977J11.2 path:04145_13 Phagosome 10 -3.78477137554249 0.000197235232877645 0.00281060206850644
OV ENSG00000256576 RP13-977J11.2 path:04151_233 PI3K-Akt signaling pathway 26 2.89822209103207 0.00418285324528429 0.0236353108771237
OV ENSG00000256576 RP13-977J11.2 path:04151_67 PI3K-Akt signaling pathway 164 -3.85548716128347 0.000159554121410144 0.00244854209394799
OV ENSG00000256576 RP13-977J11.2 path:04152_50 AMPK signaling pathway 21 -5.78683233530924 2.25405184710183e-08 2.63495367125225e-06
OV ENSG00000256576 RP13-977J11.2 path:04210_36 Apoptosis 36 -2.90585710208152 0.00396254970373128 0.0232508431145409
OV ENSG00000256576 RP13-977J11.2 path:04261_51 Adrenergic signaling in cardiomyocytes 66 -4.01728219878105 8.04069868358209e-05 0.00145829035215875
OV ENSG00000256576 RP13-977J11.2 path:04310_144 Wnt signaling pathway 11 -2.58954363975762 0.0102421643353314 0.0439421889225508
OV ENSG00000256576 RP13-977J11.2 path:04330_22 Notch signaling pathway 24 -4.29866114910335 2.45854184153318e-05 0.000891780177065217
OV ENSG00000256576 RP13-977J11.2 path:04330_24 Notch signaling pathway 16 -6.23580647680062 1.82740151120049e-09 3.64566601484497e-07
OV ENSG00000256576 RP13-977J11.2 path:04360_145 Axon guidance 8 -2.78708834026281 0.00574078435929291 0.0305409727914383
OV ENSG00000256576 RP13-977J11.2 path:04370_42 VEGF signaling pathway 22 -3.35593348422674 0.000924429141504019 0.00878207684428818
OV ENSG00000256576 RP13-977J11.2 path:04370_66 VEGF signaling pathway 14 -3.2148066522002 0.0014588578479376 0.0118792710474919
OV ENSG00000256576 RP13-977J11.2 path:04510_126 Focal adhesion 38 -3.1340842325741 0.00190824075439014 0.0140997789074383
OV ENSG00000256576 RP13-977J11.2 path:04510_137 Focal adhesion 32 -3.37413405670264 0.000871094227224639 0.00847723406494221
OV ENSG00000256576 RP13-977J11.2 path:04510_283 Focal adhesion 10 -2.95803560842298 0.00340462719426181 0.0205825189471282
OV ENSG00000256576 RP13-977J11.2 path:04540_12 Gap junction 71 -2.73535497934253 0.00683929220051194 0.0341109698500533
OV ENSG00000256576 RP13-977J11.2 path:04611_279 Platelet activation 2 3.13399671342101 0.00203565705286304 0.0145040565016491
OV ENSG00000256576 RP13-977J11.2 path:04620_60 Toll-like receptor signaling pathway 22 5.29213800726849 3.27398660395715e-07 2.61264130995781e-05
OV ENSG00000256576 RP13-977J11.2 path:04620_92 Toll-like receptor signaling pathway 11 -3.71200746582972 0.000249375441301893 0.00331669336931518
OV ENSG00000256576 RP13-977J11.2 path:04621_22 NOD-like receptor signaling pathway 28 -3.60857086764186 0.000389252752450385 0.00443748137793439
OV ENSG00000256576 RP13-977J11.2 path:04650_115 Natural killer cell mediated cytotoxicity 5 3.54873396797697 0.000500092947216272 0.00554269683164701
OV ENSG00000256576 RP13-977J11.2 path:04650_139 Natural killer cell mediated cytotoxicity 2 3.03921989305843 0.00275970094307169 0.0172050105669626
OV ENSG00000256576 RP13-977J11.2 path:04664_71 Fc epsilon RI signaling pathway 10 -3.07208583952372 0.00233224744887524 0.0155094455350203
OV ENSG00000256576 RP13-977J11.2 path:04664_75 Fc epsilon RI signaling pathway 9 -3.30611910840611 0.00106966815461868 0.00986408459467898
OV ENSG00000256576 RP13-977J11.2 path:04666_244 Fc gamma R-mediated phagocytosis 7 2.62911895605521 0.00920751163599138 0.0417476948040973
OV ENSG00000256576 RP13-977J11.2 path:04720_79 Long-term potentiation 3 -2.90037845741709 0.0040549350178003 0.0234481024942365
OV ENSG00000256576 RP13-977J11.2 path:04722_7 Neurotrophin signaling pathway 107 -2.76197107945446 0.00622816862807314 0.0325222758920518
OV ENSG00000256576 RP13-977J11.2 path:04725_86 Cholinergic synapse 18 -3.67599100039595 0.000286025224134787 0.00345830498272061
OV ENSG00000256576 RP13-977J11.2 path:04742_1 Taste transduction 14 -3.46994054573377 0.000623574639644011 0.00654753371626212
OV ENSG00000256576 RP13-977J11.2 path:04810_241 Regulation of actin cytoskeleton 4 -4.45762747828286 1.23744715633338e-05 0.000493741415377017
OV ENSG00000256576 RP13-977J11.2 path:04810_68 Regulation of actin cytoskeleton 69 -4.09540409814346 5.74542697494894e-05 0.00129206777812241
OV ENSG00000256576 RP13-977J11.2 path:04916_128 Melanogenesis 6 -3.25927881778985 0.00127426759406624 0.0110528863050528
OV ENSG00000256576 RP13-977J11.2 path:04916_139 Melanogenesis 2 -3.89573352713576 0.000122479134190625 0.00203621560591915
OV ENSG00000256576 RP13-977J11.2 path:04916_75 Melanogenesis 23 -3.11081204498855 0.00211916650219375 0.0148341655153563
OV ENSG00000256576 RP13-977J11.2 path:04917_119 Prolactin signaling pathway 10 -3.18405107200329 0.00161889003193659 0.0126654337792686
OV ENSG00000256576 RP13-977J11.2 path:04919_50 Thyroid hormone signaling pathway 33 -2.84052059895758 0.00490928389588219 0.026884904723021
OV ENSG00000256576 RP13-977J11.2 path:04919_84 Thyroid hormone signaling pathway 5 -3.06230750033102 0.00243170965719621 0.0156492282777627
OV ENSG00000256576 RP13-977J11.2 path:04940_2 Type I diabetes mellitus 2 4.09543013578257 6.47653021615246e-05 0.00129206777812241
OV ENSG00000256576 RP13-977J11.2 path:04950_1 Maturity onset diabetes of the young 22 2.68826444620679 0.00788125498302228 0.0365653574212313
OV ENSG00000256576 RP13-977J11.2 path:04960_8 Aldosterone-regulated sodium reabsorption 14 -4.22271306422235 3.23860342719988e-05 0.000923001976751965
OV ENSG00000256576 RP13-977J11.2 path:04961_12 Endocrine and other factor-regulated calcium reabsorption 11 2.947913707609 0.00361363986918087 0.0215200344448234
OV ENSG00000256576 RP13-977J11.2 path:04973_1 Carbohydrate digestion and absorption 12 -3.06547149512793 0.00238689687394195 0.0156126533229973
OV ENSG00000256576 RP13-977J11.2 path:04976_8 Bile secretion 8 2.84956614951635 0.00491879209218179 0.026884904723021
OV ENSG00000256576 RP13-977J11.2 path:05132_39 Salmonella infection 8 -2.80271653500542 0.00561198225089311 0.0302592015960318
OV ENSG00000256576 RP13-977J11.2 path:05140_54 Leishmaniasis 15 3.25671596805525 0.00134342801744696 0.0112493155924904
OV ENSG00000256576 RP13-977J11.2 path:05140_84 Leishmaniasis 3 3.16161859730166 0.00184851490103249 0.0139161782172068
OV ENSG00000256576 RP13-977J11.2 path:05206_109 MicroRNAs in cancer 14 -4.93517236608292 1.36227014325145e-06 9.05909645262217e-05
OV ENSG00000256576 RP13-977J11.2 path:05206_112 MicroRNAs in cancer 11 -3.4384758457242 0.000678480463647874 0.00691605539358514
OV ENSG00000256576 RP13-977J11.2 path:05206_42 MicroRNAs in cancer 71 -2.67896362030171 0.00780823754322106 0.0365653574212313
OV ENSG00000256576 RP13-977J11.2 path:05211_9 Renal cell carcinoma 14 -2.88844814083664 0.00420578213602954 0.0236353108771237
OV ENSG00000256576 RP13-977J11.2 path:05212_61 Pancreatic cancer 2 -2.71669211678347 0.00711535090733623 0.0342051206268332
OV ENSG00000256576 RP13-977J11.2 path:05215_50 Prostate cancer 35 -4.25050649042072 2.89913785368523e-05 0.000923001976751965
OV ENSG00000256576 RP13-977J11.2 path:05215_83 Prostate cancer 9 -3.93824050496351 0.000114138181353253 0.00198004931999774
OV ENSG00000256576 RP13-977J11.2 path:05218_1 Melanoma 63 -3.49923250838646 0.000546580778167958 0.00589420893213555
OV ENSG00000256576 RP13-977J11.2 path:05221_7 Acute myeloid leukemia 49 -4.09419821046503 5.86163616341071e-05 0.00129206777812241
OV ENSG00000256576 RP13-977J11.2 path:05231_31 Choline metabolism in cancer 35 -3.43549434221425 0.000693338886574952 0.00691605539358514
OV ENSG00000256576 RP13-977J11.2 path:05231_42 Choline metabolism in cancer 26 -2.74076173027846 0.00669466969291559 0.0338123190819408
OV ENSG00000256576 RP13-977J11.2 path:05320_2 Autoimmune thyroid disease 2 4.09543013578257 6.47653021615246e-05 0.00129206777812241
OV ENSG00000256576 RP13-977J11.2 path:05330_2 Allograft rejection 2 4.09543013578257 6.47653021615246e-05 0.00129206777812241
OV ENSG00000256576 RP13-977J11.2 path:05332_5 Graft-versus-host disease 2 4.09543013578257 6.47653021615246e-05 0.00129206777812241
OV ENSG00000256576 RP13-977J11.2 path:05414_26 Dilated cardiomyopathy 6 -2.57440740773892 0.0105393114621507 0.0447360135467887
OV ENSG00000256312 RP13-977J11.8 path:00100_1 Steroid biosynthesis 13 2.60228951743014 0.0101423341141269 0.0439421889225508
OV ENSG00000256312 RP13-977J11.8 path:00120_5 Primary bile acid biosynthesis 4 4.49439405858721 1.18949012289458e-05 0.000493741415377017
OV ENSG00000256312 RP13-977J11.8 path:00140_7 Steroid hormone biosynthesis 23 2.76769479553527 0.00627622868092228 0.0325222758920518
OV ENSG00000256312 RP13-977J11.8 path:00232_1 Caffeine metabolism 3 3.14360703553865 0.00196735095988888 0.0142722369635575
OV ENSG00000256312 RP13-977J11.8 path:00270_17 Cysteine and methionine metabolism 19 -3.29862009650208 0.00111249074376079 0.00986408459467898
OV ENSG00000256312 RP13-977J11.8 path:00270_51 Cysteine and methionine metabolism 8 -2.71658678573836 0.00699408153869485 0.0342051206268332
OV ENSG00000256312 RP13-977J11.8 path:00310_9 Lysine degradation 23 -4.69372470374386 4.49441723904539e-06 0.000256181782625587
OV ENSG00000256312 RP13-977J11.8 path:00450_8 Selenocompound metabolism 3 -5.74509564341831 2.64155756516516e-08 2.63495367125225e-06
OV ENSG00000256312 RP13-977J11.8 path:00562_2 Inositol phosphate metabolism 44 -3.09659161157344 0.00218487962452119 0.0149433350555552
OV ENSG00000256312 RP13-977J11.8 path:00562_70 Inositol phosphate metabolism 7 -3.84359974216614 0.000150452648245952 0.00240122426600539
OV ENSG00000256312 RP13-977J11.8 path:00565_22 Ether lipid metabolism 13 3.0455283758664 0.00273674122345334 0.0172050105669626
OV ENSG00000256312 RP13-977J11.8 path:00591_12 Linoleic acid metabolism 16 3.32911675328674 0.00109197521912744 0.00986408459467898
OV ENSG00000256312 RP13-977J11.8 path:00601_16 Glycosphingolipid biosynthesis - lacto and neolacto series 12 3.73687518456696 0.000247540350594157 0.00331669336931518
OV ENSG00000256312 RP13-977J11.8 path:00603_1 Glycosphingolipid biosynthesis - globo series 9 3.70664880993929 0.000260300062523332 0.0033503137079616
OV ENSG00000256312 RP13-977J11.8 path:00604_1 Glycosphingolipid biosynthesis - ganglio series 9 3.8342063989555 0.000170294818471259 0.00251657898407527
OV ENSG00000256312 RP13-977J11.8 path:00670_12 One carbon pool by folate 5 -2.71912698276967 0.00704223651908822 0.0342051206268332
OV ENSG00000256312 RP13-977J11.8 path:00760_1 Nicotinate and nicotinamide metabolism 20 4.5106070675745 1.07217432492167e-05 0.000493741415377017
OV ENSG00000256312 RP13-977J11.8 path:00770_1 Pantothenate and CoA biosynthesis 6 2.6107609886297 0.00974731940190605 0.0433802889045002
OV ENSG00000256312 RP13-977J11.8 path:00830_7 Retinol metabolism 27 2.68378564544924 0.00784848963470375 0.0365653574212313
OV ENSG00000256312 RP13-977J11.8 path:00860_2 Porphyrin and chlorophyll metabolism 10 2.75285487893177 0.00646832869269434 0.0330879890818595
OV ENSG00000256312 RP13-977J11.8 path:00983_2 Drug metabolism - other enzymes 16 4.06447152706543 7.2690485995369e-05 0.00138111923391201
OV ENSG00000256312 RP13-977J11.8 path:03320_1 PPAR signaling pathway 48 -3.20931148665437 0.00155692266341446 0.0124242428540474
OV ENSG00000256312 RP13-977J11.8 path:04012_22 ErbB signaling pathway 65 -3.08865697309306 0.00220966608590916 0.0149433350555552
OV ENSG00000256312 RP13-977J11.8 path:04014_12 Ras signaling pathway 180 -3.69072970146771 0.000271703099730903 0.00338779802476969
OV ENSG00000256312 RP13-977J11.8 path:04024_125 cAMP signaling pathway 23 -4.22797789499566 3.17974352624091e-05 0.000923001976751965
OV ENSG00000256312 RP13-977J11.8 path:04062_228 Chemokine signaling pathway 13 3.00743504234665 0.003022532217686 0.0185536977670264
OV ENSG00000256312 RP13-977J11.8 path:04062_26 Chemokine signaling pathway 106 -3.24507288881208 0.00135330112390862 0.0112493155924904
OV ENSG00000256312 RP13-977J11.8 path:04062_94 Chemokine signaling pathway 51 2.60699162413058 0.00978502757244366 0.0433802889045002
OV ENSG00000256312 RP13-977J11.8 path:04064_1 NF-kappa B signaling pathway 69 3.16177648165995 0.00181412323291729 0.0139161782172068
OV ENSG00000256312 RP13-977J11.8 path:04066_94 HIF-1 signaling pathway 15 -2.64510364414812 0.00868276486678411 0.0398209561131823
OV ENSG00000256312 RP13-977J11.8 path:04070_22 Phosphatidylinositol signaling system 29 -3.65123468544539 0.00031612321344358 0.00370979888717613
OV ENSG00000256312 RP13-977J11.8 path:04140_2 Regulation of autophagy 4 -7.03512229990188 1.44626656738175e-11 5.77060360385319e-09
OV ENSG00000256312 RP13-977J11.8 path:04141_3 Protein processing in endoplasmic reticulum 20 -2.58948394204094 0.01020792131398 0.0439421889225508
OV ENSG00000256312 RP13-977J11.8 path:04145_13 Phagosome 10 -3.78477137554249 0.000197235232877645 0.00281060206850644
OV ENSG00000256312 RP13-977J11.8 path:04151_233 PI3K-Akt signaling pathway 26 2.89822209103207 0.00418285324528429 0.0236353108771237
OV ENSG00000256312 RP13-977J11.8 path:04151_67 PI3K-Akt signaling pathway 164 -3.85548716128347 0.000159554121410144 0.00244854209394799
OV ENSG00000256312 RP13-977J11.8 path:04152_50 AMPK signaling pathway 21 -5.78683233530924 2.25405184710183e-08 2.63495367125225e-06
OV ENSG00000256312 RP13-977J11.8 path:04210_36 Apoptosis 36 -2.90585710208152 0.00396254970373128 0.0232508431145409
OV ENSG00000256312 RP13-977J11.8 path:04261_51 Adrenergic signaling in cardiomyocytes 66 -4.01728219878105 8.04069868358209e-05 0.00145829035215875
OV ENSG00000256312 RP13-977J11.8 path:04310_144 Wnt signaling pathway 11 -2.58954363975762 0.0102421643353314 0.0439421889225508
OV ENSG00000256312 RP13-977J11.8 path:04330_22 Notch signaling pathway 24 -4.29866114910335 2.45854184153318e-05 0.000891780177065217
OV ENSG00000256312 RP13-977J11.8 path:04330_24 Notch signaling pathway 16 -6.23580647680062 1.82740151120049e-09 3.64566601484497e-07
OV ENSG00000256312 RP13-977J11.8 path:04360_145 Axon guidance 8 -2.78708834026281 0.00574078435929291 0.0305409727914383
OV ENSG00000256312 RP13-977J11.8 path:04370_42 VEGF signaling pathway 22 -3.35593348422674 0.000924429141504019 0.00878207684428818
OV ENSG00000256312 RP13-977J11.8 path:04370_66 VEGF signaling pathway 14 -3.2148066522002 0.0014588578479376 0.0118792710474919
OV ENSG00000256312 RP13-977J11.8 path:04510_126 Focal adhesion 38 -3.1340842325741 0.00190824075439014 0.0140997789074383
OV ENSG00000256312 RP13-977J11.8 path:04510_137 Focal adhesion 32 -3.37413405670264 0.000871094227224639 0.00847723406494221
OV ENSG00000256312 RP13-977J11.8 path:04510_283 Focal adhesion 10 -2.95803560842298 0.00340462719426181 0.0205825189471282
OV ENSG00000256312 RP13-977J11.8 path:04540_12 Gap junction 71 -2.73535497934253 0.00683929220051194 0.0341109698500533
OV ENSG00000256312 RP13-977J11.8 path:04611_279 Platelet activation 2 3.13399671342101 0.00203565705286304 0.0145040565016491
OV ENSG00000256312 RP13-977J11.8 path:04620_60 Toll-like receptor signaling pathway 22 5.29213800726849 3.27398660395715e-07 2.61264130995781e-05
OV ENSG00000256312 RP13-977J11.8 path:04620_92 Toll-like receptor signaling pathway 11 -3.71200746582972 0.000249375441301893 0.00331669336931518
OV ENSG00000256312 RP13-977J11.8 path:04621_22 NOD-like receptor signaling pathway 28 -3.60857086764186 0.000389252752450385 0.00443748137793439
OV ENSG00000256312 RP13-977J11.8 path:04650_115 Natural killer cell mediated cytotoxicity 5 3.54873396797697 0.000500092947216272 0.00554269683164701
OV ENSG00000256312 RP13-977J11.8 path:04650_139 Natural killer cell mediated cytotoxicity 2 3.03921989305843 0.00275970094307169 0.0172050105669626
OV ENSG00000256312 RP13-977J11.8 path:04664_71 Fc epsilon RI signaling pathway 10 -3.07208583952372 0.00233224744887524 0.0155094455350203
OV ENSG00000256312 RP13-977J11.8 path:04664_75 Fc epsilon RI signaling pathway 9 -3.30611910840611 0.00106966815461868 0.00986408459467898
OV ENSG00000256312 RP13-977J11.8 path:04666_244 Fc gamma R-mediated phagocytosis 7 2.62911895605521 0.00920751163599138 0.0417476948040973
OV ENSG00000256312 RP13-977J11.8 path:04720_79 Long-term potentiation 3 -2.90037845741709 0.0040549350178003 0.0234481024942365
OV ENSG00000256312 RP13-977J11.8 path:04722_7 Neurotrophin signaling pathway 107 -2.76197107945446 0.00622816862807314 0.0325222758920518
OV ENSG00000256312 RP13-977J11.8 path:04725_86 Cholinergic synapse 18 -3.67599100039595 0.000286025224134787 0.00345830498272061
OV ENSG00000256312 RP13-977J11.8 path:04742_1 Taste transduction 14 -3.46994054573377 0.000623574639644011 0.00654753371626212
OV ENSG00000256312 RP13-977J11.8 path:04810_241 Regulation of actin cytoskeleton 4 -4.45762747828286 1.23744715633338e-05 0.000493741415377017
OV ENSG00000256312 RP13-977J11.8 path:04810_68 Regulation of actin cytoskeleton 69 -4.09540409814346 5.74542697494894e-05 0.00129206777812241
OV ENSG00000256312 RP13-977J11.8 path:04916_128 Melanogenesis 6 -3.25927881778985 0.00127426759406624 0.0110528863050528
OV ENSG00000256312 RP13-977J11.8 path:04916_139 Melanogenesis 2 -3.89573352713576 0.000122479134190625 0.00203621560591915
OV ENSG00000256312 RP13-977J11.8 path:04916_75 Melanogenesis 23 -3.11081204498855 0.00211916650219375 0.0148341655153563
OV ENSG00000256312 RP13-977J11.8 path:04917_119 Prolactin signaling pathway 10 -3.18405107200329 0.00161889003193659 0.0126654337792686
OV ENSG00000256312 RP13-977J11.8 path:04919_50 Thyroid hormone signaling pathway 33 -2.84052059895758 0.00490928389588219 0.026884904723021
OV ENSG00000256312 RP13-977J11.8 path:04919_84 Thyroid hormone signaling pathway 5 -3.06230750033102 0.00243170965719621 0.0156492282777627
OV ENSG00000256312 RP13-977J11.8 path:04940_2 Type I diabetes mellitus 2 4.09543013578257 6.47653021615246e-05 0.00129206777812241
OV ENSG00000256312 RP13-977J11.8 path:04950_1 Maturity onset diabetes of the young 22 2.68826444620679 0.00788125498302228 0.0365653574212313
OV ENSG00000256312 RP13-977J11.8 path:04960_8 Aldosterone-regulated sodium reabsorption 14 -4.22271306422235 3.23860342719988e-05 0.000923001976751965
OV ENSG00000256312 RP13-977J11.8 path:04961_12 Endocrine and other factor-regulated calcium reabsorption 11 2.947913707609 0.00361363986918087 0.0215200344448234
OV ENSG00000256312 RP13-977J11.8 path:04973_1 Carbohydrate digestion and absorption 12 -3.06547149512793 0.00238689687394195 0.0156126533229973
OV ENSG00000256312 RP13-977J11.8 path:04976_8 Bile secretion 8 2.84956614951635 0.00491879209218179 0.026884904723021
OV ENSG00000256312 RP13-977J11.8 path:05132_39 Salmonella infection 8 -2.80271653500542 0.00561198225089311 0.0302592015960318
OV ENSG00000256312 RP13-977J11.8 path:05140_54 Leishmaniasis 15 3.25671596805525 0.00134342801744696 0.0112493155924904
OV ENSG00000256312 RP13-977J11.8 path:05140_84 Leishmaniasis 3 3.16161859730166 0.00184851490103249 0.0139161782172068
OV ENSG00000256312 RP13-977J11.8 path:05206_109 MicroRNAs in cancer 14 -4.93517236608292 1.36227014325145e-06 9.05909645262217e-05
OV ENSG00000256312 RP13-977J11.8 path:05206_112 MicroRNAs in cancer 11 -3.4384758457242 0.000678480463647874 0.00691605539358514
OV ENSG00000256312 RP13-977J11.8 path:05206_42 MicroRNAs in cancer 71 -2.67896362030171 0.00780823754322106 0.0365653574212313
OV ENSG00000256312 RP13-977J11.8 path:05211_9 Renal cell carcinoma 14 -2.88844814083664 0.00420578213602954 0.0236353108771237
OV ENSG00000256312 RP13-977J11.8 path:05212_61 Pancreatic cancer 2 -2.71669211678347 0.00711535090733623 0.0342051206268332
OV ENSG00000256312 RP13-977J11.8 path:05215_50 Prostate cancer 35 -4.25050649042072 2.89913785368523e-05 0.000923001976751965
OV ENSG00000256312 RP13-977J11.8 path:05215_83 Prostate cancer 9 -3.93824050496351 0.000114138181353253 0.00198004931999774
OV ENSG00000256312 RP13-977J11.8 path:05218_1 Melanoma 63 -3.49923250838646 0.000546580778167958 0.00589420893213555
OV ENSG00000256312 RP13-977J11.8 path:05221_7 Acute myeloid leukemia 49 -4.09419821046503 5.86163616341071e-05 0.00129206777812241
OV ENSG00000256312 RP13-977J11.8 path:05231_31 Choline metabolism in cancer 35 -3.43549434221425 0.000693338886574952 0.00691605539358514
OV ENSG00000256312 RP13-977J11.8 path:05231_42 Choline metabolism in cancer 26 -2.74076173027846 0.00669466969291559 0.0338123190819408
OV ENSG00000256312 RP13-977J11.8 path:05320_2 Autoimmune thyroid disease 2 4.09543013578257 6.47653021615246e-05 0.00129206777812241
OV ENSG00000256312 RP13-977J11.8 path:05330_2 Allograft rejection 2 4.09543013578257 6.47653021615246e-05 0.00129206777812241
OV ENSG00000256312 RP13-977J11.8 path:05332_5 Graft-versus-host disease 2 4.09543013578257 6.47653021615246e-05 0.00129206777812241
OV ENSG00000256312 RP13-977J11.8 path:05414_26 Dilated cardiomyopathy 6 -2.57440740773892 0.0105393114621507 0.0447360135467887
OV ENSG00000235994 RP3-470B24.5 path:00120_6 Primary bile acid biosynthesis 3 3.18535658928001 0.00165788465840394 0.0309543292303518
OV ENSG00000235994 RP3-470B24.5 path:00330_90 Arginine and proline metabolism 6 3.96375495313566 9.42295561785887e-05 0.00694680101925293
OV ENSG00000235994 RP3-470B24.5 path:00561_55 Glycerolipid metabolism 7 3.42911855411097 0.000710060255826291 0.0176031602709445
OV ENSG00000235994 RP3-470B24.5 path:00565_8 Ether lipid metabolism 23 -3.13878614893191 0.00206304046816838 0.0348997679198484
OV ENSG00000235994 RP3-470B24.5 path:00760_14 Nicotinate and nicotinamide metabolism 15 3.04874989841356 0.00256092170374297 0.0399897773738325
OV ENSG00000235994 RP3-470B24.5 path:00983_2 Drug metabolism - other enzymes 16 3.00219547419417 0.00294155179202089 0.0442322232429807
OV ENSG00000235994 RP3-470B24.5 path:04068_37 FoxO signaling pathway 42 -4.80612289700125 3.2769338922829e-06 0.000665217580133429
OV ENSG00000235994 RP3-470B24.5 path:04140_1 Regulation of autophagy 10 -3.5047474955029 0.000562082204905186 0.0166030394707407
OV ENSG00000235994 RP3-470B24.5 path:04330_24 Notch signaling pathway 16 -3.5219030469935 0.000534233572296435 0.0166030394707407
OV ENSG00000235994 RP3-470B24.5 path:04360_145 Axon guidance 8 -3.18109905200329 0.00168047022364146 0.0309543292303518
OV ENSG00000235994 RP3-470B24.5 path:04510_310 Focal adhesion 7 -4.04510021824649 7.2690942738889e-05 0.00694680101925293
OV ENSG00000235994 RP3-470B24.5 path:04510_63 Focal adhesion 76 -3.18550052112093 0.00175357037511845 0.0309543292303518
OV ENSG00000235994 RP3-470B24.5 path:04550_2 Signaling pathways regulating pluripotency of stem cells 91 -3.41493390716594 0.00078043567703695 0.0176031602709445
OV ENSG00000235994 RP3-470B24.5 path:04621_50 NOD-like receptor signaling pathway 7 -6.92752096188275 5.40021786737194e-11 2.19248845415301e-08
OV ENSG00000235994 RP3-470B24.5 path:04623_19 Cytosolic DNA-sensing pathway 3 3.10218079489719 0.00216248720607672 0.035118792226686
OV ENSG00000235994 RP3-470B24.5 path:04666_159 Fc gamma R-mediated phagocytosis 19 -3.52129249322459 0.000550530934565086 0.0166030394707407
OV ENSG00000235994 RP3-470B24.5 path:04670_105 Leukocyte transendothelial migration 16 3.23861546253146 0.00135832133437783 0.02757392308787
OV ENSG00000235994 RP3-470B24.5 path:04670_163 Leukocyte transendothelial migration 4 -3.7922983342269 0.000198174702130028 0.0112077821550028
OV ENSG00000235994 RP3-470B24.5 path:04720_55 Long-term potentiation 18 4.19011622680633 3.72788790685877e-05 0.0050450749672822
OV ENSG00000235994 RP3-470B24.5 path:04723_39 Retrograde endocannabinoid signaling 14 3.65238104851373 0.000318443128835207 0.0143653233674549
OV ENSG00000235994 RP3-470B24.5 path:04932_84 Non-alcoholic fatty liver disease (NAFLD) 11 -3.47733475662725 0.000613412788327859 0.0166030394707407
OV ENSG00000235994 RP3-470B24.5 path:05033_8 Nicotine addiction 9 3.29797181356696 0.00111366369926839 0.0237972348369983
OV ENSG00000235994 RP3-470B24.5 path:05131_27 Shigellosis 2 -3.49264909618988 0.000574812339876785 0.0166030394707407
OV ENSG00000235994 RP3-470B24.5 path:05143_1 African trypanosomiasis 9 3.95180282508953 0.000102662084028368 0.00694680101925293
OV ENSG00000235994 RP3-470B24.5 path:05206_22 MicroRNAs in cancer 98 -3.78291492791227 0.000220842998128135 0.0112077821550028
OV ENSG00000235994 RP3-470B24.5 path:05211_17 Renal cell carcinoma 6 -3.59136233410258 0.00040762955968946 0.0165497601233921
OV ENSG00000235994 RP3-470B24.5 path:05212_5 Pancreatic cancer 46 -3.43821231229403 0.000772283036547218 0.0176031602709445
OV ENSG00000223662 SAMSN1-AS1 path:00260_35 Glycine, serine and threonine metabolism 13 -3.58588815995581 0.000413622153628066 0.0322747459852298
OV ENSG00000223662 SAMSN1-AS1 path:00600_74 Sphingolipid metabolism 2 3.59058732355848 0.000433800349263842 0.0322747459852298
OV ENSG00000223662 SAMSN1-AS1 path:04062_310 Chemokine signaling pathway 4 -4.02478841266637 8.00015795294442e-05 0.0297605875849532
OV ENSG00000223662 SAMSN1-AS1 path:04670_125 Leukocyte transendothelial migration 11 -3.6959935788423 0.000280371682664696 0.0322747459852298
OV ENSG00000223662 SAMSN1-AS1 path:05210_31 Colorectal cancer 8 -3.61199928282746 0.000381481715474208 0.0322747459852298